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Summary  
 
Socioeconomic deprivation (SED) is inversely associated with mortality. The most 
deprived are at a higher risk of all cause mortality and cardiovascular mortality. However, 
only limited study of the relationship between SED and non-fatal cardiovascular disease 
has been previously undertaken. In those studies that have examined the relationship 
between SED and non-fatal cardiovascular disease, analyses have been limited to one form 
of cardiovascular disease (CVD), such as myocardial infarction or stroke and often 
prevalent disease. Furthermore, these studies have often failed to examine the association 
between SED and CVD whilst adjusting analyses for cardiovascular risk factors which are 
more prevalent in the most deprived. The aim of this work was to examine the association 
between SED and a number of cardiovascular outcomes after adjusting for the traditional 
cardiovascular risk factors of age, sex, smoking, blood pressure, diabetes mellitus and 
cholesterol. To determine is SED is in fact a risk factor for CVD after adjustment for these 
other risk factors, the relationship between SED and a number of fatal and non-fatal 
cardiovascular outcomes was examined. A number of forms of CVD were examined, 
including all coronary heart disease, myocardial infarction, stroke and heart failure 
A cohort of over 15,000 men and women who participated in the Renfrew Paisley cohort 
study was examined. These individuals were enrolled between 1974 and 1976 and 
underwent comprehensive screening for cardiorespiratory risk factors. They have since 
been followed for hospitalisations and deaths for 28 years. SED was measured using the 
Registrar General’s social class system and the Carstairs Morris index of deprivation. 
Rates of fatal and non-fatal outcomes were calculated, as were a number of composite 
outcomes. Adjusted analyses using multivariable regression were conducted to account for 
the risk factors of age, sex, smoking, blood pressure, diabetes and cholesterol. Further 
adjustment for the risk factors of lung function as measured by forced expiratory volume in 
1 second, cardiomegaly on chest x-ray, body mass index, and a history of bronchitis was 
also made. The association between SED and the risk of recurrent cardiovascular 
hospitalisations, the burden of cardiovascular disease, as well as mortality and premature 
mortality was assessed for SED.  
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I found that SED was associated with higher rates of hospitalisation for CVD disease in 
men and women irrespective of the measure of SED, either social class or the area based 
score of the Carstairs Morris index. This association persisted after adjustment for the 
traditional cardiovascular risk factors of age, sex, smoking, systolic blood pressure and 
diabetes and cholesterol. Further adjustment for lung function, the presence of bronchitis, 
body mass index and cardiomegaly on a chest x-ray did not explain the relationship 
between SED and each outcome. This risk was long lasting and persisted to the end of 
follow up. The strength of association of SED with coronary heart disease, myocardial 
infarction and stroke and all cause mortality was similar.  
The risk of a recurrent CVD hospitalisation was not higher in the most deprived after 
adjustment for CVD risk factors. However, I observed that SED was associated with 
higher mortality following an admission to hospital with CVD, before and after adjustment 
for cardiovascular risk factors of age, sex, smoking, systolic blood pressure, cholesterol 
and diabetes and after adjusting for the year of first developing cardiovascular disease.  
All cause mortality and cardiovascular mortality was highest in the most deprived. Again 
this association persisted after adjustment for cardiovascular risk factors. The most 
deprived also experienced longer hospital stays than the least deprived for a number of 
cardiovascular diseases including myocardial infarction and stroke. As a result the costs 
associated with cardiovascular disease admissions to hospital were highest in the most 
deprived despite their higher risk of dying during follow up. The cost differential was also 
explained by the finding that the most deprived experienced a higher number of admissions 
per person. Finally, the population attributable risk associated with SED is comparable to 
that of other traditional cardiovascular risk factors.  
In conclusion, I have found that the risk of CVD in the most deprived is higher even after 
adjustment for a number of cardiovascular risk factors. The numbers of hospitalisations, 
costs and mortality are also highest in the most deprived. Efforts are required to redress 
this imbalance. This can be achieved at the level of the individual through health care 
interventions to reduce the absolute burden of cardiovascular risk factors and to treat 
disease. However, societal level interventions are also required to tackle this problem as 
SED exerts complex effects on health that seem to also be independent of risk factors.  4 
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Introduction 
This thesis will examine the relationship between socioeconomic deprivation and 
cardiovascular disease. It will review the published literature surrounding this topic and 
will report the results of a number of studies examining the relationship between 
socioeconomic deprivation (SED) and cardiovascular disease (CVD) occurring in a cohort 
of men and women in the west of Scotland followed for over 25 years.  
In the first section I will review the principles behind the measurement of socioeconomic 
deprivation before moving on to describe the literature relating SED to health and well-
being in Scotland, and the UK. The next section will describe the literature that has 
examined the association between SED and cardiovascular outcomes, highlighting the 
deficiencies in the literature that underlie the need for these analyses. Following from this I 
will state the aims and objectives of this thesis. I will then describe in detail the cohort 
studied in these analyses and some of the general statistical methods used to analyse the 
data. The subsequent chapters will present the results of the analyses performed which 
have examined the association between SED and CVD. I will present the results of 
analyses that have examined the association with a first non-fatal CVD hospitalisation and 
a number of composite outcomes, the impact of SED on recurrent hospitalisations and 
subsequent cardiovascular and all cause mortality and finally the burden of disease, 
including the numbers of CVD admissions, length of stay and health care costs. In each of 
the analyses a number of the major forms of CVD will be examined including all coronary 
heart disease, myocardial infarction, stroke and heart failure. 
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Socioeconomic Deprivation 
Measurement and definition of socioeconomic 
deprivation 
The literature surrounding the concept of socioeconomic status or deprivation is almost 
immeasurable and many concepts and terms are still open to debate and outside the scope 
of this thesis.
1 For example, multiple terms are used to describe the concept of social status 
from “social class”, “social inequality”, “socioeconomic position” and “socioeconomic 
deprivation” with each having theoretical advantages. For consistency I will refer to 
socioeconomic deprivation (SED) throughout this thesis. This can be measured by a 
number of different methods. It is often defined on an individual level using measures such 
as income, education and occupation. Each measure has its own advantages and 
disadvantages; however, comparing measures between different countries and cultures is 
often difficult as levels or scores are country or culturally specific. In addition, individual 
measures of SED may not account for the other contextual effects that poverty and the 
environment impart on an individual. As these are much harder to quantify than individual 
measures such as income, a number of different scoring systems have been developed. I 
will discuss below the theory and use of two measures of SED that I will utilise in the 
studies that I have conducted and note some of the other measures commonly encountered 
in the literature surrounding SED and CVD.  
Theoretical background to the measurement of 
socioeconomic deprivation 
Before discussing the methods by which SED can be measured in the literature it is 
important to assess the broad concepts underlying the measurement of SED. Societies are 
complex systems and social stratification is an important mechanism by which societal 
resources and goods are distributed and accumulated over time by different members of a 
population. Different measures of SED capture different aspects of social stratification. 
Each measure may be more or less related to different health outcomes and may also be 
related to health at different stages of life. For example, social class as defined by parental 
occupation is more likely to reflect social circumstances in childhood than late adulthood. 
Most indicators are correlated with each other to some degree because they all measure 
some aspect of a population’s underlying socioeconomic stratification.   
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The full theoretical and historical background of social theory is too large to summarise 
here but has been reviewed by other authors.
2 Two social theorists have informed much of 
the thinking around social stratification and the concepts which have led to different 
measures of SED.
3 The first is Karl Marx. Marxist theory defines social position as a 
structural relation between groups in a society based upon the production and ownership of 
material goods. This is based on how the owning classes exploit the non-owning classes in 
a society. The theory is underpinned by the inherent conflict in a society between the 
exploited workers and the exploiting capitalists. Therefore, in this view of SED the 
relationship is not a feature of the individual per se but of the inherent social system of the 
few exploiting the many.  
Max Weber is credited with the other major theory of SED. Weber suggested that a society 
is stratified through many dimensions. This creates groups of individuals who share a 
common position within a society and therefore share the same “life chances”. Their life 
chances are created by a common ability to beneficially use or trade their education, skills 
and attributes in the marketplace of their society. Thus, Weberian theory leads to the use of 
education, occupation and income as measures of these aspects. Weber, in contrast to 
Marx, therefore places more emphasis on the individual’s ability to change life 
circumstances as opposed to the inherent flaws in a society that Marx proposed, over 
which an individual had little influence.  
Occupation based measures 
Occupation based indicators of SED are widely used and are perhaps the most commonly 
understood method of assessing SED.
3,4 Occupation can represent SED by reflecting a 
person’s place in society in relation to their social standing, income and intellect. It can 
also characterise working relations between employers and employees. Most studies use 
the current or longest held occupation of a person to assign an individual’s SED. 
Occupational measures based on one individual are often used to define the social position 
of those around them. For example, the occupation of the ‘‘head of the household’’ can be 
used as an indicator of the SED of dependants (the most common situation is that of the 
husband’s occupation being used to define the social position of his wife and children) or 
the household as an entirety. A number of general mechanisms may explain the relation 
between occupation and health outcomes. Occupation is strongly related to income, and 
therefore, the association with health may be one of a direct relation between material 
resources and health. Alternatively, occupation may reflect social standing and be related  
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to outcomes because of the privileges that it brings, for example better access to health 
care, access to education, and so on. Occupation may also reflect social networks, stress at 
work, level of control, and autonomy and thereby affect health outcomes through a 
psychosocial process. Finally, occupation may reflect specific toxic environmental or work 
related exposures, for example, environmental smoke. 
A particular strength of this measure of SED is its availability in routine data sources, such 
as the census and death certificates. A limitation of occupational indicators is that they 
cannot be readily assigned to people who are not currently employed such as housewives. 
As a result, if used as the only source of information on SED, socioeconomic differentials 
may be underestimated through the exclusion of some of the population.
4  
In the UK, social class was measured according to industry as early as 1851. In 1911 the 
Registrar’s General’s annual report differentiated occupation and industry with a summary 
of occupations representing ‘‘social grades’’.
5 This scale is based on the prestige or social 
standing that a particular occupation has in our society. In 1990 it was revised to take into 
account more explicitly the skills needed to perform a particular occupation.  
In the Registrar General’s social class scheme, occupations are divided into six classes 
(Table 1), ranked from highest, to lowest, on the basis of prestige.
6 The table is also 
divided into two broad categories, manual and non-manual occupations. The seventh 
category of all people in the armed forces (irrespective of their rank), is generally excluded 
in health studies.  
Table 1 Registrar General’s Social Class scheme 
Grade   Example Occupations   
I Professional  Doctor, Lawyer, Executive 
II Intermediate  Sales Manager, Teacher 
III-N Skilled non-
manual 
Shop Assistant, Clerk 
Non-Manual 
III-M Skilled manual  Machinist, Brick layer 
IV Partly skilled  Postman,  
V Unskilled  Labourer, Porters 
Manual 
VI Armed forces     
 
The strength of this measure is its past official status in the UK and hence its widespread 
use in central statistics, as well as a number of censuses and surveys. It has been adapted 
and used in other countries, making comparability between studies easier. However, its 
subjective basis is a limitation. Furthermore, it does not account for recent changes in the 
occupational structure of society. There has been an increase in service jobs and a decrease  
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in unskilled and semi-skilled manual occupations. To redress these difficulties, since 2000, 
the Office for National Statistics in the UK has used the new UK National Statistics 
socioeconomic classification as its official occupation classification. Despite these issues 
the Registrar General’s social class system has been, and continues to be, widely used.  
Other occupation based measures are available. For example the Erikson and Goldthorpe 
Class Schema was devised to allow international comparisons to be more easily made. It 
has been used in some studies.
7 However, it does not have an implicit hierarchical rank and 
therefore may not capture gradients in risk across its groups. A Marxist view of occupation 
underlies the classification system of Wright, which has also been adapted.
8 It explains 
differences in outcomes across groups in terms of exploitation and conflict between the 
classes (capitalists, petty bourgeoisie and self-employed). This is an underused scheme 
though has been applied in the UK.
9 Other scores or measures of occupation include the 
Duncan socioeconomic index, and, the Cambridge social interaction and stratification 
scale.
4 Again, these scores are relatively underutilised in the health care literature 
especially with respect to CVD.  
Area level measures and indices of socioeconomic 
deprivation 
Area level indicators are also used as measures of SED. These are commonly aggregated 
from individual level or small area data, usually from census or other data sources.
4 They 
can be used to define areas as deprived, or affluent, and consequently are used as a marker 
of SED for the people living in those areas. A number of area level measures of SED, also 
often referred to as indices of deprivation, have been developed. I will discuss the index 
utilised in these analyses, but also highlight some of the other commonly used scoring 
systems. 
The Carstairs Morris deprivation index  
The Carstairs-Morris deprivation index is an area based risk score.
10 This index, based on 
official Scottish-wide census data, is used to rank postcodes of residence into seven 
deprivation categories. The geographical areas are based on postcode sectors – that is areas 
with identical postcodes except from the last two characters (e.g. ‘G84 9_ _’ omitting the 
last two letters of the postcode). There are almost 1,000 postcode sectors in Scotland, with 
an average population of around 5,000. The index was originally developed in the 1980s  
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using 1981 census data. It is composed of four indicators which were judged to represent 
disadvantage in the population. The four indicators are combined to create a composite 
score. The deprivation score is divided into seven separate categories, ranging from the 
most deprived (category 7) to the least deprived (category 1). The seven categories were 
designed so as to retain the discriminatory features of the distribution of the deprivation 
score, rather than to ensure equality of numbers between each deprivation category.
11 
Some very small postcode sectors were excluded and do not have a score. The index was 
designed with the expectation that it would be mirrored by direct measurement of 
household income if that were possible.
10 
The four variables measured were: 
1.  The degree of overcrowding:  
This was defined as the number of persons in private households living at a 
density of more than one person per room as a proportion of all persons in 
private households  
2.  Level of Male unemployment 
This is the proportion of economically active males who are seeking work in 
that postcode sector. 
3.  Proportion in Social class IV or V 
This is the proportion of all persons in private households where the head of 
household was deemed to be in social class IV or V according to the Registrar 
General’s social class scheme outlined previously. 
4.  Ownership of a car 
The proportion of all persons in private households with no car  
All the proportions are calculated using the households in a given postcode sector.  
As suggested by the above, area based indicators account for the socioeconomic conditions 
of an area, and therefore can have an independent influence on health. Recently, the 
concept that over and above individual characteristics, the place where a person lives can  
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affect their health, has received more attention. The place where a person lives can be 
defined as a neighbourhood, a city, region, or country. Studies that have investigated ‘‘area 
effects’’ tend to find smaller associations relative to the size of individual SED effects. It is 
unclear if the association between area level measures of socioeconomic circumstances, 
and health outcomes, are related to the socioeconomic characteristics of where people live 
independently of the (lifetime) characteristics of the people living in these areas.
4 One 
difficulty in disentangling this question is that area based measures are often based on 
individual level data. One disadvantage of area measures is that they are often used as 
proxies for individual level indicators when these are not available. In such a situation, 
given the misclassification of individual socioeconomic circumstances when measured by 
area characteristics, the association with a disease is likely to be underestimated. The larger 
the areas the greater the misclassification will be. In my analyses I will utilise both the 
Carstairs Morris index and occupational social class to minimise this misclassification. 
Before discussing other measures of SED it is worth noting that the Carstairs Morris index  
is not the only area based measure available. The Townsend deprivation index
12, Jarman or 
Underprivileged area score
13 are conceptually similar to the Carstairs score. They are area 
based scores constructed from census variables that are similar to the Carstairs score. For 
example, the Townsend index uses four variables, the proportion of unemployment 
amongst the ages of 16-64, proportion of non-owner occupied households, car ownership 
and overcrowding. The Breadline Britain Index is slightly different in that it includes 
variables such as proportion of individuals with long term illness and lone parent 
households.
14 These other area based measures have been used in the literature surrounding 
SED and CVD. In particular, the Townsend deprivation index is commonly used in studies 
based in England. However, despite their differences, all of these area based scores share 
the same limitations as the Carstairs Morris index with respect to misclassification and 
potential difficulties in extrapolating results to the level of the individual.  
Other measures of socioeconomic deprivation  
Other measures of SED are used by researchers, particularly in the field of cardiovascular 
disease. The most common of these are income and level of education. As these will not be 
utilised in the analyses conducted during this thesis they are discussed here in brief, 
however, they are worthy of note due to their widespread use in the cardiovascular 
literature. They have been used in multiple prior studies of the relationship between SED 
and cardiovascular disease particularly in North America.   
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Income enables an individual to purchase goods and services, such as education and health 
care, which may impact on health. Income also allows individuals to purchase items such 
as better food and shelter. It may also be beneficial through the purchase of material goods 
relevant to participation in a society, thus fostering higher self esteem in an individual, an 
example would be membership of a social group such as a sports club.
4 Income has 
limitations as a measure. Poor health may lead to an inability to work and lower income 
which may lead to reverse causality in epidemiological studies. However, the measurement 
of income is complex as individual or family income can be measured. Income may be 
adjusted for family size. Income can also come from other sources. For example, income 
can contribute to wealth over and above the primary wage in the house, through non-
monetary income such as benefits, and, an account of tax relief measures enjoyed by an 
individual may need to be included to fully determine income. One final limitation of 
income as a measure of SED is the high rates of non-response in relation to income related 
questions, which is reported at approximately 10%. Income is particularly favoured as a 
measure of SED in North America as the health care system is not a universal access for all 
system such as the National Health Service (NHS) in the UK, therefore, the treatment an 
individual receives may be directly related to their ability to pay for access to health care 
services.  
Education is a widely used measure of SED in epidemiological studies.
4 Questions on 
educational attainment have very low rates of non-response in comparison to those on 
income and questions are rarely complex. Education may also reflect future employment 
and income. As level of education is fixed after young adulthood it is not influenced by 
poor health in adulthood, as income may be, and therefore, is not likely to lead to reverse 
causality. However, poor health in childhood may lead to lower educational attainment. 
This is not the only limitation of education. There are differences between birth cohorts in 
level of education, so that the resulting social and behavioural correlates of education may 
vary according to age.  
Whilst there are many measures of SED, no one measure can adequately measure or 
capture the entire multidimensional construct behind the term socioeconomic status. In a 
recent study of SED in health research Braveman et al 
15 concluded that socioeconomic 
deprivation should be measured by as many relevant measures as possible, and, include 
individual and area based measures. Whilst it is acknowledged that no one measure is 
perfect, by examining health effects using multiple measures, the unmeasured 
socioeconomic effects are lessened.  
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Socioeconomic deprivation and health in the UK 
Before moving on to examine the relationship between SED and CVD, it is worth 
recounting the relationship between SED and general health and well being, and, the 
political agenda in the UK. This has set the scene for the current interest in health 
inequalities and government policy is one of the key drivers to reduce such inequities.  
The NHS was launched in the UK on 5 July 1948 with a guiding principle that health care 
should be available to all irrespective of wealth. Thus, one of its aims was to redress health 
inequalities through the provision of a universal health care system. However, subsequent 
Government reports noted that the NHS appeared to be failing in its aim of reducing 
inequalities in health when evidence of widening health inequalities began to emerge.
16  
The current interest in social inequalities is driven by recent reports in the UK. In the 
1980s the existence of health inequalities was famously ignored by the then  Conservative 
government who labelled such inequalities ‘variations’, explained by statistical artefacts or 
the fault of those who suffered as a result of them. Furthermore, the magnitude and 
underlying meaning of the difference was ignored. This is best exemplified by the 
persistent refusal to acknowledge the findings of the ‘Black Report’
17, and by attempts to 
bury it by publishing it on the August bank holiday in 1980 and producing only 260 copies. 
The report, by Sir Douglas Black, was not received well as noted by the foreword by the 
then Secretary of State, Patrick Jenkin. In his foreword he noted that:  
“they (Sir Douglas’ group) make clear, the influences at work in explaining the relative 
health experience of different parts of our society are many and interrelated.......It will 
come as a disappointment to many that over long periods since the inception of the NHS 
there is generally little sign of health inequalities in Britain actually diminishing and in 
some cases, they may be increasing. It will be seen that the Group has reached the view 
that the causes of health inequalities are so deep rooted that only a major and wide-
ranging programme of public expenditure is capable of altering the pattern. I must make it 
clear that additional expenditure on the scale which could result from the report's 
recommendations - the amount involved could be upwards of £2 billion a year - is quite 
unrealistic in present or any foreseeable economic circumstances....... I cannot, therefore, 
endorse the Group's recommendations. I am making the report available for discussion, 
but without any commitment by the Government to its proposals”.   
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The inequalities in death rates according to SED that were described in the Black report 
were therefore to be left un-tackled. A major issue with the Black report was the inability 
of the authors to disentangle why these inequalities were present. One explanation was that 
they were due to artefact and it is on this explanation that the Government of the day 
seized.  
However, the Black report was not the only report that documented the inequalities in 
health in UK society. Following a change of government in 1997 to that of Labour health 
inequalities became an important issue. The Independent Inquiry into Inequalities in Health 
– ‘The Acheson Report’
18 chaired by Sir Donald Acheson, reviewed the evidence of the 
most effective action to reduce health inequalities. This report also reinforced the findings 
of the Black report that health inequalities were still widening and were evident across all 
aspects of health. More reports on the health inequalities in the UK have followed 
19and in 
Scotland similar reports of health inequalities also exist 
20-22.  
Socioeconomic deprivation and Scotland   
On the 6
th of May 1999 Scotland underwent devolution from Westminster. Devolved 
powers included: health, education, local government, social work, housing, planning, the 
environment, sport, arts, agriculture, forestry, and fishing. Some aspects of law, home 
affairs and transport were also devolved. Health inequalities in Scotland had been well 
documented.
20 It has been documented that of the “worst off million” people in the UK in 
terms of health, 52% of these individuals were living in Scotland. Mortality rates in 
Scotland’s local authority areas with the worst health were twice as high as the UK 
average. Inequalities in health also existed within Scotland. The rate of coronary heart 
disease mortality was two and a half times higher in the most deprived versus the least 
deprived. In 1998, a comprehensive report looked at health and health services in Scotland 
through from a health inequalities point of view 
23. Using NHS data, it highlighted 
substantial inequalities both in the distribution and access to health care for all the major 
health issues (mental health, coronary heart disease, stroke, and cancer). As expected the 
most deprived communities experienced the worst health and least access to care, re-
affirming the inverse care law of Tudor-Hart, that the availability of good medical care 
tends to vary inversely with the need of the population served.
24  
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Summary 
Socioeconomic deprivation is a complex construct which not only refers to poverty. The 
theoretical basis of SED is founded on two philosophical schools of thought that have 
guided the development of measures of SED. The Registrar General’s social class scheme, 
an individual measure of SED, and the Carstairs Morris index, an area based measure of 
SED will be used in this thesis. The relationship between SED and health has been the 
subject of much interest in the last few decades and differences in health, between the most 
deprived and least deprived members of society, have been documented in Scotland and 
throughout the UK.  
The relationship between cardiovascular disease in particular and socioeconomic 
deprivation has also been studied. Prior studies have reported that in those with 
cardiovascular disease, the prevalence of socioeconomic deprivation is higher.
25 The 
distribution of SED in relation to prevalent disease is perhaps the best studied aspect of the 
association between SED and cardiovascular disease. Survival and case fatality in those 
with cardiovascular disease has also been studied widely. However, much less is known 
about the association between SED and incident cardiovascular disease. In the next chapter 
I will review the literature surrounding the relationship between SED and cardiovascular 
disease. I will focus on studies of incidence and subsequent mortality as well as 
cardiovascular mortality. I will review the literature surround the relationship between 
SED and recurrent cardiovascular events before examining the impact of SED on the 
burden and cost of cardiovascular disease.  
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Socioeconomic Deprivation and Cardiovascular 
Disease 
This chapter will examine the literature surrounding the relationship between SED and 
cardiovascular disease. The literature surrounding the prevalence of cardiovascular disease 
runs to hundreds of manuscripts and has been extensively reviewed in a seminal American 
Heart Association (AHA) Medical/Scientific Statement by Kaplan and Keil in 1998.
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Rather than replicate that study of the literature I will instead concentrate on the areas of 
the relationship between SED and CVD that are less well studied. It is these understudied 
areas that the present thesis aims to address. I will also focus on more recent studies, 
published after 1998 and where possible cite studies from Scotland or the UK.  
MEDLINE, CINAHL and EMBASE were searched for articles published between January 
1998 and January 2009. A generic search strategy (Appendix 1) was written in MEDLINE 
with appropriate synonyms used to search CINHAL and EMBASE. The grey literature was 
searched using the terms ‘Socioeconomic Deprivation’ or ‘Health Inequalities’ and 
‘cardiovascular disease’. Reference lists of selected articles were reviewed and citation 
checks carried out to identify further potentially relevant studies. A number of exclusions 
were applied. Studies employing a life course approach were not examined as the aim of 
the present studies was not to examine the relationship between CVD and SED over a 
lifetime but rather adult SED and CVD.  Some studies also included “softer” event types 
such as coronary artery spasm in their composite outcomes and were therefore excluded.
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Finally, studies that examined the relationship between SED and cardiovascular disease in 
developing countries or countries currently undergoing the epidemiologic transition were 
excluded. In these countries a positive association between SED and CVD is observed i.e. 
the most socioeconomically deprived exhibit the lowest risk of disease.
28 In the UK, this 
association was present until the middle of the last century for CVD.
29 However, the 
association has now reversed and the most deprived are at higher risk. In light of this, the 
findings of studies in developing countries are unlikely to be generalisable to the UK 
population.  
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Socioeconomic deprivation and coronary heart disease 
Coronary heart disease mortality 
All cause mortality has been related to SED since the 19
th century 
30 and these inequalities 
persist.
31 Cardiovascular mortality is also inversely related to SED.
32 Higher mortality rates 
are consistently found in the most deprived individuals.
33,34 Importantly coronary heart  
disease is one of the main contributors to the excess mortality in the most 
socioeconomically deprived groups.
35 
Coronary heart disease mortality is consistently higher in the most deprived, an 
observation that was reported in the middle of the last century.
29,36 Studies from 
Sweden
35,37, Finland
38,Denamrk
39, Norway
40, UK
25 and Scotland
41 and a number of other 
European countries ( Belgium, Italy, Spain, Switzerland, 
32) have all reported this 
association. Studies from other developed countries around the world such as the USA
42-44, 
Japan
45, Australia
46 and New Zealand
47 also exist and confirm the association. These 
studies are broadly similar in that the most deprived are at higher risk of CHD death over 
follow up regardless of the measure of SED used. However, such studies have been based 
on population level data, thus, are unable to fully correct for cardiovascular risk 
factors,
40,43,44 or, have been limited to men
44 or women
43. 
A few studies are however, worthy of more scrutiny.  No review of the literature on the 
relationship between SED and coronary mortality could be complete without referring to 
the seminal Whitehall study. In this study 17,530 civil servants, between the age of 40 and 
64, were screened for the prevalence of coronary heart disease. The prevalence of angina 
was nearly 53% higher in the most deprived individuals (those on the lowest employment 
grade) as compared to the least deprived (the highest employment grade). After follow up 
for 10 years the mortality rate from coronary heart disease was 3.6 times higher in the most 
versus least deprived.
48 Since this study multiple studies (outlined above) have reported 
similar findings and a repeat sample of civil servants, the Whitehall II study
25, reported that 
these inequalities persist. The finding has also been replicated in women. The gradient of 
risk seen in women may be weaker than that in men.
49 Some authors suggest that up to a 
quarter of coronary deaths in the UK are attributable to higher levels of socioeconomic 
deprivation.
50  Recently in a large study of European coronary death rates, Avendano and 
colleagues 
32 demonstrated a clear excess of coronary deaths amongst the most deprived 
members of each society. In contrast to lung cancer where the gradient followed smoking  
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trends, the trends in coronary mortality did not. In keeping with other studies the strongest 
trends were seen in women. Interestingly, they observed that socioeconomic disparities in 
coronary mortality were higher in northern European countries as compared to southern 
countries.  
A number of studies have examined the relationship between SED and CHD mortality in 
Scotland.
41,51,52 However, as with studies from other countries they are all limited by the 
inability of the authors to adjust for cardiovascular risk factors as the studies have all used 
administrative data sources, which do not hold information on patient risk factor profiles. 
Finally, and perhaps most worryingly, data from Sweden suggests that difference in CHD 
mortality by SED, as measured by neighbourhood, is in fact widening.
53 This finding has 
now been observed in Scotland.
41  
Coronary heart disease incidence 
Whilst much has been written on the relationship between SED and CHD mortality, very 
little has been published in relation to non-fatal CHD. Studies are consistent in that they all 
report that the most deprived individuals display higher rates of coronary heart disease, 
though exceptions in the literature do exist
37. Whether SED is measured by individual 
measures such as education or social class or whether area based measures are examined, 
consistent results are obtained (Table 2).  
Studies have tended to included non-fatal CHD as part of a composite outcome with fatal 
events. This makes disentangling the relationship between SED and non-fatal CHD 
difficult. However, as can be seen from Table 2, fairly consistent results are obtained 
regardless of the measure of SED utilised. Adjustment for cardiovascular risk factors is not 
comparable between studies, though it is consistently reported that adjustment attenuates, 
but does not remove, the association between SED and CHD.  
The study by Sundquist et al
54 merits further exploration. It has a number of strengths. 
Firstly the size of the sample is large, the entire Swedish population between the ages of 40 
-64 years amounting to 2.6 million people. They were followed using an administrative 
hospital discharge database which is highly accurate. It included both men and women and 
it used two measures of SED, and individual one, income, and, an area based measure. 
They reported that after accounting for individual income, the odds of developing CHD 
was 1.87 (95% CI 1.72 - 2.03) in women and 1.42 (95%CI 1.35 - 1.49) in men. However, 
as this was an administrative database only age and sex were adjusted for in the analyses.   
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Two other studies
55,56 have overcome this limitation and adjusted for the risk factors that 
are classically associated with cardiovascular risk, age, sex, smoking, diabetes, blood 
pressure and cholesterol. They both reported that education was not associated with a 
higher risk of fatal or non-fatal CHD, especially after adjustment, however, Thurston et 
al
55 found that income was associated with a higher risk after adjustment for the traditional 
cardiovascular risk factors in both men and women. 
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Table 2 Summary of the literature on socioeconomic deprivation and the association with fatal and non-fatal coronary heart disease 
Study  Design  Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Winkleby
57 
Sweden 
Prospective cohort  Fatal / non-fatal CHD  Neighbourhood   Men 1.7(1.53-1.88) 
Women 1.56(1.23-
1.74) 
 
1.36 (1.22-1.52) 
1.33 (1.08-1.65) 
 
Age, marital status, 
family income, 
education, immigration 
status, mobility, 
urban/rural area 
Sundquist
58 
Sweden 
Prospective cohort  Fatal / non- fatal CHD  Neighbourhood 
education 
 
Neighbourhood 
income 
  1.38 (1.13-1.69) 
 
 
1.36 (1.11-1.66) 
Age, sex 
Rosengren
37 
Sweden 
Prospective cohort 
(Men) 
Fatal/ non-fatal CHD  Social Class  P=not significant     
Emberson
50 
UK 
Prospective cohort 
(Men) 
Fatal CHD/ non fatal 
MI 
Social Class  1.41 (1.21-1.64)  1.23 (1.05-1.44)  Smoking, systolic blood 
pressure, cholesterol, 
BMI, physical activity, 
alcohol, FEV1 
Picciotto
59 
Italy 
Prospective cohort  Incidence of fatal/ non-
fatal CHD 
 
 
Neighbourhood 
 
 
 
  Men 
1.4 (1.3-1.5) 
Women 
1.78 (1.60-1.98)  
Age 
 
 
 
Sundquist
54 
Sweden 
Administrative 
database 
Non- fatal CHD  Income  
 
Neighbourhood  
1.75 (1.65-1.85) 
 
2.02 (1.86-2.20) 
1.70 (1.60-1.79) 
 
1.87 (1.72-2.03) 
Age, income and 
neighbourhood 
deprivation. 
Thurston
55 
USA 
Prospective cohort  Fatal/ non-fatal CHD  Education  
 
 
 
 
Income  
Men 
1.58 (1.18-2.12) 
Women 
2.15 (1.46-3.17) 
 
Men 
1.40 (1.11-1.76) 
Women 
1.64 (1.31-2.05) 
Men 
1.29 (0.90-1.74) 
Women 
1.61 (1.08-2.39) 
 
Men 
1.35 (1.06-1.71) 
Women 
1.40 (1.10-1.79) 
Systolic and diastolic 
blood pressure, 
hypertension, cholesterol, 
BMI, diabetes, smoking, 
alcohol, activity, marital 
status, ethnicity  
Yarnell
56 
Ireland and France 
Prospective cohort  Fatal/ non-fatal CHD  Education (most vs. 
least) 
0.72 (0.73-0.98)  0.9 (0.65-1.24)  Age, smoking, diastolic 
blood pressure, diabetes, 
BMI, cholesterol,  
36 
fibrinogen, study site 
Morris
60  
UK 
Prospective cohort 
(Men) 
Fatal/non-fatal CHD  Neighbourhood  1.55(1.19-2.00)  1.22(0.93-1.59)  Marital status, Housing, 
car ownership, social 
networks, social class  
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Socioeconomic deprivation and myocardial infarction 
Myocardial infarction incidence 
It is perhaps unsurprising that most research on the relationship between SED and 
cardiovascular disease has focussed on myocardial infarction (MI). Socioeconomic 
deprivation is associated with an increased risk of myocardial infarction (Table 3). This 
association again has been demonstrated in a number of countries through a number of 
years (see Table 3). The association was examined in a number of the MONICA 
(Multinational Monitoring of Trends and Determinants of Cardiovascular Disease) cohorts. 
For example, in Glasgow, Scotland, the age adjusted relative rate of myocardial infarction 
was 1.74 (95%CI 1.58-1.91) in the most versus least deprived men with the least deprived 
being less likely to survive to reach hospital alive (age adjusted odds most versus least 
deprived 0.93 (0.87-0.99)).
61 As noted above the same pattern was seen in women but the 
gradient was steeper (age adjusted relative rate most versus least deprived 2.34(1.98-
2.76)), and again the most deprived were less likely to reach hospital alive (age adjusted 
odds 0.94(0.85-1.05)). In the Finnish MONICA study similar patterns were observed when 
education and income were used as measures of SED in contrast to the area-based measure 
of SED used in the Scottish study.
62,63 However, both studies, being registry based, failed 
to adjust for the traditional cardiovascular risk factors such as smoking, blood pressure, 
diabetes and cholesterol, a major limitation of these otherwise informative studies. As can 
be seen from Table 3 many studies have failed to adequately adjust for all cardiovascular 
risk factors or have examined the incidence of MI in conjunction with all cause mortality 
or in other composite outcomes.  
A number of studies, including that of Morrison et al
61 have been conducted in Scotland. 
Each study has utilised a hospital discharge database (the Scottish Morbidity Record 
Scheme [SMR]) which records all discharges from NHS hospitals in Scotland. Each have 
employed slightly different methods, and examined different outcomes. In one study the 
likelihood of reaching hospital alive was lower in the most deprived versus the least 
deprived as measured by Carstairs Morris index (16% less in deprived men and 3% in 
deprived women).
64 In another study of all fatal MIs occurring in Scotland between 1986-
1995 the risk was highest in the deprived and the gradient appears steeper in younger 
women.
65 A recent study examining all discharges where MI appeared in any of the 
diagnoses at discharge and all coronary heart disease deaths, confirmed this finding,  
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however, the use of such broad inclusion criteria make extrapolation of these results 
difficult.
66  
More recently, the INTERHEART study 
67 confirmed that a number of risk factors, 
psychosocial factors (stress, stressful life events, perceived locus of control and 
depression), apolipoprotein B/apolipoprotein A1 ratio, hypertension, diabetes, smoking, 
exercise, vegetables and fruits, alcohol consumption and abdominal obesity) were 
responsible for the majority of cases of myocardial infarction. In a study that added 
education into the collection of explanatory variables, SED as measured by education was 
a significant risk factor.
68  
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Table 3 Summary of the literature on socioeconomic deprivation and incidence of MI (including studies where MI was part of a composite outcome) 
Study  Design  Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Stjarne
69 
Sweden 
Prospective cohort  Non-fatal MI  Social class index of 
area  
Age 
Men 1.50 (1.12-2.00) 
Women 1.94 (1.22-
3.09) 
 
Men 1.19 (0.88-1.62) 
Women 1.60 (0.96-
2.66) 
Age, individual level 
socioeconomic status, 
education, employment 
status, marital status, 
ethnicity 
Hallqvist
70 
Sweden 
Prospective cohort  Fatal / non-fatal MI  Social class    Men 1.99 (1.58-2.53) 
Women 2.34 (1.52-
3.61) 
Age 
Emberson
50 
UK 
Prospective cohort 
(Men) 
Fatal CHD/ non fatal 
MI 
Social Class  1.41 (1.21-1.64)  1.23 (1.05-1.44)  Smoking, systolic blood 
pressure, cholesterol, 
BMI, physical activity, 
alcohol, FEV1 
Albert
71 
USA 
Prospective cohort 
(Women) 
Cardiovascular death 
or Non-fatal MI/stroke 
or revascularisation 
 
Education (most vs. 
least) 
Income (most vs. 
least) 
Age and race 
0.5 (0.3-0.7) 
 
0.4 (0.3-0.7) 
 
0.8 (0.5-1.2) 
 
0.8 (0.5-1.2) 
Age, race, BMI, 
smoking, hypertension, 
diabetes, LDL and HDL 
cholesterol, triglycerides, 
hormone use, family 
history of CHD, alcohol, 
activity, CRP, ICAM, 
fibrinogen, homocysteine 
Diex-Roux
72 
USA 
Prospective cohort  Fatal CHD/ non-fatal 
MI 
Neighbourhood  Age and study site 
White  
2.1 (1.6-2.8) 
Black 
1.7 (1.2-2.3) 
 
White  
1.6 (1.1-2.2) 
Black 
1.5 (1.0-2.3) 
Smoking, activity, 
hypertension, diabetes, 
LDL and HDL 
cholesterol, BMI 
Morrison
11 
Scotland 
Registry  Fatal/ non-fatal MI  Neighbourhood 
(Carstairs) 
Men 1.74 (1.58-1.91) 
Women 1.28 (1.22-
1.24) 
   
Salomaa
63† 
Finland  
Registry  Incident MI 
 
 
 
 
 
Income  
 
 
Education 
 
 
  Men 1.67 (1.57-1.78) 
Women 1.52 (1.38-
1.68) 
Men 1.48 (1.40-1.55) 
Women 1.65 (1.48-
1.83) 
Study area, urban/rural 
residence 
Rose
73   Prospective cohort  Non fatal MI  Neighbourhood  Black men       
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USA  1.63(1.20-2.06) 
Black women 
2.14(1.69-2.58) 
White men 
1.24(1.07-1.41) 
White women 
1.79(1.58-2.00) 
 
Davies
66 
Scotland 
Administrative  
database 
Fatal CHD/Non fatal 
MI 
Neighbourhood  1990-92 
2000-02 
1.74(1.58-1.92) 
1.94(1.76-2.15) 
 
Rosengren
68 
Multinational* 
Multiple case control 
cohorts 
Non fatal MI  Education    1.95(1.71-2.21)  Age, sex , psychosocial 
factors (stress, stressful 
life events, perceived 
locus of control and 
depression), 
apolipoprotein 
B/apolipoprotein A1 
ratio, hypertension, 
diabetes, smoking, 
exercise, vegetables and 
fruits, alcohol 
consumption, 
abdominal obesity, and 
region 
Macintyre 
65 
Scotland 
Administrative 
database 
Fatal MI  Neighbourhood 
(Carstairs) 
Men‡ 
<65 years RR 1.93 
65-74 RR 1.39 
>75 RR 1.08 
Women‡ 
<65 years RR 2.58 
65-74 RR 1.50 
>75 RR 1.12 
   
† Duplicate study 
62 not included, * Results from high income countries only included, ‡Estimated from figures given 
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Myocardial infarction and case fatality 
Similarly survival following a myocardial infarction varied according to SED in the 
MONICA studies.
61-63 In the Glasgow MONICA cohort the rate of CHD death in hospital 
was not different according to SED, though CHD mortality following discharge was.
61 It is 
in the setting of post infarction survival that most studies are concentrated (Table 4). As 
noted previously, the most deprived have higher rates of adverse risk factors.
74 Most of 
these studies have used well characterised members of registries and therefore are able to 
adjust for cardiovascular risk factors. However, despite this many studies have found that 
after adjustment the relationship is attenuated to such and extent that it becomes non-
significant.
75-77 Multiple studies have tried to explain this association. Some studies would 
suggest that the most deprived receive the least aggressive pharmacotherapy
78, the least 
follow up
79,80 and lower rates of revascularisation.
62,79   
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Table 4 Summary of the literature on socioeconomic deprivation and case fatality following a myocardial infarction 
Study  Design  Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Gerber 
81 
Israel 
Prospective cohort  Mortality following MI 
 
 
IHD mortality 
following MI 
Income   2.64 (1.92-3.63) 
 
 
 
2.68 (1.79-4.01) 
1.58 (1.13-2.21) 
 
 
 
1.52 (1.02-2.31) 
Age, sex, smoking, 
hypertension, diabetes, 
physical activity, MI 
severity, ejection 
fraction, killip class, 
anterior MI, admission to 
intensive care, 
comorbidity index, 
coronary  angiography, 
angioplasty, 
thrombolysis, aspirin, 
beta blockers, race, 
employment status 
Gerward
82 
Sweden 
Registry  28 day survival  
following MI  
Neighbourhood   
 
1.25 (1.03-1.52)  Age and sex 
Engstrom
83 
Sweden 
Prospective cohort   3 year survival 
following MI 
Neighbourhood  *Men R=0.6, p<0.01 
*Women R=0.37, 
p=0.35 
   
Pilote
76 
Canada 
Administrative 
database 
MI mortality 
 
 
 
 
 
 
 
 
 
 
 
 
Neighbourhood  
 
 
 
 
 
 
Income or 
employment rate or 
education or 
population size, 
average rent 
  Quebec, Ontario, 30 
day – NS, 1 year - 
NS 
British Columbia 30 
day – NS, 1 year 
1.18(1.09-1.28) 
 
All areas, 30 day and 
1 year – NS 
 
 
 
 
Age, sex, comorbidities, 
hospital 
Stjarne
69 
Sweden 
Case Control  Case fatality at 28 days  Neighbourhood 
(Carstairs) 
Age adjusted 
Men 0.98 (0.90-1.07) 
Women 1.01 (0.89-
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1.16) 
Alter
84 
USA 
Prospective cohort  2 year post MI 
mortality 
Income (high vs. 
low) 
0.45 (0.35-0.57)  0.62 (0.48-0.74) 
 
0.77 (0.54-1.10) 
Age, sex, ethnicity, 
psychosocial factors and 
pre-existing 
cardiovascular diseases 
Alter
85 
USA 
Registry  1 year MI mortality  Neighbourhood 
income (high vs. 
low) 
  0.90 (0.86-0.94)  Age, sex, specialty of 
admitting physician, 
hospital 
Gerber
75 
USA 
Prospective cohort  Post MI mortality  Neighbourhood 
income 
 
Education 
2.10 (1.42-3.12) 
 
 
2.21 (1.47-3.32) 
1.62 (1.08-2.45) 
 
 
1.01 (0.65-1.58) 
Age, sex, race, 
comorbidities, ejection 
fraction, hypertension, 
hypercholesterolaemia, 
smoking, BMI, beta 
blocker, aspirin, statin, 
angioplasty, bypass 
surgery, ST elevation 
Rao 
USA 
Retrospective cohort  30 day case fatality 
following MI 
 
 
1 year mortality 
following MI 
Income of area 
 
  Low vs. middle 
1.09 (1.04-1.13) 
High vs. middle 
0.89 (0.85-0.94) 
Low vs. middle 
1.05 (1.0-1.10) 
High vs. middle 
0.92(0.88-0.97) 
Age, sex, ethnicity, 
smoker, diabetes, 
mobility, past history of 
MI or CABG, 
hypertension, stroke, 
COPD, dementia, 
hospital, treatment and 
revascularisation. 
Rosvall
86 
Sweden 
Registry  5 year mortality post 
MI 
Income    Men 
1.63 (1.51-1.77) 
Women 
1.44 (1.27-1.63) 
Age 
Chang
87 
Canada 
Retrospective cohort  1 year mortality post 
MI 
Neighbourhood 
median income (per 
$10,000 increase) 
0.87 (0.83-0.90)  0.94(0.91-0.98)  Age, sex, diabetes, 
hypertension, 
hypercholesterolaemia, 
cancer, peripheral 
vascular disease, past MI. 
Cesana
88 
Italy 
Registry  28 day post MI 
mortality 
Social Class  2.46 (1.52-3.99)     
Rasmussen
89 
Denmark 
Registry  30 day case fatality 
 
 
 
Income  
Education 
 
 
 
1.54 (1.36-1.79) 
1.24 (1.03-1.50) 
Age, sex, year, civil 
status, comorbidity, 
education or income.   
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>31 days 
 
Income 
Education 
1.65 (1.45-1.85) 
1.33 (1.11-1.59) 
Bernheim
77 
USA 
Cohort  1 year mortality 
 
Income  2.80 (1.37-5.72) 
 
 
1.19 (0.54-2.62) 
 
 
 
Age, sex, ethnicity, 
health insurance, 
smoking, diabetes, 
hypertension, 
hypercholesterolemia, 
COAD, HF, ejection 
fraction <40% 
Picciotto
59 
Italy 
Prospective cohort  28 day case fatality 
post MI 
 
 
1 year case fatality 
post MI 
 
 
 
28 day case fatality 
post MI 
 
 
1 year case fatality 
post MI 
 
 
 
Neighbourhood 
 
 
 
 
 
 
 
 
Education 
  Men 
0.91 (0.69-1.19) 
Women 
1.35 (0.94-1.94)  
Men 
1.23 (0.86-1.75) 
Women 
1.36 (0.85-2.17) 
 
Men 
1.22 (0.95-1.56) 
Women 
1.31 (0.91-1.88)  
Men 
1.02 (0.75-1.38) 
Women 
1.02 (0.64-1.62)  
 
Age 
 
 
 
Age, co morbidities, 
angioplasty 
 
 
 
Salomaa
63† 
Finland  
Registry  28 day case fatality 
following MI 
 
 
 
 
1 year case fatality 
following MI 
Income  
 
 
Education 
 
 
Income  
 
 
Education 
  Men 3.18 (2.82-3.58) 
Women 2.17 (1.76-
2.68) 
Men 1.92 (1.74-2.11) 
Women 2.43 (1.91-
3.09) 
Men 3.18 (2.84-3.55) 
Women 2.15 (1.77-
2.62) 
Men 1.87 (1.71-2.05) 
Women 2.34 (1.88-
Study area, urban/rural 
residence  
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2.92) 
Morrison
11 
Scotland 
Registry  28 day CHD case 
fatality 
Neighbourhood 
(Carstairs) 
  Men 0.98 (0.90-1.07) 
Women 1.01 (0.89-
1.16) 
Age 
MacIntyre 
65 
Scotland 
Administrative 
database 
30 day case fatality  Neighbourhood 
(Carstairs) 
Men‡ 
<65 years RR 1.96 
65-74 RR 1.29 
>75 RR 1.02 
Women‡ 
<65 years RR 2.62 
65-74 RR 1.40 
>75 RR 1.23 
   
Chaix
53 
Sweden 
Prospective cohort  Post MI IHD case 
fatality 
Neighbourhood  1.40 (0.71-2.85)     
Tonne
90 
USA 
Prospective cohort  MI case fatality  Neighbourhood  Age and sex 
1.55 (1.24-1.93) 
 
1.38 (1.14-1.67) 
Age, sex, hospital, AF, 
heart failure, shock, 
angina, Q-waves, 
hypertension, diabetes, 
stroke, past MI and age-
sex interaction 
Manderbacka
91 
Finland 
Administrative 
database 
Post MI 2 year CHD 
case fatality 
 
 
 
28 day case fatality 
Income  Age 
Men 1.39(1.18-1.63) 
Women 1.26(1.02-
1.55) 
 
Men 1.94(1.81-2.08) 
Women 1.49(1.34-
1.67) 
 
 
Men 1.35(1.15-1.59) 
Women 1.17(0.95-
1.43)  
 
Men 1.93(1.80-2.07) 
Women 1.44(1.29-
1.61) 
 
Age, heart failure, 
arrhythmia, hypertension, 
diabetes, asthma and 
chronic obstructive 
pulmonary disease, 
severe mental disorders, 
thyroid insufficiency, 
multiple sclerosis, 
Parkinson’s disease, 
epilepsy, malignant 
tumours, sarcoidosis, 
rheumatoid arthritis, 
ulcerative colitis, 
Crohn’s disease, and 
gouty arthritis 
** Correlation coefficient  ‡Estimated from figures given  
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Recurrence of myocardial infarction 
Following from this, despite there being a large body of literature on the epidemiology of 
recurrent myocardial infarction, there are very little data on the association between SED 
and recurrent infarction (Table 5). One study did examine recurrent ischaemic events 
(Death, MI or unstable angina) following a non-fatal MI according to SED.
92 Interestingly 
the authors reported that after adjustment for age, sex, diabetes, race, treatment with aspirin 
and thrombolysis and left ventricular failure the adjusted risk of an event in the most 
versus the least deprived was 1.59 (95% CI 1.03-2.44). After further adjustment for the use 
of secondary prevention (aspirin and beta-blockers) at discharge the association became 
non-significant 1.78 (0.80 -3.99). This would support the hypothesis of others that the 
differential survival post MI by SED is explained by differential treatment following the 
event.
79,93 However, as noted above not all authors have found this in relation to case 
fatality.
81 
In another study by Scheffler et al
94 of the Kaiser Permanente Health Insurance Database 
in California USA, the rate of recurrent fatal or non-fatal MI was lower with increasing 
income (HR 0.94 95%CI 0.91-0.97) after adjustment for sex, race, age, measures of 
income inequality of an area, societal capital and race mix of an area. After further 
adjustment for past medical history and pharmacotherapy including revascularisation 
therapy the association persisted (HR 0.97 95%CI 0.95-1.00). 
As can bee seen from Table 5, inconsistent results have been reported when the risk of 
recurrent coronary events associated with SED has been examined. This may be related to 
the different populations, different outcomes (many of which are composite outcomes) and 
different methods of adjustment in the multivariable models.  
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Table 5 Summary of the literature on socioeconomic deprivation and recurrent myocardial infarction and coronary heart disease 
Study  Design  Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Pilote
76 
Canada 
Administrative 
database 
Readmission for 
MI/HF/Angina 
Neighbourhood or 
income or 
employment rate or 
education or 
population size, 
average rent 
  All areas, 30 day and 
1 year - NS 
Age, sex, comorbidities, 
hospital 
Scheffler
94 
USA 
Administrative 
database 
Recurrent acute 
coronary syndrome  
Income  0.94(0.91-0.97)  0.97(0.95-1.00)  Age, sex, race, social 
capital indices, medical 
therapy, hypertension, 
diabetes, depression, 
stroke, heart failure, 
peripheral vascular 
disease, revascularisation  
Barakat
92 
UK 
Prospective cohort  Readmission 
Angina/MI/Death  
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
 
30 days 
 
31 days to 1 year 
Neighbourhood 
(Carstairs) 
 
 
1.54(1.02-2.32) 
 
1.02(0.66-1.60) 
 
 
1.56(1.01-2.39) 
 
1.05(0.66-1.67) 
 
1.60(1.04-2.48) 
 
1.08(0.68-1.71)  
 
1.59(1.03-2.44) 
 
1.07(0.68-1.70) 
 
1.78(0.80-3.99) 
 
1.00(0.63-1.59) 
 
 
Age, sex, race 
 
 
 
Age, sex, race 
 diabetes, aspirin and 
thrombolysis  use 
 
Age, sex, race 
 LVF 
 
 
Age, sex, race 
discharge aspirin and 
betablockers 
Rao
95 
USA 
Trial registry  Death or recurrent MI   Income    30 days 
1.3(0.8-2.1) 
6 month 
1.4 (0.9-2.1) 
Age, weight, height, 
smoking, systolic blood 
pressure, heart rate, 
presence of rales, time to 
treatment  
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Bernheim
77 
USA 
Prospective cohort  Post MI all cause 
rehospitalisation at 1 
year 
Income  1.55 (1.17-2.05)  1.36 (1.01-1.89)  Age, sex, ethnicity, 
health insurance, 
smoking, diabetes, 
hypertension, 
hypercholesterolaemia, 
COAD, CHF, ejection 
fraction <40% 
Picciotto
59 
Italy 
Prospective cohort  1 year MI 
rehospitalisation 
 
 
1 year other CVD 
rehospitalisation 
 
 
 
1 year MI 
rehospitalisation 
 
 
1 year other CVD 
rehospitalisation 
Neighbourhood 
 
 
 
 
 
 
 
 
Education 
  Men 
1.06 (0.63-1.78) 
Women 
0.94 (0.44-1.98) 
Men 
0.93 (0.74-1.17) 
Women 
0.99 (0.68-1.42) 
 
Men 
0.83 (0.56-1.25) 
Women 
1.39 (0.61-3.18) 
Men 
0.98 (0.81-1.19) 
Women 
1.03 (0.73-1.47) 
Age, comorbidities, 
angioplasty 
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Socioeconomic deprivation and stroke 
 
The relationship between stroke and SED has been well studied in relation to mortality and 
case fatality or survival. The incidence of stroke and its relation to SED has also been 
studied. As with coronary heart disease, the relationship between SED and stroke is inverse 
i.e. the most deprived suffer from higher rates of stroke, higher case fatality and higher 
stroke mortality.  
 
Stroke mortality 
Stroke mortality is higher in the most deprived members of a number of societies including 
Europe
96, USA
33 and Japan
45. In a study of 22 European countries the mortality rates from 
stroke was consistently higher in the most versus the least deprived members (as measured 
by social class and education) of each society.
31 In another international comparison by 
Avendano and colleagues
97, the association between SED (measured by educational level 
and occupational class) and stroke mortality, appeared to be stronger than that for SED and 
coronary mortality in six European societies. More worryingly, in their study, they also 
examined trends over time (comparing the period 1981-1985 to 1991-1995), and found that 
not only had inequalities persisted, but may have in fact widened in some societies.  
Finally, Kunst et al
7 reported in a further study on behalf of the European Union Working 
Group on Socioeconomic Inequalities in Health, that the rate of stroke mortality was 
consistently higher in the most deprived versus the least deprived in 12 European 
countries.   
 
Stroke incidence 
The association between SED and stroke incidence has been examined in a number of 
studies (Table 6). Irrespective of the measure of SED the most deprived are at higher risk 
of experiencing an incident stroke. Many studies have examined both fatal and non-fatal 
first strokes together. 
98-104 Most have used income as a measure of SED a large proportion 
have incompletely adjusted for known risk factors for stroke.  
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Stroke case fatality  
It is not only the relationship between socioeconomic status and the development of stroke 
that is understudied and thus unclear. The relationship between stroke case fatality and 
socioeconomic status has only been examined in the short term, at 30 days, or, 1 year at 
most, though consistent results have been reported (Table 7). As with studies of stroke 
incidence, whilst results have been consistent irrespective of the measure of SED used, 
most studies have failed to adjust for the major cardiovascular risk factors.  
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Table 6 Summary of the literature on socioeconomic deprivation and stroke incidence 
Study  Design (all stroke 
types unless stated) 
Outcome   Measure of SED  Unadjusted  Adjusted  Adjustment 
Li
105 
Sweden 
Prospective cohort  Non fatal incidence  Men: Income 
Social Class  
Women: Income 
Social Class 
**1.37(1.06-1.58) 
1.62(1.16-2.28) 
1.72(1.34-2.20) 
3.14(1.61-6.11) 
1.29(1.06-1.58) 
1.43(1.21-1.68) 
1.75(1.36-2.25) 
2.84(1.45-5.56) 
Age, marital status, 
country of birth, housing 
Avendano
98  
USA 
Prospective cohort  Fatal/Non-fatal 
incidence 
Age 65-74  
Education 
Income 
Age >75  
Education 
Income 
Age and sex 
2.07(1.04-4.13) 
2.08(1.01-4.27) 
 
0.42(0.22-0.79) 
0.43(0.22-0.86) 
 
 
1.10(0.52-2.31) 
 
 
0.50(0.24-1.08) 
 
Age, sex, race, 
hypertension, smoking, 
diabetes, alcohol, BMI, 
activity, psychosocial 
factors and functioning 
level 
Thrift
106 
Australia 
Prospective cohort  Fatal incidence 
Non-fatal incidence 
Index of relative 
socioeconomic 
disadvantage (area 
based) 
†1.56 
†1.91 
 
   
Kuper
104 
Sweden 
Prospective cohort  Fatal/Non-fatal 
incidence 
Education  Age adjusted 
All stroke 
2.1(1.4-2.9) 
Ischaemic stroke 
2.9(1.8-4.7) 
Haemorrhagic stroke 
1.4(0.7-2.7) 
 
All stroke 
1.5(1.0-2.2) 
Ischaemic stroke 
2.2(1.3-3.7) 
Haemorrhagic stroke 
1.1(0.5-2.4) 
 
Age, smoking, BMI, 
alcohol, hypertension, 
diabetes, exercise 
Kleindorfer
107 
USA 
Prospective cohort   
Fatal/Non-fatal 
incidence 
 
Non-fatal incidence 
Area based measure  
All stroke 
 
 
Hospitalised stroke 
 
†White1.49 
Black1.49 
 
White 1.79 
Blacks 1.78 
  Age and sex 
Jakovljevic
108  
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
Fatal/Non-fatal 
incidence 
 
Income  Age 25-59 
†Men 3.22 
Women 3.37 
Age 60-74 
Men1.37 
    
52 
Women 0.84 
Jakovljevic
99  
Finland 
Prospective cohort 
(ischaemic stroke) 
Fatal/Non-fatal 
incidence 
 
Income‡ 
 
 
 
 
 
Age 25-59 
†Men 2.05 
Women 1.96 
Age 60-74 
Men1.51 
Women 1.63 
   
Jakovljevic
109  
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
Fatal/Non-fatal 
incidence 
 
Income  † Age 25-44 
Men3.37 
Women3.71 
Age45-59 
Men 1.92 
Women1.36 
Age 60-74 
Men 1.24 
Women1.18 
   
Wolfe
110 
England 
Prospective cohort  Fatal/Non-fatal 
incidence 
Social class  1.65(1.21-2.23)     
van Rossum
111 
Holland 
Prospective cohort  Fatal/Non-fatal 
incidence 
 
Education (most vs. 
least) 
Social class (High vs. 
low) 
Age adjusted 
0.18(0.02-1.28) 
 
0.60(0.38-0.96) 
 
0.19(0.03-1.36) 
 
0.57(0.26-1.24) 
Age, blood pressure, 
hypertension, 
antihypertensive use, 
smoking, CHD, AF, 
diabetes BMI, alcohol, 
fibrinogen, left 
ventricular hypertrophy 
Hart
101 
Scotland 
Prospective cohort  Non-fatal incidence   
Social class 
Carstairs Morris 
Index 
Age adjusted 
1.37(1.13-1.66) 
1.17(0.96-1.42) 
 
1.07(0.87-1.31) 
0.96(0.79-1.18) 
Age, smoking, FEV1, 
diastolic and systolic 
blood pressure, height, 
alcohol, history of CHD 
Hart
100 
Scotland 
Prospective cohort  Fatal/Non-fatal 
incidence 
 
Social class 
 
 
 
Carstairs Morris 
Index 
Age adjusted 
Men 1.80(1.05-3.06) 
Women 1.62(0.90-
2.89) Men 2.09(1.24-
3.54) 
Women 2.27(1.42-
3.62) 
 
Men 1.31 (0.76-2.26) 
Women 1.24(0.69-
2.24) Men 1.58(0.93-
2.69) 
Women 1.72(1.07-
2.77) 
Age, smoking, FEV1, 
diastolic and systolic 
blood pressure, height, 
BMI, diabetes, history of 
CHD 
Gillum
102 
USA 
Prospective cohort  Fatal/Non-fatal 
incidence 
 
Education (most vs. 
Age adjusted 
White 
Age adjusted 
White 
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least) 
 
 
 
 
 
 
Poverty index(most 
vs. least poor) 
Men 0.86(0.61-1.20) 
Women 0.60(0.42-
0.86) 
Black 
0.59(0.42-0.85) 
 
White 
Men 0.64(0.46-0.88) 
Women 0.65(0.46-
0.91) 
Black 
0.62(0.41-0.95) 
Men 1.03(0.72-1.46) 
Women 0.72(0.50-
1.03) 
 
 
 
White 
Men 0.80(0.57-1.12) 
Women 0.74(0.52-
1.05) 
Black 
0.70(0.46-1.08) 
Smits
112 
Netherlands 
Prospective cohort  Non-fatal incidence  Area based measure  1.27(1.08-1.51)     
*multiple other measures all non significant (antiplatelet agents, thrombolysis, blood glucose measurement, temperature measurement, physiotherapy, 
occupational therapy and speech therapy) 
**Age adjusted 
†confidence interval not calculable from data presented 
‡only income shown due to wide confidence intervals for education  
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Table 7 Summary of the literature on socioeconomic deprivation and stroke case fatality 
Study  Design(all stroke 
types unless stated) 
Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Saposnik
113 
Canada 
Retrospective cohort  7 Day in hospital 
fatality 
Fatality at discharge 
Income and hospital 
volume 
  1.26(1.07-1.49) 
1.27(1.11-1.45) 
Age, sex, hospital of 
admission, Charleson 
score, hospital location 
Arrich
114 
Austria 
Retrospective cohort  Case fatality  Education (most vs. 
least) 
Occupation 
Income 
0.71(0.44-1.14) 
 
2.25(0.84-6.06) 
0.96(0.38-2.39) 
0.77(0.40-1.48) 
 
1.17(0.39-3.49) 
1.44(0.51-4.08) 
Age, sex, stroke severity,  
Li
105 
Sweden 
Prospective cohort  Case fatality 
28 day 
 
1 year 
 
Men income 
Women income  
Men income 
Women income 
   
3.13(1.35-7.24) 
1.68(0.69-4.08) 
2.17(1.18-4.00) 
1.29(0.67-2.45) 
 
Weir
115 
Scotland  
Prospective cohort  6 month case fatality 
6 month case fatality + 
institutional care 
6 month case fatality 
+dependency 
Carstairs Morris 
index 
Non-significant  
Non-significant 
 
2.43(1.51-3.91) 
 
 
 
1.89(1.09-3.30) 
Age, sex, history of 
CHD, diabetes, stroke 
type, onset in hospital, 
function at admission, 
systolic blood pressure, 
neuroimaging 
Casper
116 
USA 
Retrospective cohort  Case fatality   Social class  †White 2.3 
†Black 2.8 
   
Aslanyan
117 
Scotland 
Retrospective cohort  Case fatality  Womersley score 
Murray score 
1.01(0.98-1.04) 
1.03(0.94-1.13) 
1.03(1.00-1.06) 
1.09(0.99-1.19) 
Age, sex, stroke severity, 
blood pressure, subtype 
and past medical history 
Kapral
118 
Canada 
Retrospective cohort  30 day case fatality 
1 year case fatality 
Income    0.91(0.87-0.96) 
0.95(0.92-0.99) 
Age, sex, comorbidity, 
physician and hospital of 
admission 
Jakovljevic
108 
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
28 day case fatality 
 
Income  Age 25-59 
Men 2.10(1.00-4.42) 
Women 2.68(0.88-
8.19) 
Age 60-74 
Men 2.29(0.98-5.34) 
Women 1.40(0.63-
3.13) 
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Jakovljevic
108 
Finland 
Prospective cohort 
(intracerebral 
haemorrhage) 
1 year case fatality  Income  Age 25-59 
Men 2.12(1.02-4.40) 
Women 2.43(0.80-
7.40) 
Age 60-74 
Men 2.40(1.04-5.55) 
Women 1.15(0.52-
2.57) 
   
Jakovljevic
99 
Finland 
Prospective cohort 
(ischaemic stroke) 
28 day case fatality  Income ‡ 
 
 
 
 
 
Age 25-59 
Men 2.61(1.46-4.68) 
Women 1.53 (0.65-
3.60) 
Age 60-74 
Men1.62(1.03-2.54) 
Women 1.53(0.89-
2.63) 
   
Jakovljevic
99 
Finland 
Prospective cohort 
(ischaemic stroke) 
1 year case fatality  Income ‡ 
 
Age 25-59 
Men 2.41(1.48-3.93) 
Women 1.81 (0.86-
3.80) 
Age 60-74 
Men1.48(1.06-2.07) 
Women 1.58(1.03-
2.44) 
   
Jakovljevic
109 
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
28 day case fatality  Income    Age 25-44 
Men 3.88(1.87-8.05) 
Women 1.09(0.41-
2.89) 
Age 45-74 
Men 1.05(0.67-1.64) 
Women 1.68(1.00-
2.81) 
Age, study area, urban/ 
rural residence 
Jakovljevic
109 
Finland 
Prospective cohort 
(subarachnoid 
haemorrhage) 
1 year case fatality  Income    Age 25-44 
Men 4.25(2.05-8.78) 
Women 1.14(0.43-
3.01) 
Age 45-74 
Men 1.07(0.67-1.70) 
Age, study area, urban/ 
rural residence  
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Women 1.86(1.12-
3.10) 
*multiple other measures all non significant (antiplatelet agents, thrombolysis, blood glucose measurement, temperature measurement, physiotherapy, 
occupational therapy and speech therapy) 
**Age adjusted 
†confidence not calculable from data presented 
‡only income shown due to wide confidence intervals for education  
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Recurrent stroke  
The burden of recurrent stroke according to SED has not been well studied (Table 8). The 
risk of readmission following a stroke according to SED has only been examined in a small 
number of studies. In a study by Li et al 
105,of men and women in Malmo, Sweden, despite 
finding a relationship between SED and incident stroke and case fatality, after adjustment 
for covariates (age, marital status, country of birth, and housing condition) they only found 
that low income in women was associated with higher rates of readmission for stroke. 
Some, but not all authors, have reported that stroke severity varies by SED, as does access 
to therapies such as physiotherapy, occupational therapy and carotid surgery
118,119. 
However, length of stay does not seem to be related to SED. Functional recovery may be 
related to SED following a stroke
115 and therefore, the burden of stroke is likely to be 
higher in the most deprived.  
 
Table 8 Summary of the literature on socioeconomic deprivation and stroke recurrence 
Study  Design  Outcome  Measure of 
SED 
Unadjusted  Adjusted  Adjustment 
Aslanyan
117 
Scotland 
Retrospective 
cohort 
Readmission 
any CVD 
Womersley 
score 
Murray score 
1.05(1.01-
1.09) 
1.21(1.08-
1.35) 
1.06(1.02-
1.10) 
1.23(1.10-
1.38) 
Age, sex, 
stroke 
severity, 
blood 
pressure, 
subtype 
and past 
medical 
history 
Li 
105 
Sweden 
Prospective 
cohort 
Recurrent 
stroke 
Men: Income 
Social Class  
 
Women: 
Income 
Social Class 
  1.15(0.72-
1.82) 
1.00(0.46-
2.20) 
2.04(1.03-
4.01) 
2.78(0.70-
10.98) 
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Socioeconomic deprivation and heart failure 
The relationship between SED and heart failure is similarly understudied (Table 9). Given 
that coronary heart disease is a major risk factor for developing heart failure and the 
multiple studies outlined above relating SED to coronary heart disease it is surprising that 
few studies have examined the relationship between heart failure and SED. A systematic 
review by Blair et al
120 published in 2001 identified only 8 relevant studies (two of which 
were published only in abstract form). Since that report only a handful of other studies 
have addressed this relationship (Table 9). 
The prevalence of heart failure clearly varies with socioeconomic status. In cross sectional 
study from Scotland the prevalence of heart failure in primary care practices was higher in 
the most deprived.
121 In the most affluent the rate was 6.4 per 1000 population rising to 7.2 
in the most deprived, a 13% increase.  
The incidence of heart failure is consistently higher in the most socioeconomically 
deprived. In the same study of primary care practices in Scotland the incidence of heart 
failure was 44% higher in the most deprived versus the least deprived intervals.
121 A study 
from Goteborg, Sweden reported that in 6999 men followed for 28 years a hospitalisation 
for heart failure were 72% more likely in the most as compared to the least deprived men 
as measured by social class after adjustment for age, height, BMI, smoking, activity levels, 
systolic BP, diabetes, alcohol problems and cholesterol.
122 In a further study of 2841 men 
from Uppsala, Sweden, after follow up for a median of 29.6 years the rate of incident heart 
failure hospitalisation was twice as high in those with only an elementary education versus 
a college education.
123 Furthermore, when occupational class was examined as a marker of 
SED the risk was approximately 50% higher in those with a low occupational as opposed 
to high occupational class. I have reported that in Scotland rates of first hospitalisation for 
heart failure in Scotland were 56% higher in the most deprived compared to the least 
deprived.
124 Finally, we have reported in an analysis of 15703 participants in the Renfrew 
Paisley cohort, that the risk of heart failure as measured by a hospitalisation for heart 
failure was 40% higher in the most deprived versus the least deprived.
125 This association 
was evident after adjustment for age, sex, history of angina, stroke, blood pressure, FEV1, 
smoking status, atrial fibrillation, abnormal ECG, cardiomegaly on a chest x-ray and BMI.  
Survival in those with heart failure is poorer amongst the most deprived. In a study of all 
hospitalisations for heart failure in Scotland we reported that the risk of death at 30 days 
was 18% higher in the most deprived versus the least deprived men after adjustment for  
59 
age, year of admission and previous admissions for multiple causes.
124 In women the 
excess risk was 3% and not significant. At 1 year the excess risk was 11% and 14% at 5 
years in men. In women the respective figures were 3% (non-significant) at 1year and 4% 
at 5 years which was a significant difference.  
It is not only first hospitalisation rates for heart failure that very by SED, the burden of 
heart failure is highest in the most deprived. Readmission rates for heart failure are 
inversely related to SED. In a study of admissions in New York, USA, after adjustment for 
a risk score (comprising of ethnicity, comorbidities, type of discharging facility and 
procedures performed and finally health insurance type) the risk of readmission for heart 
failure was 18% higher in those in the lowest income group compared to the highest 
income group.
126 Similar results were reported from a study of hospitalisations amongst the 
elderly in Rome, Italy, where rates of hospitalisations for heart failure were inversely 
related to deciles of income.
127 Hospital admissions for cardiac causes in those with heart 
failure are also inversely related to SED. Using the Carstairs Morris Index, Struthers et al 
128 reported that the rate of cardiac hospitalisations was 26% in the least deprived versus 
40% in the most deprived, irrespective of disease severity, diuretic dose and adherence and 
age and sex. One explanation for this finding may be that the most deprived individuals 
with heart failure are in contact with their primary care physician less than their affluent 
counterparts.   
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Table 9 Summary of the literature on socioeconomic deprivation and heart failure 
Study   Design  Outcome  Measure of SED  Unadjusted  Adjusted  Adjustment 
Antonelli Incalzi
127 
Italy 
Retrospective 
cohort 
Readmission 
rates  
Income  
Men  
Women 
 
2.32(2.04-2.63) 
3.28(2.95-3.65) 
   
Auerbach
129USA  Prospective 
cohort 
Care by 
cardiologist 
Income (low vs. 
high) 
Education (College 
vs. high school) 
  0.65(0.45-0.93)  
 
1.89(1.02-3.51) 
Acute Physiology Score, site of enrolment, 
history of dementia admitted to an intensive 
care unit 
Coughlin
130  
USA 
Case control  Cardiac 
transplantation 
listing 
Income (low)  
No private health 
insurance 
P<0.05     
Compos Lopes
131  
Brazil 
Prospective 
cohort 
Cardiac death  Public vs. private 
health care 
  OR 3.46(1.91-6.27)  Aetiology of HF, Digoxin use, No of past MI, 
history of hypertension 
Gottinder
132  
USA 
Retrospective 
cohort 
Incidence   Income  P=0.0002 
(women) 
P<0.0001(men) 
   
Jhund
124 
Scotland 
Retrospective 
cohort 
Case fatality  
30 day (men) 
(women) 
1 year 
 
5 years 
Carstairs Morris 
Index 
Most vs. least 
deprived 
   
1.18 (1.10–1.28)  
1.03 (0.96–1.10)  
1.11 (1.07–1.16)  
1.03 (0.99–1.07)  
1.14 (1.11–1.18)  
1.04 (1.01–1.08) 
Age, prior admissions (MI, Stroke, AF, CHD, 
renal failure, diabetes, hypertension, 
peripheral arterial disease, respiratory disease, 
cancer) 
Ingelsson
123 
Sweden 
Prospective 
cohort 
Incidence  Social Class 
Education 
Marital status 
1.82(1.20-2.74) 
2.47(1.34-4.55) 
0.90(0.50-1.61) 
1.46(0.97-2.21) 
1.94(1.04-3.59) 
0.83(0.46-1.48) 
Hypertension, diabetes, Left ventricular 
hypertrophy, smoking, BMI, cholesterol 
Latour Perez
133 
Spain 
Retrospective 
cohort 
HF on 
admission with 
MI 
Social Class    2.4(1.1-5.2)  Age, diabetes, marital status, sex 
McAlister
121 
Scotland 
Retrospective 
cohort 
Incidence  
Prevalence 
Health care 
usage 
Prescribing of 
ACE inhibitors  
Survival 
Carstairs Morris 
Index Most vs. least 
deprived 
  1.44 
1.13 
0.84 
 
 
NS* 
0.88 
Age, sex  
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Philbin
126  
USA 
Prospective 
cohort 
Readmissions 
with HF 
Income (High vs. 
low) 
  1.18(1.10-1.26)  Risk score comprising of race, insurance, 
aetiology of HF diabetes, renal disease, 
chronic lung disease, history of prior cardiac 
surgery, referral to 
home health services upon hospital discharge, 
telemetry monitoring during the index 
admission, admission to rural hospital, 
discharge to a nursing facility 
echocardiography, cardiac catheterisation.  
Rathore
134 
USA 
Retrospective 
cohort 
**Case fatality 
30 day 
1 year 
Readmission at 
1 year  
Area based score   
0.90(0.75-1.08) 
0.93(0.86-0.99) 
1.11(1.07-1.15) 
 
1.13(0.92-1.38) 
1.10(1.02-1.19) 
1.08(1.03-1.12 
 
Age, race, Left ventricular function, medical 
history and mortality prediction score 
Romm
135 
USA 
Prospective 
cohort 
Activity score 
Symptoms 
Social class  R= -0.181 
R= -0.185 
   
Schaufelberger 
122 
Sweden 
Retrospective 
cohort 
Incidence  Social Class  2.00(1.42-2.82) 
(age adjusted) 
1.72(1.34-2.20)  Age, height, BMI, smoking, activity, systolic 
blood pressure, diabetes, alcohol, cholesterol 
Stewart
125  
Scotland 
Prospective 
cohort 
Incidence   Carstairs Morris 
Index 
1.39 (1.04 to 
2.01) 
  Age (per year),Sex, History of angina,  
Stroke, smoking, atrial fibrillation,  
LBBB and ischaemia  
Systolic and diastolic blood pressure  
FEV1, Cardiomegaly Blood sugar  
Body mass index 
Struthers 
128 
Scotland 
 
Prospective 
cohort 
Readmission: 
Cardiac  
All 
Carstairs Morris 
Index 
 
1.11(1.004-
1.225) 
1.007(0.933-
1.008) 
 
1.11(1.002-1.224) 
1.013(0.937-1.096) 
 
Age, sex 
*measure of effect not stated 
**also multiple measures of quality of care   
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Socioeconomic deprivation and the health care costs of 
cardiovascular disease 
The health care costs associated with various cardiovascular diseases have been 
documented in multiple health care systems.
136,137 However, in a search of the literature 
only one study directly examined the costs of cardiovascular health care according to 
socioeconomic status. In a report from the Women’s Ischaemia Symptoms Evaluation 
study, the cost associated with a 5 year follow up of 819 women referred for clinically 
indicated coronary angiography was higher in the most versus the least deprived as 
measured by household income.
138 The total hospital costs over five years in the most 
deprived was $40,477 compared to $23,132 in the least deprived (p<0.001). Of course this 
study did not include men limiting its utility. More importantly, the costs in this study were 
determined over a five year period only. As SED confers a higher risk of all cause and 
cardiovascular mortality, would this translate in less opportunity to accrue health care costs 
over time given that the most deprived die earlier? This question remains unanswered as 
does the precise calculation of the costs of cardiovascular hospitalisations according to 
SED.  
 
Socioeconomic deprivation and the health care burden of 
cardiovascular disease 
The literature surrounding SED and CVD may be abundant with studies on the association 
with mortality and case fatality (albeit with great deficiencies). However, with regards to 
the burden of CVD the only information in the literature stems from studies of the cross 
sectional prevalence of disease in various communities according to levels of SED. 
However, a greater burden of prevalent disease according to SED does not necessarily 
equate to greater health care usage. No studies have explicitly examined the relationship 
between SED and the health care system burden of CVD. A few studies of some forms of 
CVD, such as heart failure have presented data on the primary care burden of disease by 
SED 
121.  
In a study of the primary care burden of angina in Scotland, the most deprived individuals 
in 55 general practices, attended their general practitioner less than the least deprived 
individuals (Odds ratio (OR) most versus least deprived 0.67  95% CI 0.57-0.79).
139 In the  
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same setting another report from the same authors found that the most deprived individuals 
with heart failure were also less likely to visit their general practitioner than the least 
deprived individuals with heart failure (OR 0.77, 95% CI not stated, p<0.001). From this it 
can be inferred that the most deprived individuals utilise the health services less than the 
least deprived members of society, however, extrapolating these trends outside of the 
setting of primary care is difficult. A study of patients with heart failure demonstrated that 
the most deprived were less likely to receive specialist care OR 0.65(0.45-0.93). It is not 
known if these trends translate into fewer hospitalisations for CVD in the most deprived 
for certain conditions such as heart failure. The observations above in the primary care 
setting may simply relate to a different health behaviour and health seeking behaviour on 
the part of the most deprived.  
Relationship between socioeconomic deprivation and 
cardiovascular risk factors 
Numerous risk factors for cardiovascular disease have been proposed. What is consistent is 
the finding that some risk factors are undoubtedly the most important. This has been 
demonstrated in multiple studies throughout the 20th and 21st centuries.
67,140 Moreover, 
the importance of these modifiable risk factors has been underlined by the finding that 
reducing exposure to these risk factors through avoidance or drug therapy reduces the rates 
of cardiovascular disease. The main modifiable risk factors for cardiovascular disease are 
smoking, the presence of diabetes mellitus, hypertension, hypercholesterolaemia.
140 
Inevitably as interest in SED and CVD has grown it has been hypothesised that differences 
in the distribution of these risk factors explains the gradient in CVD rates by 
SED.
38,40,71,98,100,141-143 SED has been associated with higher levels of all of these risk 
factors.
25,142,144-148, including in those with and  without cardiovascular disease.
149 In the 
following section I will present the literature surrounding the association between SED and 
these risk factors. In the Renfrew Paisley cohort a number of other variables were 
measured that are also associated with cardiovascular risk. These are body mass index 
(BMI), adjusted forced expiratory volume in 1 second (FEV1), bronchitis measured by the 
Medical Research Council questionnaire and cardiomegaly on chest x-ray. In further 
analyses, these variables were examined in a multivariable model to determine if they 
explained any of the potential gradients in disease risk according to SED. Therefore, the 
association between SED and these additional risk factors will also be discussed here.   
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Smoking 
Smoking is undeniably an important cardiovascular risk factor.
67 A large number of studies 
have examined the relationship between smoking and SED. Smoking is consistently related 
to SED
25,147,150,151 and this is seen in a number of countries
152, but is related to cultural and 
other factors also.
152,153 Whilst in this thesis it would be impossible to summarise all the 
literature surrounding smoking and the relationship with SED there are a number of 
important aspects to the relationship that are worthy of highlighting here. The most 
obvious perhaps is that the deprived consistently display higher rates of smoking at around 
20%.
145 This association is seen in all ages and in both sexes.
146 The relationship is found 
irrespective of the method of measuring SED whether an individual
25 or area based 
measure
154. The relationship is seen in all developed countries.
147,155 Overall, whilst 
smoking rates are falling, in the most deprived the rate of smoking is falling more slowly 
than in the least deprived in the UK.
146 This is not an isolated finding, and has been 
reported in the USA
151 and Denmark
74. Consequently, as a major risk factor for 
cardiovascular disease, this gives rise to the concern that this trend could increase 
inequalities in CVD in the future.  
Hypertension  
Hypertension is another of the major cardiovascular risk factors that is modifiable through 
lifestyle and pharmacological interventions. An inverse relationship with SED has been 
described widely in the developed world and has been comprehensively reviewed 
elsewhere.
156,157 Again, irrespective of the measure of SED used, and whether examining 
systolic or diastolic blood pressure, the most deprived display higher rates of elevated 
blood pressure.
144,147,151,158,159 The relationship persists after adjustment for factors such as 
salt intake and obesity.
160 Furthermore, treatment rates do not affect this relationship.
155 
Whilst overall blood pressure has been falling in the community as a result of primary 
prevention, SED gradients remain.
146,151  
The relationship between blood pressure and SED is one where progress has been made in 
elucidating the determinants of the association. Awareness of the risks of hypertension 
may be lower in the most deprived.
161 The foetal programming hypothesis of Barker has 
been applied to this area in an attempt to explain this association.
162 Factors related to 
foetal under nutrition were associated with the development of hypertension, indicating 
that more deprived life circumstances in-utero, predispose to greater deprivation in later 
life and the development of hypertension. Genetic influences on the relationship between  
65 
SED and hypertension have been reported. A polymorphism of the alpha 2 beta-adrenergic 
receptor has been shown to interact with job strain (jobs with high demands and low 
decision making responsibility i.e. manual class jobs) to lead to raised blood pressure.
163 
Therefore, while the association between SED and hypertension is clear, it is in this area 
where some of the greatest strides are being made to disentangle the pathways by which 
SED leads to higher blood pressure. 
Cholesterol 
Whilst hypercholesterolaemia is a major cardiovascular risk factor the relationship with 
SED is less clear. Many studies have reported that cholesterol increases as the level of SED 
increases.
25,144,147,150,151,164 In a study of over 37,000 women and 33,000 men undergoing 
risk factor screening serum cholesterol was significantly higher in the most deprived as 
compared to the least deprived (as measured by Townsend score).
150 However, the 
magnitude of the difference was reported to be only 0.02mmol/l though this was 
statistically significant (95%CI 0.01 - 0.03). Similar differences in serum total cholesterol 
and HDL cholesterol were recorded in the EUROASPIRE II study.
155 The magnitude of 
difference being similar to the study by Layratzopoulos et al at 0.07mmol/l. However, 
despite these differences the rates of prescribing of appropriate lipid lowering therapy is 
lower in the most deprived.
155,165 Finally, it is not only total cholesterol that is related to 
SED, subclasses of lipids are also related to SED. The most deprived have higher levels of 
triglycerides and  low density lipoprotein cholesterol and lower levels of HDL  
cholesterol.
71,166,167  
Diabetes 
As with cholesterol and blood pressure the presence of non-insulin dependant (Type II) 
diabetes varies according to SED.
147,148,151,155,167 The relationship between the presence of 
diabetes and SED is independent of body habitus. In addition to this the most deprived in 
one study displayed higher levels of insulin, greater blood glucose, greater insulin 
resistance and higher levels of glycosolated haemoglobin A1c
168. These associations 
persisted after correction for body habitus as measured by BMI.
168 In the Whitehall studies, 
the fasting glucose levels of individuals did not seem to differ according to SED.
169 
However, one large epidemiological study reported that there was no relationship between 
SED and diabetes in men.
164 These conflicting studies used only one measure of SED 
highlighting the sentiments of Braveman et al
170 that multiple measures of SED should be  
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used to explore relationships with health outcomes. However, as with smoking, there are 
reports that the disparities in diabetes prevalence by SED may be increasing.
151 
Obesity 
Obesity is consistently associated with a higher risk of cardiovascular disease. This is 
perhaps the best studied risk factor in relation to SED. A recent systematic review of the 
relationship between SED and obesity reported that 144 relevant studies were published 
between 1960 and the mid 1980s and from 1998 to 2004 a further 344 studies were 
identified.
171 Again, many of the studies that have been referenced above in relation to 
other risk factors have reported an inverse relationship between SED and 
obesity.
74,146,147,151 Multiple measures of obesity have been used, BMI, waist hip ratio, as 
have multiple measures of SED.
171 Overall, McLaren et al
171 concluded from their 
comprehensive review that in developed countries socioeconomic deprivation is associated 
with higher rates of obesity in women though in men the association is less clear with 
many studies reporting non-significant associations. In the UK, however, there have been 
reports that this disparity is widening.
146  
Lung function 
Lung function is an understudied risk factor for cardiovascular disease. In a study of the 
Renfrew Paisley cohort, FEV1 was strongly associated with all cause mortality.
172 Multiple 
studies have reported that reduction in a number of measures of lung capacity such as 
forced vital capacity and FEV1 are associated with higher cardiovascular risk.
173-177 The 
risk of coronary heart disease, myocardial infarction and stroke are all higher in those with 
reduced lung function. The Framingham investigators have also reported that reduced lung 
function predicts the development of heart failure.
178 Poorer lung function is associated 
with socioeconomic deprivation.
179,180 Vital capacity, FEV1 and the ratio of the two 
measures are all reduced in the most deprived.  FEV1 may be reduced by up to 300ml in 
men and 200ml in women in the most deprived when compared to the least deprived 
individuals.
179  
Whilst lung function is related to SED, it has been noted above that smoking is related to 
SED and may confound this relationship. However, in one of the largest studies to examine 
the relationship between SED (in this case determined by occupation) and lung function, 
FEV1 in 32,905 people was 2.7% lower in the most deprived compared to the least  
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deprived.
181 This difference was present after correction for height, age, smoking status 
and respiratory illnesses. Amongst non-smokers the association also exists.
182  
Cardiomegaly 
Enlargement of the heart is a well studied cardiovascular risk factor.
183 Increased left 
ventricular mass or chamber size as measured by echocardiography is associated with 
greater cardiovascular risk.
184 Cardiomegaly on a chest x-ray (defined as a cardiac to 
thoracic ratio of greater than 50%) is a simpler measure of cardiac enlargement. The 
presence of cardiomegaly on a chest x-ray increases the risk of developing heart failure 
(over and above the finding of left ventricular hypertrophy on an ECG) in the Framingham 
studies
140 and is also a marker of poor outcome in those with heart failure.
185 A report from 
the Whitehall II study found that cardiomegaly is also associated with an approximately 
doubling of the risk of cardiovascular and coronary heart disease mortality over 25 years of 
follow up independently of cardiovascular risk factors such as age, systolic BP, diastolic 
BP, heart rate, total cholesterol, smoking, history of angina and ECG abnormalities.
186  
Socioeconomic status is related to cardiomegaly. In the Renfrew paisley cohort, a greater 
proportion of the most deprived had cardiomegaly on their chest x-ray
154 and was a 
predictor of future heart failure
125. Whilst chest radiography may be a crude method to 
assess cardiac size, echocardiography allows more accurate quantification of cardiac mass 
and chamber size. In an echocardiographic study, SED as measured by education, was 
inversely related to cardiac mass.
184 
Other cardiovascular risk factors and socioeconomic deprivation 
A number of other novel cardiovascular risk factors have been examined in relation to 
SED. These include other biochemical and haematological risk factors such as 
fibrinogen
71,166,187, c-reactive protein
71,166,188,189, interleukin-6
71,166,189,190, von Willebrand 
factor
166,intercellular adhesion molecule 1
71,189, homocysteine
71,191, serum amyloid A
188 
and monocyte chemoattractant protein-1
189. With the exception possibly of c-reactive 
protein 
192 none of these markers have found their way into everyday clinical use. 
Other physiological risk factors for CVD have been associated with SED. These include 
heart rate variability
193, blood pressure reactivity
194, functional capacity and heart rate 
recovery
195. Whilst these have been studied in an effort to explain the differential outcomes 
observed according to SED, no definitive proof of their role is forthcoming.   
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Finally, one hypothesis that has linked the relationship between SED and CVD is that of 
infection as a cause of CVD. Studies have linked pathogen burden to the risk of  CHD.
196 It 
was hypothesised that greater SED and hence poorer living conditions would expose and 
individual to more pathogens and hence a higher risk of CVD. In a study of the Whitehall 
II cohort, seropositivity for Chlamydia pneumoniae, cytomegalovirus and herpes simplex 
virus 1 did not explain the risk of CHD associated with SED.
180 
Summary 
It is clear from the literature above that SED is related to a number of cardiovascular 
diseases. However, as has been demonstrated most studies have focussed on fatal outcomes 
hence less is known about non-fatal outcomes. Similarly, the majority of prior studies have  
focussed on either coronary heart disease or stroke, hence little is known about the effect 
of, and comparative relationship between, socioeconomic deprivation on the incidence of 
(and outcomes from) other types of CVD such as heart failure. As a consequence of 
relatively small cohort sizes, and, short follow-up, almost all studies have focused on first 
events and have been unable to describe the relationship between SED and recurrent 
cardiovascular events i.e. the complete burden of the disease on secondary care services. 
Another limitation of past studies is the extent of baseline characterisation of the subjects 
and consequent ability to perform comprehensive multivariate analysis in order to 
determine whether socioeconomic deprivation is truly an independent predictor of 
outcome. This is especially important as each of the classical cardiovascular risk factors 
and a number of other risk factors vary by SED. In this thesis I will seek to fill these gaps 
in our knowledge of SED and cardiovascular disease. To do this I will utilise the Renfrew 
Paisley study which is a prospective cohort study of 7,048 men and 8,354 women on 
whom comprehensive cardiorespiratory measurements are available and who have been 
followed for over 25 years. This will be achieved through the aims and objectives outlined 
in the next chapter.   
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Aims and Objectives 
 
Aims 
As a result of the literature review the following aim of this thesis was developed 
·  To describe the association between SED and a number of cardiovascular outcomes 
in an entire cohort of men and women adjusting for cardiovascular risk factors. 
The above aim was translated in to the following objectives 
Objectives 
·  To describe the baseline characteristics and cardiovascular risk factors according to 
SED.  
·  To examine the independent effect of socioeconomic deprivation on the risk of 
admission to hospital with a specific cardiovascular diagnosis.  
·  To compare the absolute and relative strength of association between 
socioeconomic deprivation and cardiovascular morbidity. 
·  To examine the effect of socioeconomic deprivation on the risk of recurrent 
cardiovascular events as well as on first events and the effect on subsequent 
mortality from specific cardiovascular diseases and a number of other composite 
end points. 
·  To examine the impact of socioeconomic deprivation on hospital sector costs. 
·  To estimate the impact of socioeconomic deprivation on the population burden of 
cardiovascular disease, premature mortality, any cardiovascular mortality and all 
cause mortality. 
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Methods 
Data Source 
The Midspan studies are four separate occupational and general population cohort studies 
based in Scotland
197. The original three studies were conducted between 1964 and 1976. 
The Main and Tiree study, 1964-68, was a study of an industrial group of 3,931 individuals 
from 13 factories in the central belt of Scotland. The Collaborative study, 1970-1973, was 
an occupational cohort study of 7,028 individuals from 27 workplaces in the central belt of 
Scotland. The Renfrew/Paisley study, conducted between 1972-1976, was a general 
population cohort from the two towns of Renfrew and Paisley in the outskirts of Glasgow 
(Figure 1).  
Figure 1 Map of Scotland showing the position of Glasgow and Paisley (Red box outlines 
area of detail in Figure 2) 
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Figure 2 Area of detail showing the location of Renfrew and Paisley in relation to Glasgow 
 
 
A fourth study, the Family study, was conducted in 1993-1994 and is a cohort study of the 
offspring of 1,477 families who took part in the original Renfrew/Paisley cohort. The 
Midspan studies originated from a post war drive to control pulmonary tuberculosis using 
mass miniature radiography. In addition to improving the detection and control of 
tuberculosis, the Midspan studies utilised this effective screening method to examine 
cardiovascular and respiratory risk and disease. For this thesis data from the 
Renfrew/Paisley study were used and will be discussed in more detail. 
Population Sample  
The Renfrew/Paisley study is a general population cohort study consisting of 7,048 men 
and 8,354 women who lived in the industrialised towns of Renfrew and Paisley, to the west 
of Glasgow in the west of Scotland. The Renfrew/Paisley study was funded by the by the 
Renfrewshire King Edward Memorial Trust. Eligibility for the Renfrew/Paisley study was 
established by a door-to-door census of all households in the two towns in 1972. Between 
1972 and 1976, all persons aged 45-64 years who met residency criteria were invited to 
complete a questionnaire and attend for a screening examination at one of twelve nearby 
temporary screening centres. Participation rates at baseline were 78.8% of the target 
population in Renfrew and 77.9% in Paisley. Approximately 60% of participants re-
attended for repeat screening between 1977 and 1979.  
Baseline Data 
Each subject’s demographic profile and cardiorespiratory health status was documented 
during their screening visit. Figure 3 shows a floor plan of the accommodation, 
examination stations and route that participants took through a typical temporary 
examination centre as used in the Renfrew/Paisley study. A mobile X-ray unit was 
positioned outside the entrance to perform the chest radiographs.  Approximately ten  
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participants arrived every 10 minutes during each session. Individual questionnaires were 
checked and standardised. Investigations lasting approximately 20 minutes were 
undertaken as participants moved through the examination stations. A further visit six 
weeks later was arranged for participants whose clinical measurements required 
confirmation or clarification. 
Figure 3 Layout of the screening station used in the Renfrew/Paisley cohort study 
 
 
The questionnaire used in the Renfrew/Paisley study was very similar in appearance to that 
used in the Collaborative study but some new questions were included and others (e.g. 
questions on diet and early life) omitted. The data were coded and entered onto computer, 
anonymously. The original questionnaires are currently stored at the University of 
Glasgow archive. The data gathered from the questionnaire are detailed in Table 10. 
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Table 10 Questionnaire data collected at screening 
Questionnaire data 
Sex 
Marital status 
Date of birth 
Occupation 
Exercise 
Medical Research Council bronchitis questionnaire 
Chest wheeze 
Effect of weather on breathing 
Smoking habit 
Rose angina questionnaire 
Severe chest pain 
Diabetes 
Past history of hospital admissions 
Stroke symptoms 
Treatment for blood pressure 
Asthma / hay fever 
Years in present home (Paisley only) 
 
The standard Rose angina classification was used to define the presence of angina.
3,4 The 
validity of the Rose angina questionnaire has been tested in studies comparing it to a 
clinical diagnosis of angina, electrocardiogram abnormality, thallium scanning and as a 
predictor of coronary artery disease mortality.
5,6,7,8  In the classification, Grade I angina is 
defined as pain or discomfort when walking uphill or hurrying. Grade II angina is when the 
subject also reports chest pain or discomfort when walking at an ordinary pace on the level. 
Angina is further classified as “definite” if, in addition, the pain is sited in the sternum or 
the left chest and arm, causes the subject to stop or slow down and resolves within 10 
minutes of the subject stopping or slowing down. If these additional criteria are not 
satisfied, angina is classified as “possible”. For the purpose of this study, “angina” was 
defined as Rose grade I and II “definite” angina and was not confirmed by investigation or 
evaluation. Possible MI (identified by a separate question on Rose questionnaire as having 
ever experienced a severe pain across the front of chest lasting for half an hour or more) 
was noted.
9 The diagnosis of chronic bronchitis was determined by the Medical Research 
Council’s chronic bronchitis questionnaire.
10  A smoking history was recorded including 
average number of cigarettes smoked per day (never smoked, 1-14, 15-24, 25-34, 35 or 
more), ex-smoker (less than 5 years or 5 years or more) or pipe or cigar smoker. A history  
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of diabetes was obtained from the patient and was positive if they reported having been 
told they had diabetes by a doctor.  
A number of clinical variables were also measured at screening (Table 11). Blood pressure 
was recorded as the mean of two measurements taken in the seated position and diastolic 
pressure was recorded at the disappearance of the fifth Korotkoff sound. Height and weight 
were measured and used to calculate body mass index in kg/m
2 (weight in kg divided by 
height in meters squared). Forced expiratory volume in 1 second (FEV1) was measured. 
An adjusted FEV1 was calculated as a percentage of the “expected” FEV1 (derived from a 
linear regression equation of age and height for men and women separately from a healthy 
subset of the sample who were non-smokers and had no respiratory symptoms) and the 
actual FEV1. These equations were: 
Men:     FEV1 = -185.92-2.86 x age + 3.69 x height   
Women:  FEV1 = -22.47-2.89 x age + 2.37 x height 
The cardiothoracic ratio was based on a chest radiograph and cardiomegaly was defined as 
a cardiothoracic ratio <= 0.55. Plasma cholesterol and glucose concentrations were 
measured in a 10ml non-fasting blood sample. Glucose concentration was not measured 
during the whole screening period.  A six-lead electrocardiogram (ECG) was also obtained 
(leads I, II, III, aVR, aVL and aVF) and coded using the Minnesota coding system.  
Table 11 Clinical measurements made at screening 
Clinical measurements 
Blood pressure 
Chest X-ray 
Tine test 
Sputum sample 
Cholesterol (plasma, non-fasting) 
Blood glucose* 
Cardiothoracic ratio  
Height 
Weight 
ECG (Minnesota code) 
Respiratory function, FEV1, FVC 
Biochemical tests*: Sodium (Renfrew only), potassium, Oxygen, Haemoglobin, 
carboxyhaemoglobin 
* only available on some subjects  
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Measures of socioeconomic deprivation 
Measures of SED have been discussed earlier. Two measures of SED were obtained in the 
Renfrew/Paisley study. The first was social class as determined by the participant’s 
occupation recorded on the questionnaire. This was coded according to the Registrar 
General’s classification. For housewives and retired women the occupation of their 
husband or father was used. The classification is outlined in Table 12. Class I is the most 
affluent class and class V the most deprived. Class VI, which denotes service in the armed 
forces, was not used in the cohort.  
Table 12 Registrar General’s Social Class Scheme 
Grade   Example Occupations   
I Professional  Doctor, Lawyer, Executive 
II Intermediate  Sales Manager, Teacher 
III-N Skilled non-
manual 
Shop Assistant, Clerk 
Non-Manual 
III-M Skilled manual  Machinist, Brick layer 
IV Partly skilled  Postman,  
V Unskilled  Labourer, Porters 
Manual 
VI Armed forces     
 
The second measure was determined from a participant’s postcode of residence. Postcode 
sectors were used to assign a Carstairs-Morris index category.
10 The index was originally 
developed in the 1980s using 1981 census data. It is composed of four indicators which 
were judged to represent disadvantage in the population (Table 13). The four indicators are 
combined to create a composite score. The deprivation score is divided into seven separate 
categories, ranging from the most deprived (category 7) to the least deprived (category 1). 
The seven categories were designed so as to retain the discriminatory features of the 
distribution of the deprivation score, rather than to ensure equality of numbers between 
each deprivation category. Some very small postcode sectors were excluded and do not 
have a score. The index was designed with the expectation that it would be mirrored by 
direct measurement of household income if that were possible. Whilst the cohort was 
recruited between 1972-1976, the Carstairs Morris index applied was derived from the 
1981 census. Therefore, the index may not accurately reflect the socioeconomic conditions 
of the cohort at recruitment. However, previous analyses of the cohort 
100,101,125,172,198 and 
their congruency with the published literature would suggest that this potential bias has 
little meaningful effect on the results of the study.  
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There are 1010 postcode sectors in Scotland, identified by a combination of the first five 
characters of the postcode (representing 937 areas) and the Council Area. The average 
population is 5012 (range 51 people to 20,512). A total of 15,370 participants (99.8% of 
the total cohort) had a documented postcode of residence that was used to determine SED 
based on the Carstairs–Morris Deprivation category. It should be noted that none of the 
postcode sectors of the participants in the Renfrew/Paisley study mapped to deprivation 
category 2. 
Table 13 Constituent variables in the Carstairs Morris Index 
Variable   Definition 
Degree of Overcrowding   Persons in private households living at a density of 
more than one person per room as a proportion* of 
all persons in private households 
Level of Male unemployment   Proportion of economically active males who are 
seeking work 
Proportion in Social class 4 or 
5 
Proportion of all persons in private households with 
head of household in social class 4 or 5 
Ownership of a car  Proportion of all persons in private households with 
no car 
 
Ethical approval and Follow-up  
Written consent was given at the time of enrolment into the study for hospital records to be 
subsequently monitored. Latterly ethical permission was obtained from Argyll and Clyde 
local and regional ethics committee for linkage with the Scottish Morbidity Record (SMR) 
system. Electronic linkage to hospital and death records is possible for all residents of 
Scotland through the SMR.  
Scottish Morbidity Record (SMR) 
Healthcare data for individual patients in Scotland is collected as a series of Scottish 
Morbidity Records.
199 The record type denotes the general type of healthcare received 
during an episode. The hospital activity SMRs are outpatient attendances (SMR00), all 
discharges from acute hospitals (SMR01), maternity units (SMR02), psychiatric units 
(SMR04), neonatal units (SMR11) and geriatric long stay inpatients (SMR50). Analysis of 
SMR01 data were used for this study. An SMR01 record is an episode-based patient record 
relating to all inpatient or day case discharges from non-obstetric and non-psychiatric 
specialties. Elective and emergency admissions are included. A SMR01 record is generated 
when a patient is discharged home from hospital, transferred to another clinician (either at  
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the same or a different hospital), changes specialty (either under the same or a different 
clinician), or dies. Data collected include patient identifiable and demographic information 
as well as episode management details (such as length of stay) and general clinical 
information. Each patient is given a principal diagnosis and up to five secondary diagnoses 
and up to four operative procedures. These secondary diagnoses are recorded if they affect 
the management of the patient or are associated with the main condition or are chronic 
conditions. Diagnosis at discharge is coded using the World Health Organisation (WHO) 
International Classification of Diseases (ICD) system. Diseases are coded initially using 
the eighth revision (ICD-8, a small number of initial episodes), the ninth revision (ICD-9) 
up to March 31st 1996 and the tenth revision (ICD-10) thereafter. The data are abstracted 
from case notes and then transcribed onto an SMR01 form. The Information and Statistics 
Division (ISD) of the NHS Scotland collates the data at National level. The General 
Register Office for Scotland records the causes of death for all Scottish residents. The 
codes used to classify deaths are allocated using the WHO International Classification of 
Diseases.  ICD9 was used between 1979 and 1999 and ICD10 has been used since 1st 
January 2000. Classification of the cause of death is based on information collected on the 
medical certificate of cause of death which contains information on the underlying cause of 
death and up to three other causes considered to have contributed to death.    
Since the 1970’s these datasets, SMR and death registration records, belonging to the same 
patient in Scotland have been linked together in the Scottish Record Linkage System.
199 
Therefore, the linked data set holds hospital discharge records for non-psychiatric, non-
obstetric specialties (SMR01) together with Registrar General’s death records from 1981 
until the present day.  Ad hoc linkages can also be carried out dating back to 1968. Records 
from individual hospital episodes from different SMR schemes and records from the 
Registrar General are linked using probability matching record linkage to provide profiles 
for each patient. Over the last thirty years, methods of probability matching have been 
developed and refined in Oxford, Scotland and Canada and are used by the Record 
Linkage System to allow for inaccuracies in the identifying information.
199 When records 
are linked, two records are compared using identifying items such as surname, first initial, 
sex, year, month and day of birth and postcode and a decision is made as to whether they 
belong to the same individual. Surnames are changed to coded format in order to avoid the 
effects of differences in spelling. A computer algorithm calculates a score for each pair of 
records that is proportional to the likelihood that they belong to the same person.  The huge 
volume of data would mean it is be impossible to carry out probability matching on all 
pairs of records involved in the linkage and blocking is used to cut down the number of 
comparisons required. Only those records that have a minimum level of agreement in  
78 
identifying items are compared. Probability matching then allows mathematically precise 
assessment of the implications of the levels of agreement and disagreement between 
records. 
Quality of the data 
The self-completed health questionnaire at baseline screening was checked by experienced 
interviewers at the screening examination.  
The linkage process is largely automatic as a threshold score based on probability 
matching dictates the decision as to whether the records belong together. Clerical checking 
has shown that the accuracy of probability matching is 98%. The accuracy of follow up 
using this method has been validated against standard follow up using a clinical trial. In 
comparison to the standard method of follow up, linkage of records to SMR compared 
favourably.
144  
The Quality Assessment and Accreditation Unit of Information and Statistics Division of 
NHS Scotland monitors the quality of SMR data, by assessing accuracy, completeness, 
consistency and fitness for purpose. It carries out routine validation of a sample of SMR01 
records where data held on the sampled records are compared with information contained 
in the medical case notes. An assessment of the accuracy of SMR01 data, carried out 
between 2000 and 2002, on a 2% sample of SMR01 data found the accuracy for recording 
of clinical data at the three-digit level was 88% for the main diagnosis falling to 81% at the 
four-digit level.
200 The accuracy of the main diagnosis was 89% from the 1997/98 audit. 
The accuracy for main procedure/ operation was 91% accurate and other procedures/ 
operations 92% accurate. The accuracy for non-clinical data items was 97%. 
Cardiovascular diagnoses were 91% accurate overall.  
Organisation and extraction of the data 
The Renfrew/Paisley study is co-ordinated from the Department of Public Health and 
Health Policy in the University of Glasgow. Data pertaining to the initial and follow-up 
screening visits are held in SPSS file format. The cohort is updated for mortality on a three 
monthly basis including full checks on the status (dead/alive) of the oldest participants. At 
the time of commencing these studies subsequent hospital admission data for the cohort 
were available to the date of 31
st of March 2004. In collaboration with Midspan staff, Dr  
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Carole Hart and Mrs Pauline McKinnon, a data extraction specification was written which 
detailed the nature of the baseline and follow-up data required for the studies in this thesis. 
Ethical approval and data extracted for present studies 
The Midspan Steering Committee approved the studies. Permission was given by the 
Privacy Advisory Committee of the Information and Statistics Division to use the linked 
data. All studies were approved by the University of Glasgow ethics committee.  
Each patient record contained all information available from the baseline questionnaire. 
Date of death and cause of death until 31st March 2004 were also included. In addition the 
date of all hospitalisations and cause of all hospitalisations was also available up until this 
date. Date of censorship was from the date of each individual’s initial screening visit to 
death, end of follow up or in a few cases date of emigration. Loss to follow up occurred in 
less than 1% of the cohort. 
Statistical analysis 
All analyses were undertaken using Stata (Version 10, Stata Corporation, College Station, 
Texas, USA). All tests of statistical significance were two tailed. Statistical significance 
was taken at the conventional level of 5% (P<0.05). The use and limitations of, p values 
has been widely discussed in the scientific literature.
201,202 The p value dichotomises the 
results of statistical analyses into “significant” or “non-significant” and removes any 
further interpretation of the data.
203 A non-significant p value indicates that there is no 
difference between two or more groups, or that that the study is underpowered to detect the 
difference between groups; it does not indicate which of these two options is true.
204 A 
more appropriate analysis is to calculate a confidence interval which allows an assessment 
of the strength of evidence.
205 For analyses in this thesis 95% confidence intervals were 
calculated. Major scientific journals insist on the presentation of confidence 
intervals.
201,205,206  As Altman
204 states “The main purpose of confidence intervals is to 
indicate the (im)precision of the sample study estimates as population values.”  He 
discusses the interpretation of confidence intervals, making a number of important points 
about their interpretation.
204 Firstly, values outside of the interval are not excluded by the 
interval, they are simply less likely. Secondly, the middle of the interval is more likely to 
contain the true population value than the two extreme quarters. The final, and perhaps the 
most often overlooked aspect of the interpretation of confidence intervals, is that regardless  
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of the width of the confidence interval, the sample estimate is the best indicator of the true 
population value.  
Confidence intervals, as with p values, are open to misuse.
206 The most common misuse of 
confidence intervals occurs when they include the null value (the confidence interval 
crosses the value of no effect).
203,204,207,208  In this case the confidence interval is often 
interpreted as proof of no effect.
208 Whilst this is based on a correct link with the p value, 
interpretations of confidence intervals in this way effectively dichotomise the interval back 
into “significant” or “non-significant” test. This denies the reader the option of making a 
more informative interpretation of the interval as outlined above.
204,207 Therefore, the 95% 
confidence intervals calculated are interpreted as intervals, following the above, and not as 
tests of significance.
204 Finally, epidemiologists such as Bradford Hill
209 suggest that the 
results of analyses should be interpreted in relation to the other analyses performed and of 
other published literature.
210  Therefore, analyses were interpreted in relation to each other 
and whether they were consistent with the published literature if available.  
Rates 
Rates were calculated from date of screening to the date of event or censoring (death or 
end of follow up). Rates are expressed per 1000 person years follow up. Rate ratios were 
calculated using the Mantel-Cox method.  
Cox regression 
Cox proportional hazards regression
211 was used to model the effect of a number of 
covariates and their association with the risk of various events. Models were used to adjust 
for the variation in distribution of various risk factors between individuals of differing 
SED. Initially variables which have been consistently associated with cardiovascular risk, 
were entered into the model to adjust for their variable distribution between socioeconomic 
groups. Next variables that are not considered “traditional” risk factors but have previously 
been shown to be associated with cardiovascular disease, body mass index, adjusted FEV1, 
history of bronchitis and cardiomegaly, were entered into the model. Backwards stepwise 
regression was used to determine those additional variables that would be adjusted for in 
further analyses after adjustment for the “traditional” cardiovascular risk factors, age, sex, 
smoking, blood pressure, cholesterol and diabetes mellitus. The significance level of the 
likelihood ratio test of these variables is given in table 14.  
81 
Table 14 Significance level of additional variables entered into the model 
Variable  P 
Body mass index  0.0004 
Adjusted FEV1  <0.0001 
Bronchitis on MRC questionnaire  0.0013 
Cardiomegaly (cardiothoracic ratio of 
>=0.5 on chest radiograph) 
<0.0001 
 
Therefore, the final models used in these analyses included, age, sex, SED (measured by 
Carstairs Morris index or social class), diabetes, smoking, cholesterol, systolic blood 
pressure, body mass index, adjusted FEV1, bronchitis and cardiomegaly.  
Inequality was measured by comparing the hazard and rate ratio in the most versus the 
least deprived. It was also measured using the population attributable fraction. These are 
the most common methods of exploring health inequalities in the literature. Other  methods 
do exist and have advantages and disadvantages, in particular they describe the relationship 
between health outcomes and the whole distribution of SED.
212-215 The Gini coefficient, 
modified Gini coefficient and index of dissimilarity all enable inequalities in health to be 
measured from the most to least deprived and all levels between.
212,213 However, they are 
univariate measures and were therefore unsuitable for examining the aims of this thesis.
212  
The concentration index
212,214,215 can discriminate between a situation where the most 
deprived are the sickest and where the least deprived are the sickest whilst describing the 
gradient in inequality (the Gini index cannot and will arrive at the same answer in both of 
these situations). However, it can only be used where the socioeconomic categories can be 
ranked in strict hierarchical order, for example when using education or income as a 
measure of SED. This measure is not suitable for measures such as social class where this 
very strict ordering is not true. Multivariable measures do exist. Regression coefficients 
and Pearson’s correlation coefficients may be calculated to fully describe the relationship 
between SED and health.
214 However, they require that the health outcome and scale used 
to measure socioeconomic status are continuous variables. As such they were not 
appropriate for use in the setting of survival analysis as in this thesis. Finally, the slope 
index of inequality and a transformation of this, the relative index of inequality may also 
be used to describe the frequency of a health outcome and socioeconomic 
category.
212,214,215  However, the indices rely on the assumptions of linear regression, and, 
most importantly, that again the socioeconomic categories must be strictly hierarchical. 
Therefore, these indices are not useful in the current thesis as linear regression would not  
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be a valid technique for the analysis of survival times and the measures of SED are not 
strictly hierarchical.  
As noted above, in this thesis I will examine inequalities in outcomes through the rate ratio 
and comparison of the hazard ratio of the most versus the least deprived. The hazard ratio 
has a number of advantages over the other measures outlined above. Firstly, it is easily 
interpretable. Secondly, the technique of survival analysis can be employed which is the 
most appropriate method of analysing these longitudinal data. Thirdly, adjustment can be 
made for traditional risk factors in examining the relationship between CVD and SED 
which is difficult with the above techniques. Finally, none of the techniques outlined above 
allow the relationship between SED and an outcome to be compared across outcome types 
which can be done using the Cox model and this is one of the aims of the thesis. Survival 
analysis and rate ratios are also the most commonly used methods in the literature for 
examining health inequalities making the analyses in this thesis easily comparable. These 
advantages outweigh the limitation of this approach, that only the ends of the 
socioeconomic spectrum will be described and not the relationship across all categories. 
The proportional hazards assumption was tested using Schoenfeld residuals
216 and was met 
for all variables in the model.    
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Risk of a first Cardiovascular Hospitalisation 
In this section I will present the results of analyses examining the association between SED 
and the risk of a number of first cardiovascular hospitalisations after adjustment for a 
number of recognised risk factors. The relationship is examined using traditional methods 
of survival analysis and competing risks analysis to account for the risk of various different 
cardiovascular diseases. As a result, I aim to determine if SED is associated with a higher 
risk of certain cardiovascular outcomes. In addition, a range of composite endpoints will be 
examined including endpoints incorporating all cause mortality.  
Methods 
Introduction to the competing risks model 
Cox regression is a well studied and frequently used method of analysing the survival 
experience of a cohort. Standard survival data measure the time from one point until the 
event of interest occurs e.g. myocardial infarction or death. In a typical setting, such as 
clinical trial, the effect of an intervention such as a new pharmacotherapy that is thought to 
prevent the outcome of interest is examined on the time to outcome in relation to a gold 
standard treatment or more commonly placebo. In epidemiological studies data are 
obtained from observational studies such as the present cohort study. In such studies we 
are interested in the association between a variable (in this case SED) and the event of 
interest. However, in cohort studies (and indeed clinical trials) more than one type of event 
can occur during follow up and the variable under study may be associated with a higher 
risk of more than one type of event. This situation arises in the current study where SED is 
associated with multiple cardiovascular outcomes and also death. Whilst one event is 
usually chosen as the event of interest the occurrence of the other event may prevent the 
event of interest from occurring (e.g. death prevents an individual experiencing a 
myocardial infarction) or it may lead to a change in therapy that alters the risk of the event 
of interest from occurring (e.g. the prescription of secondary prevention following a 
myocardial infarction). Similarly, as in this thesis, we may be concerned with the 
relationship between a variable and a number of different outcomes. In such a situation 
caution should be exercised when estimating the probability of the event of interest 
occurring in the presence of these "competing risks". Treating the events of the competing 
causes as censored observations, as is done in standard survival analysis techniques such as 
Kaplan-Meier analysis, will lead to a bias in the Kaplan-Meier estimate if one of the  
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fundamental assumptions underlying the Kaplan-Meier estimate is violated: the 
assumption of independence of the time to event and the censoring distributions. The Cox 
proportional hazards model can still be used in this situation though interpretation of the 
results becomes more problematic. One other situation where the competing risks approach 
is of use is worthy of mention at this point as I will not be expanding further on this in the 
thesis. Individuals throughout life, despite the best efforts of health care professionals, 
move between different states of ill-health and health. One simple example is that of a 
cancer that can be put into remission. An individual may start as "healthy", during follow 
up develop the cancer of interest and receive treatment and then enter remission. This 
individual may then move between the state of remission and disease throughout follow up 
or indeed die from the cancer at any point during follow up. A similar parallel in 
cardiovascular medicine would be angina. One may develop angina, receive 
revascularisation therapy and be free of angina though develop it again later in follow up 
whilst all the time being at risk of myocardial infarction. Therefore, instead of survival data 
or time-to-event data, data on the history of events are available. Multi-state models 
provide a framework that allow for the analysis of such event history data and they can be 
seen as an extension of competing risk models.
217 I will not examine multistate models in 
this thesis though more detail can be found elsewhere.
217 
Bias of the Kaplan Meier estimates 
The need for the competing risk approach comes from the finding that in certain situations 
the Kaplan-Meier approach is flawed because the assumptions of the technique are violated 
in this setting. The assumption of independence of the censoring distribution, i.e. the 
distribution of the time to the competing events is violated in a competing events situation. 
Putter et al 
218succinctly state that "If the competing event time distributions were 
independent of the distribution of time to the event of interest, this would imply that at each 
point in time the hazard of the event of interest is the same for subjects that have not yet 
failed and are still under follow-up as for subjects that have experienced a competing event 
by that time. However, a subject that is censored because of failure from a competing risk 
will with certainty NOT experience the event of interest. Since subjects that will never fail 
are treated as if they could fail (they are censored), the naive Kaplan-Meier overestimates 
the probability of failure (and hence underestimates the corresponding survival 
probability)." An example is censoring people who die during follow up when examining a 
non-fatal event. This is theoretically different from censoring due to end of study or loss to 
follow-up. In the latter situation, individuals may still fail at a later time point. In such a  
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situation the naive Kaplan-Meier estimates describe what would happen if the competing 
event could be prevented, thus creating an imaginary world in which an individual remains 
at risk for failure from the event of interest. These issues have been the subject of debate in 
the literature though it is now accepted that in the presence of competing risks the Kaplan-
Meier estimates are biased. Putter et al
218 in their paper explore the issues in much greater 
detail than I am able to do so here, and they are also succinctly discussed by Rao and 
Schoenfeld in another article 
219.  
The analysis of competing risk data 
As noted the competing risks approach makes the used of traditional methods such as the 
Kaplan-Meier estimate problematic. Instead the presentation of cumulative survival curves 
is the preferred method for presenting these analyses. The mathematical derivation of 
cumulative incidence curves is beyond the scope of this thesis but is eloquently explained 
through worked examples by Putter et al
218. In essence however the cumulative incidence 
curves are simply plots of the proportion of patients with the event of interest or the 
competing event as time progresses. In Kaplan-Meier analysis the two curves or groups of 
interest can be compared using a log-rank test and the association between the outcome 
and variable of interest examined using a Cox regression analysis whilst adjusting for other 
risk factors. In a competing risks situation, the equivalent steps are to generate cumulative 
incidence curves then test the difference between cumulative incidence curves using the 
Fine and Gray
220 method, and perform a competing risk regression analysis. Again for the 
same reasons that the Kaplan-Meier plot is not suitable in this situation the standard Cox 
proportional hazards model analysis is not adequate in the presence of competing risks. 
This is because the cause-specific Cox model treats the competing risks of the event of 
interest as censored observations. To overcome this problem two methods of regression 
analysis have been proposed in the setting of competing risks, regression on cause-specific 
hazards, which will be used in this thesis, and regression on the cumulative incidence 
functions.  
Regression on the cause-specific hazards 
If the covariate is continuous or association between the cause-specific event is of interest, 
a competing risks analogue of a Cox proportional hazards model is possible as the 
regression on the cause-specific hazards is possible. In proportional hazards regression on 
the cause-specific hazards, we model the cause-specific hazard of cause k for a subject  
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with covariate vector Z, observation time t as  
 
 One advantage of this method over that of regression on the cumulative incidence 
functions is that the equality of covariate effects across different events or outcomes can be 
assessed. It is this feature of regression on the cause-specific hazards that will be utilised in 
this thesis to determine if the effect of SED on the risk of a cardiovascular event is equal 
across a number of different cardiovascular event types.  
Regression on the cumulative incidence functions 
Fine and Gray
220 described a method to perform a regression directly on cumulative 
incidence functions that are calculated in a competing risk analysis.  
The Fine and Gray regression does not yet allow the flexibility (e.g. in testing for or 
assuming equality of covariate effects across different failures or events) of regression on 
cause-specific hazards. Given this limitation of this approach in not allowing the equality 
of covariate effects across different events, the Fine and Gray method is not used here.  
Implementation of the technique 
Both techniques are available in standard statistical packages. The method of Fine and 
Gray, regression on cumulative incidence is implemented in R using the cmprsk command. 
However, I have used the stcompet module in Stata to implement the regression on cause-
specific hazards in this thesis. Further information on implementing this command can be 
found online at http://www.stata.com/support/faqs/stat/stmfail.html.  
The use of composite endpoints to deal with competing 
risks 
One method of examining competing risks that has not been discussed above is the use of 
composite endpoints. The use of composite endpoints is widespread in the medical 
literature. They are commonly used to examine an outcome of interest in the presence of  
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other outcomes of interest or competing outcomes such as death. Their use is widely 
debated in the medical literature.
221-224 They can be useful from a number of standpoints: 
1. To decrease the sample size required to show and effect of the treatment in a clinical 
trial 
2. To examine the totality of effect of a therapy or association with a variable. 
3. To deal with competing risks 
I will concentrate on their third use above, that of a method to deal with competing risks. 
For example, if we take the scenario of a study of patients with angina, an endpoint of 
hospitalisation for myocardial infarction would be problematic as it does not account for 
death. In such an analysis deaths would be censored, however these deaths are 
‘‘informative’’. A patient who is censored due to death is not at the same risk of 
hospitalisation, had they survived, as a patient who survived as long and is still at risk for 
hospitalisation but say censored because they emigrated and left the study. If censoring 
because of death varied by groups of interest, the estimate of effect would be biased. 
Therefore, a composite of death or myocardial infarction hospitalisation is used. Therefore, 
in this thesis I also examine composite endpoints to assess the impact of SED on 
cardiovascular outcomes.  
The impact of regression dilution 
During the multivariable regression analyses, follow up was taken until the end of the 
study i.e. 28 years. For first hospitalisations models were also constructed at 5 year 
intervals up until this point. From the results of the multivariable analysis there was 
evidence of regression dilution when analyses were extended past 25 years. Regression 
dilution is a phenomenon that occurs when the association between a variable and outcome 
is underestimated because of the long period of time between the measurement of the 
variable and the occurrence of the event of interest.
225 Whilst methods exist to account for 
regression dilution bias, given the magnitude of the potential loss to follow up by limiting 
analyses to a period where regression dilution was not occurring (i.e. the loss of 3 years of 
follow up), limiting the length of follow up was the most appropriate method. This did not 
alter the conclusions of the studies and removed this bias. Therefore, univariable and 
survival analyses are limited to 25 years of follow up. Hazard ratios for 28 years of follow  
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up are presented in the table of regression analyses of first cardiovascular hospitalisations 
to demonstrate this phenomenon. 
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Results  
 
Model Building and baseline characteristics of the cohort 
Model Building  
Prior to commencing analyses of the association between SED and cardiovascular disease 
a multivariable model was built and variables associated with the development of 
cardiovascular disease were examined. Individuals with no prior history suggestive of 
CHD were identified. Prior CHD was defined by a positive answer to the questions on MI 
in Rose questionnaire or definite angina as defined by the Rose questionnaire or ECG 
findings compatible with previous MI (Q waves or left bundle branch block). The outcome 
of admission for CVD was used as the endpoint in the model building stage.  Initially 
variables which have been consistently associated with cardiovascular risk were entered 
into the model to adjust for their variable distribution between socioeconomic groups. 
Next, variables that are not considered “traditional” risk factors but have previously been 
shown to be associated with CVD, body mass index, adjusted FEV1 , history of bronchitis 
and cardiomegaly, were entered into the model. Backwards stepwise regression was used 
to determine those additional variables that would be adjusted for in further analyses after 
adjustment for the “traditional” cardiovascular risk factors outlined in Table 15.  The 
significance level of the likelihood ratio test of these variables is given in Table 15 for SED 
measured by Carstairs Morris index of deprivation and Table 16 for SED measured by 
social class. 
Table 15 Significance level of cardiovascular risk factors in a multivariable model when 
Carstairs Morris index is used as a measure of socioeconomic deprivation 
Variable  P 
Carstairs Morris index  0.0022 
Age  <0.0001 
Sex   <0.0001 
Diabetes  <0.0001 
Smoking  <0.0001 
Cholesterol  <0.0001 
Systolic blood pressure   <0.0001 
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Table 16 Significance level of cardiovascular risk factors in a multivariable model when 
social class is used as a measure of socioeconomic deprivation 
Variable  P 
Social Class  0.0066 
Age  <0.0001 
Sex   <0.0001 
Diabetes  0.0007 
Smoking  <0.0001 
Cholesterol  <0.0001 
Systolic blood pressure   <0.0001 
 
The relative contribution of these factors to the model can be measured using the Chi 
squared distribution and is given in Table 17. As can be seen from the Chi square value the 
largest contributor to the model is systolic blood pressure followed by age. These two 
variables contributed most to the model when modelling all cause cardiovascular 
hospitalisation. As can be seen from the values SED as measured by the Carstairs Morris 
index made a greater contribution to the model than either cholesterol or diabetes.  
A similar pattern was seen when social class was used as the measure of SED.  This was a 
greater contributor to the model than diabetes (Table 18). 
Table 17 Contribution of each variable to the multivariable model when Carstairs Morris 
index is used to measure socioeconomic deprivation  
Variable  Chi 
Systolic blood pressure   225.1 
Age  178.4 
Sex   150.7 
Smoking  116 
Carstairs Morris Index  31.2 
Cholesterol  18.4 
Diabetes  9.6 
 
 
Table 18 Contribution of each variable to the multivariable model when Social Class is used 
to measure socioeconomic deprivation 
Variable  Chi 
Systolic blood pressure   222.8 
Age  182.4 
Sex   140.8 
Smoking  125.9 
Cholesterol  23.7 
Social Class  16.1 
Diabetes  14.4 
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As noted above the contribution of each of the variables to the model was again tested for a 
model that included the variables of BMI, adjusted FEV1, history of bronchitis and 
cardiomegaly on chest x-ray. This was examined both for Carstairs Morris index of 
deprivation (Table 19) and social class (Table 20) as measures of deprivation.  
Table 19 Significance level of variables in the multivariable model with Carstairs Morris 
index as the measure of deprivation after stepwise selection of additional risk factors 
Variable  P 
Carstairs Morris Index  0.0022 
Age  <0.0001 
Sex   <0.0001 
Diabetes  <0.0001 
Smoking  <0.0001 
Cholesterol  <0.0001 
Systolic blood pressure  <0.0001 
BMI  0.0004 
FEV1  <0.0001 
Bronchitis  0.0013 
Cardiomegaly   <0.0001 
 
 
Table 20 Significance level of variables in the multivariable model with Social Class as the 
measure of deprivation after stepwise selection of additional risk factors  
Variable  P 
Social Class  0.035 
Age  <0.0001 
Sex   <0.0001 
Diabetes  <0.0001 
Smoking  <0.0001 
Cholesterol  <0.0001 
Systolic blood pressure   <0.0001 
BMI  0.0003 
FEV1  <0.0001 
Bronchitis  0.0009 
Cardiomegaly   <0.0001 
 
 
 
Interactions 
Finally, for each of the main types of cardiovascular hospitalisation, interactions between 
age and sex and SED measured using the Carstairs Morris index and social class were 
examined (Table 21 and 22). No interactions were found with the exception of that 
between social class and age. This was the only interaction found, it was not congruent 
with the Carstairs Morris index or strongly suggested by previous literature and therefore it 
was not entered into the models.   
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Table 21 P value of interactions between age and sex with socioeconomic deprivation 
measured by Carstairs Morris index 
  Deprivation Age   Deprivation Sex 
CVD  0.6693  0.4215 
MI  0.5575  0.2446 
Stroke  0.3041  0.1364 
HF  0.4129  0.8635 
CHD    0.2151  0.8368 
 
 
 
Table 22 P value of interactions between age and sex with socioeconomic deprivation 
measured by social class 
  Social Class Age   Social Class Sex 
CVD  0.7379  0.9768 
MI  0.0069  0.1529 
Stroke  0.9696  0.2513 
HF  0.7923  0.8454 
CHD    0.7307  0.0709 
 
 
Baseline characteristics 
The baseline characteristics of the cohort according to SED are outlined in table 23 and 24 
according to both Carstairs Morris index and social class.  
As can be seen from Table 23 a number of variables were statistically significantly 
distributed unevenly across categories of the Carstairs Morris index. For example, mean 
age in the least deprived was 54.9 years and 54.6 in the most deprived (P<0.001). Similarly 
cholesterol and body mass index varied across groups and reached statistical significance. 
Each of systolic blood pressure, adjusted FEV1, the proportion of men, smokers, those 
with cardiomegaly and bronchitis was also statistically significantly different across each 
group.  
When individuals were split by social class mean age in the most deprived was higher than 
the least deprived. Similarly systolic blood pressure, adjusted FEV1, the proportion of 
men, smokers, those with cardiomegaly or bronchitis was also statistically significantly 
different across social groups. Cholesterol and body mass index were also statistically 
significantly different.   
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Missing data 
No variables were clinically significantly different between those with missing SED by 
Carstairs Morris index and those assigned SED (Table 20). Those with missing social class 
had a slightly higher blood pressure (149.3mmHg (SD 24.3mmHg)) than those who has 
social class assigned (151.8 (SD 25.8)), P=0.04. They were also less men, P<0.001 and less 
smokers, P<0.001. All other variables were not different between those with and without 
social class assigned.  
In those with missing social class there were fewer men, smokers, and less with 
cardiomegaly (Table 24).   
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Table 23 Baseline characteristics of individuals according to Carstairs Morris index of deprivation 
    1    3    4    5    6 & 7    P  Missing    P 
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    54.9  (5.5)  53.7  (5.5)  54.0  (5.5)  53.7  (5.5)  54.6  (5.6)  <0.001  53.6  (5.7)  0.3 
Systolic BP (mmHg)    148.9  (23.7)  149.4  (23.6)  145.5  (23.1)  151.3  (24.4)  147.9  (24.2)  <0.001  145.8  (23.1)  0.55 
Cholesterol (mmol/l)    6.1  (1.0)  6.2  (1.0)  6.2  (1.0)  6.1  (1.1)  6.1  (1.0)  <0.001  6.3  (1.0)  0.48 
Body mass index (kg/m
2)    25.3  (3.6)  25.4  (3.7)  25.5  (3.8)  25.8  (4.0)  25.9  (4.3)  <0.001  25.9  (2.8)  0.98 
adjusted FEV1 (% predicted)    97.7  (22.0)  95.7  (20.5)  92.8  (22.2)  91.8  (22.0)  88.2  (23.0)  <0.001  97.1  (27.9)  0.15 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    363         (42.2)  830       (47.1)  1,236       (44.2)  2,100       (45.9)  1,213  (43.4)  0.03  20  (66.7)  0.01 
Smoker       597       (60.3)  1,281       (61.5)  2,242       (67.0)  3,837       (69.3)  2,402          (70.9)  <0.001  20  (58.8)  0.28 
Diabetes    7          (0.7)  28          (1.3)  40          (1.2)  69          (1.3)  46   (1.4)  0.6  7  (0.5)  0.51 
Cardiomegaly    251                 (25.4)  451  (21.6)  749       (22.4)  1,322         (23.9)  930  (27.4)  <0.001  6  (23.1)  0.81 
Bronchitis      24                  (2.4)  68  (33)  154         (4.6)  276         (4.9)  231           (6.8)  <0.001  2  (5.8)  0.79 
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Table 24 Baseline characteristics of individuals according to Social Class 
    I    II    III (NM)    III (M)    IV    V    P  Missing    P 
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    52.9  (5.1)  53.6  (5.4)  53.8  (5.5)  54.2  (5.6)  54.8  (5.4)  54.5  (5.8)  <0.001  54.5  (5.8)  0.04 
Systolic BP (mmHg)    146.1  (20.9)  146.7  (23.0)  147.7  (23.6)  150.1  (23.7)  149.0  (24.7)  151.6  (26.0)  <0.001  151.2  (24.81)  0.04 
Cholesterol (mmol/l)    6.2  (1.0)  6.2  (1.0)  6.3  (1.1)  6.0  (1.1)  6.1  (1.1)  6.1  (1.0)  <0.001  6.1  (1.2)  0.58 
Body mass index (kg/m
2)    25.2  (3.4)  25.6  (3.6)  25.2  (3.8)  26.0  (3.9)  25.8  (4.1)  26.2  (4.6)  <0.001  25.2  (4.2)  0.08 
adjusted FEV1 (% predicted)  99.5  (21.3)  97.4  (21.2)  95.1  (21.6)  90.6  (21.9)  89.4  (22.4)  87.0  (23.1)  <0.001  90.5  (22.6)  0.08 
    N   %  N   %  N   %  N   %  N   %        N   %   
Men    302         (64.4)  829       (43.3)  673       (27.9)  2,302       (65.5)  1,274  (40.7)  326  (31.1)  <0.001  56  (16.2)  <0.001 
Smoker       296       (63.1)  1,199       (62.6)  1,459       (60.7)  2,557       (72.7)  2,114          (67.6)  726          (69.3)  <0.001  185  (53.6)  <0.001 
Diabetes    5          (1.1)  22          (1.2)  20          (0.8)  34   (0.9)  36   (1.2)  14   (1.3)  0.77  6  (1.8)  0.08 
Cardiomegaly    70                 (15.4)  374  (20.6)  549       (23.6)  775         (25.8)  302  (29.7)  773  (25.8)  <0.001  93  (27.7)  0.26 
Bronchitis      3                  (0.6)  30  (1.6)  49    (2.0)  139        (3.9)  110           (3.5)  52           (4.8)  <0.001  7  (2.0)  0.78 
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Study participants 
Of the 15,344 cohort members (which excludes 24 individuals who were lost to follow up) 
with an assigned deprivation category, 2,594 were excluded from the present analyses as 
they had a history of ischaemic heart disease, leaving 5,742 men and 7,053 women in the 
analyses. Of the 14,995 assigned to social class, 2,475 were excluded with a history of 
ischaemic heart disease (leaving 5,706 men and 6,774 women). 
The numbers of each type of first cardiovascular hospitalisation experienced by each 
deprivation group is outlined in Table 25 according to Carstairs Morris index and Table 26 
according to social class.   
97 
Table 25 Number of cardiovascular hospitalisations by Carstairs Morris 
index category and years of follow up 
  Years  1  3  4  5  6 & 7 
CVD  5  49  93  145  224  170 
  10  85  188  289  503  388 
  15  152  305  494  848  612 
  20  211  450  732  1295  878 
  25  273  594  956  1646  1060 
             
CHD  5  18  29  32  84  59 
  10  25  58  76  195  136 
  15  51  111  159  339  233 
  20  71  182  256  526  333 
  25  89  239  346  679  408 
             
MI  5  13  24  28  75  46 
  10  20  49  61  174  114 
  15  42  84  130  291  186 
  20  59  136  200  419  250 
  25  70  174  256  510  304 
             
Stroke  5  4  6  17  31  23 
  10  12  34  44  88  68 
  15  23  62  88  180  127 
  20  37  101  173  308  218 
  25  64  159  261  447  307 
             
HF  5  3  1  6  12  9 
  10  7  5  16  34  24 
  15  14  19  42  86  55 
  20  29  40  80  167  118 
  25  42  64  135  251  169 
 
Table 26 Number of cardiovascular hospitalisations by social class and 
years of follow up 
  Years  I  II  III M  III NM  IV  V 
CVD  5  19  100  129  206  153  64 
  10  35  196  264  444  367  124 
  15  62  340  422  740  597  206 
  20  105  515  646  1066  871  297 
  25  143  680  837  1311  1082  380 
               
CHD  5  8  30  38  83  43  19 
  10  13  62  84  175  112  40 
  15  21  128  147  311  206  72 
  20  38  194  245  450  315  108 
  25  55  266  320  553  405  136 
               
MI  5  6  24  29  75  35  16 
  10  11  51  70  157  94  31 
  15  18  103  117  265  168  57 
  20  28  150  189  366  244  79 
  25  43  186  235  432  302  101 
               
Stroke  5  1  9  13  29  16  13 
  10  6  23  35  83  72  25 
  15  9  51  81  142  134  49 
  20  25  100  150  237  221  83 
  25  38  157  221  345  321  130 
               
HF  5  1  4  2  12  8  4 
  10  4  7  9  26  25  12 
  15  6  25  29  71  58  22 
  20  14  53  62  135  124  40 
  25  20  97  100  200  173  59 
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Rates of cardiovascular hospitalisations  
The rate of non-fatal cardiovascular hospital discharges, after 25 years of follow up, was 
highest amongst the most deprived compared to the least deprived rate ratio (RR) = 1.48 
(95% confidence interval (CI) 1.23-1.61) (Figure 4). The strongest inverse relationship 
appeared to be between stroke and SED, RR most deprived vs. least deprived = 
1.75(95%CI 1.34-2.29), although 95% confidence intervals overlapped substantially. 
Similar results were observed when social class was examined as the measure of SED 
(Figure 5)  
Figure 4 Rate of cardiovascular events during 25 years of follow up by socioeconomic 
deprivation measured by Carstairs Morris index.  
Category 1 = least deprived, categories 6&7 = most deprived. RR = rate ratio with 95% confidence 
interval, CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure 
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Figure 5 Rate of cardiovascular events during 25 years of follow up by social class  
Class I=least deprived, Class V=most deprived. RR = rate ratio with 95% confidence interval, CVD 
= all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial infarction, 
Stroke = stroke, HF = chronic heart failure. 
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Unadjusted Kaplan Meier survival 
Survival from enrolment to experiencing a cardiovascular hospitalisation discharge was 
analysed using the Kaplan Meier estimates of survival (Figures 6-16). SED was 
significantly associated with the risk of a CVD, CHD, MI, stroke and HF hospitalisations. 
The association was present when both Carstairs Morris index and social class were used 
as the measures of SED.   
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Figure 6 Kaplan Meier estimates of survival to a first cardiovascular 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 7 Kaplan Meier estimates of survival to a first cardiovascular 
hospitalisation by social class over 25 years of follow up 
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Figure 8 Kaplan Meier estimates of survival to a first coronary heart disease 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 9 Kaplan Meier estimates of survival to a first coronary heart disease 
hospitalisation by social class over 25 years of follow up 
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Figure 10 Kaplan Meier estimates of survival to a first myocardial infarction 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 11 Kaplan Meier estimates of survival to a first myocardial infarction 
hospitalisation by social class over 25 years of follow up 
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Figure 12 Kaplan Meier estimates of survival to a first stroke hospitalisation 
by Carstairs Morris index of deprivation over 25 years of follow up 
 
Figure 13 Kaplan Meier estimates of survival to a first stroke hospitalisation 
by social class over 25 years of follow up 
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Figure 14 Kaplan Meier estimates of survival to a first heart failure 
hospitalisation by Carstairs Morris index of deprivation over 25 years of 
follow up 
 
Figure 15 Kaplan Meier estimates of survival to a first heart failure 
hospitalisation by social class over 25 years of follow up 
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Adjusted risk of cardiovascular hospitalisation 
The higher risk associated with higher deprivation was similar for each type of 
cardiovascular event, with the exception of HF where there was a weaker association. For 
example in the most deprived individuals (measured by Carstairs Morris index) the 
unadjusted risk of a non-fatal cardiovascular hospitalisation over 25 years was 42% higher 
than the least deprived (hazard ratio HR=1.42, 95% CI 1.24-1.62) (Table 27). Again stroke 
displayed one of the strongest gradients of association with SED with an approximate 
doubling of risk in the most versus least deprived. Whilst adjustment for “traditional” 
cardiovascular risk factors attenuated these associations, the relationship was clearly 
evident with all outcomes. Further adjustment for body mass index, FEV1 and 
cardiomegaly attenuated the relationship only slightly. The excess risk associated with 
higher SED was evident, albeit non-significant, after 5 years follow up, was clearer and 
significant by 10 years, and persisted over 25 years of follow up. Similar results were 
observed when social class was used as the measure of SED (Table 28). In analyses of both 
Carstairs Morris index and social class, by 28 years of follow up (i.e. until the end of 
follow up), the HR associated with SED started to fall. This most likely represents 
regression dilution. In subsequent models in this chapter, follow up for 25 years only is 
therefore presented.  
The results of the full models with the HR associated with each variable, in each model, 
are presented in Appendix 1. Only the results for the hospitalisations of any cardiovascular 
diseases are presented, however, results for the other outcomes analysed separately were 
similar.  
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Table 27 Unadjusted and adjusted risk of non-fatal cardiovascular hospitalisation over 28 years at 5 year intervals by Carstairs Morris index of deprivation 
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction, HF = heart failure 
    Unadjusted        Adjusted (“traditional” risk factors*)    Fully adjusted ** 
 
Follow 
up 
(years)  HR  95% CI  P    HR  95% CI  P    HR  95%CI  P 
CVD  5  1.07  0.78  1.48  0.656    1.02  0.74  1.40  0.904    0.97  0.70  1.35  0.855 
  10  1.46  1.15  1.85  0.002    1.38  1.09  1.75  0.007    1.34  1.05  1.71  0.019 
  15  1.33  1.12  1.59  0.001    1.28  1.07  1.53  0.007    1.22  1.01  1.46  0.035 
  20  1.45  1.25  1.69  <0.001    1.41  1.21  1.64  <0.001    1.33  1.14  1.56  <0.001 
  25  1.42  1.24  1.62  <0.001    1.39  1.21  1.58  <0.001    1.30  1.14  1.49  <0.001 
  28  1.36  1.20  1.54  <0.001    1.34  1.18  1.51  <0.001    1.27  1.11  1.44  <0.001 
                               
CHD  5  1.02  0.60  1.72  0.955    1.02  0.60  1.72  0.955    0.97  0.56  1.67  0.905 
  10  1.73  1.13  2.65  0.012    1.65  1.08  2.53  0.022    1.62  1.04  2.50  0.032 
  15  1.51  1.12  2.05  0.008    1.45  1.07  1.96  0.017    1.45  1.06  1.98  0.021 
  20  1.63  1.26  2.10  <0.001    1.57  1.22  2.03  0.001    1.55  1.19  2.02  0.001 
  25  1.66  1.32  2.08  <0.001    1.61  1.28  2.02  <0.001    1.57  1.24  1.99  <0.001 
  28  1.55  1.25  1.91  <0.001    1.51  1.22  1.86  <0.001    1.46  1.18  1.81  0.001 
                               
MI  5  1.10  0.59  2.03  0.767    1.04  0.56  1.92  0.903    1.08  0.57  2.04  0.824 
  10  1.81  1.13  2.92  0.014    1.73  1.07  2.78  0.024    1.77  1.08  2.88  0.023 
  15  1.46  1.04  2.03  0.028    1.38  0.99  1.93  0.058    1.42  1.00  2.01  0.049 
  20  1.45  1.09  1.92  0.011    1.39  1.04  1.84  0.024    1.40  1.04  1.88  0.026 
  25  1.53  1.18  1.99  0.001    1.48  1.14  1.92  0.003    1.49  1.14  1.95  0.004 
  28  1.48  1.16  1.89  0.002    1.43  1.12  1.83  0.004    1.43  1.11  1.84  0.005 
                               
Stroke  5  1.78  0.62  5.15  0.286    1.74  0.60  5.05  0.305    1.55  0.53  4.55  0.424 
  10  1.80  0.98  3.33  0.059    1.73  0.94  3.20  0.079    1.56  0.84  2.90  0.16 
  15  1.82  1.16  2.83  0.009    1.78  1.14  2.78  0.011    1.53  0.98  2.40  0.063 
  20  2.04  1.44  2.89  <0.001    2.04  1.44  2.90  <0.001    1.87  1.31  2.68  0.001 
  25  1.75  1.34  2.29  <0.001    1.78  1.36  2.33  <0.001    1.60  1.22  2.11  0.001  
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  28  1.66  1.31  2.12  <0.001    1.71  1.34  2.17  <0.001    1.56  1.22  2.00  <0.001 
                               
HF  5  0.93  0.25  3.44  0.916    0.88  0.24  3.25  0.846    0.88  0.18  4.19  0.87 
  10  1.09  0.47  2.54  0.836    1.03  0.44  2.40  0.938    0.78  0.31  1.95  0.6 
  15  1.30  0.72  2.34  0.379    1.26  0.70  2.27  0.436    1.05  0.56  1.99  0.869 
  20  1.42  0.95  2.13  0.089    1.41  0.94  2.12  0.097    1.11  0.73  1.70  0.628 
  25  1.48  1.05  2.07  0.024    1.49  1.06  2.09  0.022    1.22  0.86  1.74  0.258 
  28  1.32  0.98  1.78  0.066    1.34  0.99  1.80  0.055    1.10  0.81  1.49  0.555 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Table 28 Unadjusted and adjusted risk of non-fatal cardiovascular events over 28 years at 5 year intervals by social class 
Hazard ratio for social class V (most deprived) versus I (least deprived). RR= rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary 
heart disease, MI = acute myocardial infarction, HF = chronic heart failure 
    Unadjusted          Adjusted (“traditional” risk factors)*    Fully adjusted*   
 
Follow 
Up 
(Years)  HR  95% CI  P    HR  95% CI  P    HR  95% CI  P 
CVD  5  1.55  0.93  2.58  0.095    1.64  0.98  2.75  0.061    1.68  0.96  2.93  0.07 
  10  1.68  1.15  2.44  0.007    1.69  1.16  2.46  0.007    1.63  1.10  2.42  0.015 
  15  1.63  1.23  2.17  0.001    1.67  1.26  2.23  <0.0001    1.63  1.21  2.20  0.001 
  20  1.44  1.15  1.80  0.001    1.48  1.19  1.86  0.001    1.40  1.11  1.76  0.005 
  25  1.40  1.16  1.70  0.001    1.44  1.19  1.75  <0.0001    1.36  1.11  1.66  0.003 
  28  1.36  1.14  1.63  0.001    1.40  1.17  1.68  <0.0001    1.31  1.08  1.57  0.005 
                               
CHD  5  1.08  0.47  2.47  0.855    1.31  0.57  3.02  0.524    1.65  0.65  4.19  0.295 
  10  1.43  0.76  2.67  0.265    1.63  0.87  3.06  0.129    1.77  0.90  3.49  0.099 
  15  1.65  1.02  2.69  0.043    1.94  1.19  3.16  0.008    1.99  1.19  3.33  0.008 
  20  1.42  0.98  2.06  0.061    1.65  1.13  2.39  0.009    1.60  1.09  2.35  0.017 
  25  1.28  0.94  1.75  0.122    1.47  1.07  2.02  0.016    1.42  1.03  1.97  0.035 
  28  1.23  0.93  1.63  0.153    1.43  1.07  1.90  0.015    1.37  1.02  1.84  0.035 
                               
MI  5  1.22  0.48  3.11  0.682    1.47  0.57  3.78  0.427    1.80  0.65  4.96  0.257 
  10  1.31  0.66  2.60  0.443    1.49  0.75  2.99  0.255    1.65  0.80  3.38  0.175 
  15  1.52  0.89  2.58  0.121    1.77  1.04  3.01  0.037    1.82  1.05  3.14  0.033 
  20  1.40  0.91  2.16  0.124    1.64  1.06  2.53  0.026    1.61  1.03  2.51  0.036 
  25  1.20  0.84  1.71  0.323    1.41  0.98  2.02  0.061    1.39  0.96  2.02  0.078 
  28  1.22  0.88  1.71  0.23    1.44  1.03  2.01  0.032    1.41  1.00  1.99  0.049 
                               
Stroke  5  5.95  0.78  45.48  0.086    4.99  0.65  38.49  0.123          0 
  10  1.97  0.81  4.79  0.137    1.39  0.57  3.41  0.471    1.44  0.54  3.81  0.462 
  15  2.65  1.30  5.39  0.007    1.99  0.97  4.07  0.059    1.91  0.90  4.07  0.093 
  20  1.68  1.08  2.63  0.023    1.41  0.90  2.22  0.134    1.29  0.81  2.06  0.276 
  25  1.81  1.26  2.59  0.001    1.57  1.09  2.26  0.015    1.45  0.99  2.11  0.054  
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  28  1.71  1.23  2.38  0.001    1.50  1.07  2.09  0.017    1.36  0.97  1.92  0.076 
                               
HF  5  1.83  0.20  16.38  0.589    1.56  0.17  14.24  0.692    1.08  0.12  10.02  0.946 
  10  1.41  0.45  4.37  0.553    1.22  0.39  3.83  0.737    0.74  0.23  2.37  0.612 
  15  1.79  0.73  4.42  0.206    1.68  0.67  4.16  0.266    1.09  0.43  2.72  0.858 
  20  1.47  0.80  2.69  0.218    1.39  0.75  2.57  0.294    1.06  0.56  2.01  0.853 
  25  1.57  0.95  2.61  0.081    1.47  0.88  2.46  0.138    1.22  0.71  2.09  0.476 
  28  1.90  1.21  3.00  0.006    1.78  1.12  2.81  0.014    1.43  0.88  2.31  0.146 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Accounting for the impact of all cause mortality 
A number of composite outcomes incorporating all cause mortality were also examined. 
As with each individual cardiovascular disease type, the most deprived displayed higher 
rates of each of the composite outcomes (Tables 29 and 30 and Figures16 and 17). For 
example, the risk of a non-fatal cardiovascular hospitalisations or all cause mortality was 
higher in the most deprived vs. the least deprived measured using Carstairs Morris index  
RR=1.44(95%CI 1.30-1.59). Similarly the higher unadjusted risk associated with SED was 
observed for each of the composite outcomes (Table 31), for example the unadjusted 
hazard of death or cardiovascular disease was HR=1.44 (95%CI 1.31-1.59). The 
association again persisted after adjustment for “traditional” major cardiovascular risk 
factors and following the addition of further risk factors (Table 31). Again, similar results 
were seen using social class as the measure of SED (Table 32). 
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Table 29 Number of events by composite outcome according to Carstairs Morris index of deprivation 
    1  3  4  5  6 & 7 
Death/CVD  5  25/49  64/93  99/145  191/224  120/170 
  10  59/85  155/188  249/289  430/503  292/388 
  15  104/152  248/305  429/494  716/848  507/612 
  20  160/211  370/450  619/732  999/1295  727/878 
  25  232/273  475/594  811/956  1334/1646  928/1060 
             
Death/CHD  5  31/18  75/29  113/32  224/84  148/59 
  10  73/25  188/58  303/76  523/195  385/136 
  15  135/51  328/111  558/159  921/339  682/233 
  20  220/71  490/182  833/256  1375/526  1025/333 
  25  330/89  667/239  1156/346  1918/679  1377/408 
             
Death/ MI  5  32/13  75/24  113/28  225/75  151/46 
  10  76/20  189/49  306/61  524/174  391/114 
  15  193/42  335/84  563/130  932/291  695/186 
  20  225/59  506/136  851/200  1404/419  1055/250 
  25  336/70  694/174  1190/256  1988/510  1421/304 
             
Death/Stroke  5  34/4  75/6  113/17  233/31  151/23 
  10  80/12  193/34  311/44  547/88  397/68 
  15  147/23  339/62  566/88  963/180  714/127 
  20  236/37  517/101  857/173  1445/308  1059/218 
  25  335/64  705/159  1164/261  2001/447  1410/307 
             
Death/ HF  5  32/3  78/1  117/6  240/12  161/9 
  10  78/7  206/5  321/16  570/34  425/24 
  15  148/14  361/19  594/42  1022/86  757/55 
  20  237/29  554/40  901/80  1523/167  1127/118 
  25  348/42  760/64  1246/135  2121/251  1503/169 
             
Death/ MI / Stroke  5  31/13/4  72/24/6  107/27/17  211/75/27  137/45/20  
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  10  71/19/12  174/49/33  287/60/43  486/172/76  348/112/64 
  15  127/41/23  302/84/58  508/128/85  834/288/155  616/181/121 
  20  205/57/37  447/135/93  752/195/161  1234/409/265  916/240/202 
  25  297/66/60  599/170/142  1020/245/244  1712/495/388  1209/290/281 
             
Death/ CHD / Stroke  5  30/18/4  72/29/6  107/30/17  21/84/27  137/58/20 
  10  69/24/11  173/58/33  285/74/43  485/193/76  342/135/63 
  15  124/50/22  295/111/58  504/156/83  824/336/153  64/227/120 
  20  201/69/36  432/179/91  736/249/158  1209/512/260  890/321/197 
  25  292/85/59  575/233/139  991/333/235  1657/659/373  1172/392/271 
             
Death/ MI / Stroke/ HF  5  28/9/4/2  72/17/6/1  107/22/16/6  205/45/28/12  133/40/20/8 
  10  67/14/11/6  172/97/33/5  282/46/41/15  468/119/89/32  336/87/64/23 
  15  118/33/22/12  289/63/59/18  488/96/80/41  798/206/159/80  587/134/120/53 
  20  190/46/35/27  426/98/93/36  714/146/154/76  1153/297/275/158  856/177/204/112 
  25  273/54/61/40  564/127/148/60  961/187/236/126  1589/372/396/237  1118/213/286/160 
             
Death/ CHD / Stroke/ HF  5  27/13/4/2  72/22/1/6  107/24/16/6  204/51/28/12  130/51/20/8 
  10  65/18/11/6  171/45/33/5  281/55/41/15  467/136/83/32  330/106/64/23 
  15  115/41/22/12  282/85/59/18  485/115/80/41  790/242/159/80  575/174/120/53 
  20  186/55/35/27  413/136/94/35  702/186/154/76  1135/377/275/158  834/244/204/112 
  25  269/69/61/40  543/183/149/59  941/251/236/126  1553/496/396/237  1087/299/286/160 
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Table 30 Number of events by composite outcome according to social class 
    I  II  III N  III M  IV  V 
Death/CVD  5  12/19  61/100  77/129  158/206  117/153  57/64 
  10  35/35  125/196  169/264  391/444  298/367  126/124 
  15  60/62  227/340  285/422  638/740  529/597  197/206 
  20  93/105  346/515  406/646  903/1066  761/871  273/297 
  25  119/143  476/680  593/837  1155/1311  984/1082  347/380 
               
Death/CHD  5  15/8  72/30  94/38  190/83  137/43  64/19 
  10  42/13  153/62  213/84  490/175  376/112  151/40 
  15  72/21  298/128  378/147  830/311  703/206  258/72 
  20  12/38  472/194  590/245  1221/450  1046/315  375/108 
  25  164/55  693/266  878/320  1636/553  1426/405  504/136 
               
Death/ MI  5  15/6  73/24  95/29  192/75  137/35  65/16 
  10  43/11  154/51  215/70  493/157  381/94  154/31 
  15  73/18  303/103  386/117  841/265  712/168  267/57 
  20  123/28  484/150  608/189  1247/366  1072/244  385/79 
  25  172/43  720/186  909/235  1686/432  1469/302  520/101 
               
Death/Stroke  5  15/1  70/9  93/13  199/29  139/16  71/13 
  10  43/6  158/23  224/35  513/83  389/72  157/25 
  15  75/9  320/51  391/81  879/142  727/134  260/49 
  20  120/25  501/100  619/150  1311/237  1084/221  368/83 
  25  173/38  727/157  906/221  1732/345  1439/321  497/130 
               
Death/ HF  5  15/1  75/4  97/2  206/12  142/8  74/4 
  10  43/4  167/7  234/9  540/26  406/25  166/12 
  15  74/6  337/25  417/29  925/71  768/58  277/22 
  20  126/14  524/53  671/62  1361/135  1134/124  402/40 
  25  182/20  761/97  985/100  1821/200  1533/173  540/59 
               
Death/ MI / Stroke  5  14/0/6  66/24/9  89/29/12  179/75/25  130/34/15  61/15/13  
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  10  40/11/4  140/51/23  201/34/68  448/156/76  351/92/66  142/30/23 
  15  68/18/7  270/103/50  350/114/72  753/263/131  636/164/122  235/55/46 
  20  107/28/20  430/146/94  529/183/130  1106/362/217  944/233/200  332/76/77 
  25  148/42/33  623/179/145  777/225/197  1464/421/310  1256/288/286  438/96/119 
               
Death/ CHD / Stroke  5  14/8/0  65/30/9  88/38/12  177/82/25  130/42/15  60/18/13 
  10  40/13/3  139/62/23  199/173/76  446/173/76  346/110/66  139/39/23 
  15  68/21/6  265/128/50  342/145/71  744/307/130  627/201/121  230/70/44 
  20  106/38/19  420/190/92  512/240/126  1084/439/213  920/302/198  323/104/75 
  25  143/54/30  599/259/140  748/311/192  1427/535/299  1218/389/279  425/129/114 
               
Death/ MI / Stroke/ HF  5  13/5/0/1  64/18/9/4  87/21/12/2  175/50/26/10  127/24/14/8  60/14/13/4 
  10  38/9/3/4  136/41/23/7  197/48/33/9  435/114/79/23  337/65/69/25  140/23/23/11 
  15  65/13/6/6  257/74/50/25  339/86/73/26  718/195/133/66  603/117/119/56  225/45/45/21 
  20  100/22/19/14  403/109/92/52  504/140/133/57  1036/265/222/123  877/164/197/119  315/60/77/39 
  25  138/33/32/20  576/139/144/93  733/174/195/94  1365/314/322/184  1162/208/289/165  405/76/119/5613 
               
Death/ CHD / Stroke/ HF  5  13/6/0/1  63/23/9/4  86/27/12/2  173/57/26/10  127/30/14/8  59/17/13/4 
  10  38/10/3/4  135/50/23/7  195/59/33/9  433/128/79/23  333/79/69/25  137/31/23/11 
  15  65/14/6/6  252/94/50/25  331/111/73/26  711/231/133/66  595/147/119/56  220/56/45/21 
  20  100/28/19/14  394/144/93/51  488/188/133/57  1020/327/222/123  860/216/197/119  307/84/77/39 
  25  136/40/32/20  557/201/145/92  709/247/195/94  1341/401/322/184  1134/288/289/165  394/104/119/56 
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Figure 16 Rate of composite cardiovascular events during 25 years of follow up by socioeconomic deprivation measured by Carstairs Morris index deprivation 
category  
Category 1 = least deprived, categories 6&7 = most deprived. RR = rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary heart 
disease, MI = acute myocardial infarction, Stroke = stroke, HF = chronic heart failure. 
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Figure 17 Rate of composite events during 25 years of follow up by social class 
Class I=least deprived, Class V=most deprived, RR = rate ratio with 95% confidence interval, CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure.  
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Table 31 Unadjusted and adjusted risk of composite endpoints with death 
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived).  CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction, Stroke = stroke, HF = chronic heart failure. 
      Unadjusted           Adjusted (“traditional” risk factors*)     Fully adjusted ** 
   Years  HR  95% CI  P     HR  95% CI  P     HR  95%CI  P 
Death or CVD  5  1.21  0.94  1.57  0.136    1.16  0.90  1.50  0.254    1.08  0.83  1.40  0.58 
  10  1.51  1.26  1.81  <0.001    1.45  1.21  1.73  <0.001    1.34  1.12  1.62  0.002 
  15  1.45  1.27  1.66  <0.001    1.40  1.22  1.60  <0.001    1.30  1.13  1.49  <0.001 
  20  1.51  1.35  1.69  <0.001    1.47  1.31  1.65  <0.001    1.37  1.22  1.54  <0.001 
   25  1.44  1.31  1.59  <0.001     1.42  1.28  1.56  <0.001     1.31  1.19  1.45  <0.001 
Death or CHD  5  1.31  0.96  1.79  0.089    1.25  0.92  1.71  0.155    1.17  0.85  1.61  0.342 
  10  1.70  1.37  2.10  <0.001    1.64  1.32  2.03  <0.001    1.49  1.19  1.85  <0.001 
  15  1.63  1.39  1.90  <0.001    1.58  1.35  1.85  <0.001    1.45  1.24  1.71  <0.001 
  20  1.62  1.43  1.84  <0.001    1.59  1.40  1.81  <0.001    1.47  1.29  1.67  <0.001 
   25  1.55  1.40  1.73  <0.001     1.54  1.38  1.71  <0.001     1.41  1.27  1.58  <0.001 
Death or MI  5  1.36  0.98  1.88  0.064    1.30  0.94  1.80  0.111    1.22  0.87  1.70  0.246 
  10  1.66  1.34  2.06  <0.001    1.61  1.29  2.00  <0.001    1.47  1.17  1.83  0.001 
  15  1.59  1.35  1.86  <0.001    1.54  1.32  1.81  <0.001    1.42  1.20  1.67  <0.001 
  20  1.57  1.38  1.78  <0.001    1.54  1.35  1.75  <0.001    1.42  1.24  1.62  <0.001 
   25  1.52  1.36  1.69  <0.001     1.51  1.36  1.68  <0.001     1.39  1.24  1.55  <0.001 
Death or Stroke  5  1.42  1.00  2.02  0.05    1.36  0.96  1.94  0.083    1.24  0.87  1.78  0.235 
  10  1.61  1.28  2.01  <0.001    1.56  1.25  1.95  <0.001    1.39  1.11  1.75  0.005 
  15  1.62  1.37  1.91  <0.001    1.58  1.34  1.87  <0.001    1.42  1.20  1.68  <0.001 
  20  1.60  1.40  1.82  <0.001    1.59  1.39  1.81  <0.001    1.45  1.27  1.66  <0.001 
   25  1.54  1.38  1.72  <0.001     1.55  1.39  1.73  <0.001     1.41  1.26  1.58  <0.001 
Death or HF  5  1.51  1.05  2.17  0.027    1.45  1.00  2.08  0.047    1.30  0.90  1.89  0.166 
  10  1.68  1.33  2.12  <0.001    1.63  1.29  2.05  <0.001    1.45  1.14  1.84  0.002 
  15  1.64  1.39  1.94  <0.001    1.61  1.36  1.90  <0.001    1.44  1.21  1.71  <0.001 
  20  1.60  1.40  1.82  <0.001    1.58  1.39  1.81  <0.001    1.43  1.24  1.63  <0.001 
   25  1.53  1.37  1.71  <0.001     1.54  1.38  1.72  <0.001     1.39  1.24  1.56  <0.001 
Death/MI/Stroke  5  1.31  0.95  1.79  0.097    1.25  0.91  1.72  0.162    1.18  0.85  1.63  0.317  
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  10  1.64  1.33  2.03  <0.001    1.59  1.28  1.96  <0.001    1.45  1.17  1.80  <0.001 
  15  1.59  1.36  1.85  <0.001    1.54  1.32  1.81  <0.001    1.42  1.21  1.67  <0.001 
  20  1.57  1.38  1.78  <0.001    1.54  1.36  1.75  <0.001    1.43  1.26  1.63  <0.001 
   25  1.52  1.37  1.69  <0.001     1.52  1.36  1.69  <0.001     1.40  1.25  1.56  <0.001 
Death/CHD/Stroke   5  1.26  0.93  1.71  0.131    1.21  0.89  1.64  0.216    1.13  0.83  1.55  0.425 
  10  1.66  1.35  2.05  <0.001    1.60  1.30  1.97  <0.001    1.45  1.17  1.80  0.001 
  15  1.61  1.38  1.88  <0.001    1.56  1.34  1.83  <0.001    1.44  1.23  1.68  <0.001 
  20  1.60  1.42  1.82  <0.001    1.58  1.39  1.78  <0.001    1.46  1.29  1.66  <0.001 
   25  1.54  1.39  1.71  <0.001     1.53  1.38  1.70  <0.001     1.41  1.27  1.57  <0.001 
                               
Death/MI/Stroke/HF  5  1.45  1.05  2.02  0.026    1.40  1.00  1.94  0.047    1.29  0.92  1.80  0.137 
  10  1.66  1.34  2.07  <0.001    1.61  1.30  2.00  <0.001    1.45  1.17  1.81  0.001 
  15  1.60  1.36  1.87  <0.001    1.56  1.33  1.82  <0.001    1.42  1.21  1.67  <0.001 
  20  1.56  1.38  1.77  <0.001    1.54  1.36  1.75  <0.001    1.42  1.25  1.62  <0.001 
   25  1.51  1.36  1.67  <0.001     1.50  1.35  1.67  <0.001     1.38  1.24  1.54  <0.001 
Death/CHD/Stroke/HF  5  1.41  1.03  1.94  0.034    1.36  0.98  1.87  0.062    1.25  0.90  1.73  0.181 
  10  1.67  1.35  2.07  <0.001    1.61  1.30  2.00  <0.001    1.45  1.17  1.81  0.001 
  15  1.61  1.38  1.88  <0.001    1.57  1.34  1.83  <0.001    1.43  1.22  1.68  <0.001 
  20  1.60  1.42  1.82  <0.001    1.58  1.39  1.79  <0.001    1.46  1.28  1.66  <0.001 
   25  1.53  1.38  1.70  <0.001     1.53  1.38  1.69  <0.001     1.40  1.26  1.56  <0.001 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Table 32. Unadjusted and adjusted risk of composite endpoints with death at 5 year intervals  
Hazard ratio for social class V (most deprived) versus I (least deprived). (CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute myocardial 
infarction, Stroke = stroke, HF = chronic heart failure)   
 
    Unadjusted        Adjusted (“traditional” risk factors)*      Fully adjusted**     
  Years  HR  95% CI  P    HR  95% CI  P    HR  95% CI  P 
Death or CVD  5  1.79  1.21  2.66  0.004    1.75  1.18  2.61  0.006    1.66  1.10  2.53  0.017 
  10  1.69  1.30  2.21  <0.0001    1.64  1.26  2.14  <0.0001    1.52  1.15  2.00  0.003 
  15  1.62  1.33  1.99  <0.0001    1.61  1.31  1.98  <0.0001    1.47  1.19  1.81  <0.0001 
  20  1.47  1.25  1.73  <0.0001    1.47  1.25  1.73  <0.0001    1.33  1.13  1.57  0.001 
   25  1.47  1.28  1.69  <0.0001    1.46  1.27  1.68  <0.0001    1.33  1.15  1.54  <0.0001 
Death or CHD  5  1.64  1.04  2.61  0.035    1.56  0.98  2.48  0.061    1.55  0.95  2.54  0.082 
  10  1.61  1.20  2.18  0.002    1.54  1.14  2.08  0.005    1.44  1.05  1.96  0.024 
  15  1.71  1.36  2.15  <0.0001    1.68  1.34  2.12  <0.0001    1.50  1.18  1.90  0.001 
  20  1.52  1.27  1.82  <0.0001    1.51  1.26  1.81  <0.0001    1.37  1.13  1.65  0.001 
   25  1.52  1.31  1.78  <0.0001    1.50  1.28  1.75  <0.0001    1.34  1.14  1.57  <0.0001 
Death or MI  5  1.76  1.09  2.85  0.021    1.66  1.02  2.69  0.041    1.61  0.97  2.66  0.066 
  10  1.59  1.18  2.16  0.003    1.51  1.12  2.06  0.008    1.41  1.03  1.93  0.033 
  15  1.70  1.34  2.14  <0.0001    1.66  1.31  2.10  <0.0001    1.46  1.15  1.86  0.002 
  20  1.53  1.28  1.84  <0.0001    1.52  1.26  1.83  <0.0001    1.36  1.13  1.65  0.001 
   25  1.49  1.28  1.75  <0.0001    1.47  1.25  1.71  <0.0001    1.31  1.12  1.54  0.001 
Death or Stroke  5  2.41  1.41  4.11  0.001    2.11  1.23  3.62  0.006    1.89  1.08  3.29  0.025 
  10  1.75  1.28  2.40  0.001    1.56  1.13  2.14  0.006    1.38  1.00  1.91  0.052 
  15  1.78  1.40  2.27  <0.0001    1.65  1.29  2.10  <0.0001    1.42  1.11  1.82  0.005 
  20  1.56  1.30  1.88  <0.0001    1.49  1.24  1.80  <0.0001    1.33  1.09  1.61  0.004 
   25  1.55  1.33  1.81  <0.0001    1.47  1.26  1.72  <0.0001    1.32  1.12  1.55  0.001 
Death or HF  5  2.23  1.30  3.82  0.004    1.93  1.12  3.32  0.017    1.74  0.99  3.04  0.052 
  10  1.77  1.29  2.45  <0.0001    1.61  1.16  2.22  0.004    1.42  1.02  1.98  0.037 
  15  1.80  1.41  2.31  <0.0001    1.69  1.32  2.17  <0.0001    1.45  1.13  1.87  0.004 
  20  1.58  1.31  1.92  <0.0001    1.52  1.25  1.84  <0.0001    1.34  1.10  1.63  0.004 
   25  1.54  1.32  1.81  <0.0001    1.47  1.25  1.72  <0.0001    1.31  1.11  1.55  0.001 
Death/MI/Stroke  5  2.04  1.26  3.32  0.004    1.93  1.19  3.15  0.008    1.77  1.07  2.92  0.026  
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  10  1.66  1.23  2.24  0.001    1.56  1.15  2.11  0.004    1.41  1.04  1.92  0.028 
  15  1.75  1.39  2.20  <0.0001    1.69  1.34  2.13  <0.0001    1.47  1.16  1.86  0.001 
  20  1.57  1.31  1.88  <0.0001    1.56  1.30  1.87  <0.0001    1.39  1.15  1.67  0.001 
   25  1.53  1.31  1.78  <0.0001    1.51  1.29  1.76  <0.0001    1.35  1.15  1.58  <0.0001 
Death/CHD/Stroke   5  1.89  1.19  3.01  0.007    1.81  1.13  2.89  0.013    1.70  1.04  2.78  0.034 
  10  1.68  1.25  2.26  0.001    1.59  1.18  2.14  0.002    1.44  1.06  1.96  0.02 
  15  1.75  1.40  2.20  <0.0001    1.72  1.36  2.16  <0.0001    1.50  1.19  1.90  0.001 
  20  1.55  1.30  1.85  <0.0001    1.54  1.29  1.85  <0.0001    1.38  1.15  1.66  0.001 
   25  1.54  1.33  1.80  <0.0001    1.53  1.31  1.78  <0.0001    1.36  1.17  1.59  <0.0001 
Death/MI/Stroke/HF  5  2.20  1.34  3.61  0.002    2.04  1.24  3.36  0.005    1.86  1.12  3.11  0.017 
  10  1.71  1.27  2.31  <0.0001    1.59  1.17  2.15  0.003    1.43  1.05  1.95  0.024 
  15  1.81  1.44  2.29  <0.0001    1.75  1.38  2.21  <0.0001    1.50  1.18  1.91  0.001 
  20  1.60  1.34  1.92  <0.0001    1.58  1.32  1.90  <0.0001    1.40  1.16  1.68  <0.0001 
  25  1.55  1.33  1.80  <0.0001    1.53  1.31  1.78  <0.0001    1.37  1.17  1.60  <0.0001 
 Death/CHD/Stroke/HF  5  2.13  1.32  3.46  0.002    2.00  1.23  3.26  0.005    1.91  1.14  3.18  0.013 
  10  1.72  1.28  2.32  <0.0001    1.61  1.19  2.18  0.002    1.46  1.07  1.99  0.016 
  15  1.83  1.45  2.30  <0.0001    1.78  1.41  2.25  <0.0001    1.55  1.22  1.97  <0.0001 
  20  1.60  1.34  1.91  <0.0001    1.59  1.33  1.90  <0.0001    1.42  1.18  1.71  <0.0001 
  25  1.57  1.35  1.82  <0.0001    1.56  1.34  1.81  <0.0001    1.39  1.19  1.62  <0.0001 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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In a competing risk multivariable regression (Table 33), the most deprived (measured 
using Carstairs Morris index) displayed a higher risk of a cardiovascular hospitalisation 
than the least deprived (HR=1.47 95%CI 1.27-1.69), whilst also exhibiting a higher risk of 
all cause mortality (HR=1.41, 95%CI 1.24-1.61) before adjustment for the “traditional” 
risk factors. This association persisted after adjustment so that the most deprived were at 
higher risk of cardiovascular events than the least deprived (HR=1.45 95%CI 1.26-1.68) 
whilst still displaying a higher risk of all cause mortality (HR= 1.39 95%CI 1.24-1.58). 
Again, similar results were observed when social class was used to determine SED (Table 
34) 
Comparison of the association of SED with different 
cardiovascular events 
Although the relationship between SED and various cardiovascular outcomes were broadly 
similar it appeared that the relationship with stroke was strongest. This was formally tested 
in a competing events analysis between all coronary heart disease and stroke, and, 
myocardial infarction and stroke (Tables 33 and 34). The unadjusted risk of coronary heart 
disease was higher in the most versus least deprived HR=1.67 (95%CI 1.33-2.12) whilst 
the risk of stroke was also higher HR=1.72 (95%CI 1.29-2.28). When these hazards were 
formally tested no statistically significant difference was found indicating the risk 
associated with socioeconomic deprivation and coronary heart disease is not statistically 
different from that with stroke. The relationship did not change after adjustment. The risk 
associated with SED was also not different when myocardial infarction was compared with 
stroke. Whilst the association with HF was the weakest this could not be tested due to a 
lack of statistical power.  
This comparison is displayed graphically in the cumulative incidence curves for death and 
cardiovascular disease (Figures 18 and 19), coronary heart disease and stroke (Figures 20 
and 21) and myocardial infarction and stroke (Figures 22 and 23). As can be seen from the 
plots the relationship between SED and each outcome is similar as tested by the competing 
risks analysis.  
122 
Table 33. Unadjusted and adjusted risk of non-fatal cardiovascular events as composite endpoints and in a competing risk model by Carstairs Morris index  
Hazard ratio for deprivation category 6&7 (most deprived) versus 1 (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction. 
 
N  
Category 6&7 
Events 
Category 6&7  Unadjusted   95% CI 
Adjusted 
(“traditional” 
risk factors*)  95% CI 
Fully 
adjusted **  95% CI 
Death or CVD  2796  1060 deaths, 928 CVD  1.47  1.28  1.69  1.46  1.27  1.68  1.33  1.15  1.54 
Competing risk  
(Death and CVD)                     
Death  2796  1060  1.41  1.24  1.61  1.39  1.24  1.58  1.30  1.13  1.49 
CVD  2796  928  1.47  1.27  1.69  1.45  1.26  1.68  1.32  1.14  1.53 
                       
CHD or Stroke  2796  392 CHD, 271 Stroke  1.69  1.41  2.02  1.67  1.21  1.71  1.60  1.33  1.92 
Competing risk 
 (CHD or Stroke)                     
CHD  2796  392  1.67  1.33  2.12  1.62  1.28  2.05  1.60  1.26  2.04 
Stroke  2796  271  1.72  1.29  2.28  1.74  1.31  2.30  1.58  1.19  2.11 
                       
MI or Stroke  2796  290 MI, 281 Stroke  1.64  1.35  1.99  1.62  1.33  1.96  1.56  1.28  1.9 
Competing risk  
(MI or Stroke)                     
MI  2796  290  1.56  1.19  2.03  1.50  1.15  1.96  1.52  1.15  2.00 
Stroke  2796  281  1.73  1.31  2.29  1.75  1.33  2.32  1.60  1.20  2.13 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Table 34 Unadjusted and adjusted risk of non-fatal cardiovascular events as composite endpoints and in a competing risk model by social class 
Hazard ratio for social class V (most deprived) versus social class I (least deprived). CVD = all cardiovascular disease, CHD = coronary heart disease, MI = acute 
myocardial infarction 
 
N  
Social Class V 
Events  
Social Class V  Unadjusted   95% CI 
Adjusted 
(“traditional” 
risk factors*)  95% CI 
Fully 
adjusted **  95% CI 
Death or CVD  1301 
347 deaths,  
380 CVD  1.40  1.16  1.70  1.58  1.23  2.02  1.48  1.15  1.92 
Competing risk  
(Death and CVD)                     
Death  1301  347  1.40  1.16  1.70  1.44  1.19  1.75  1.35  1.11  1.66 
CVD  1301  380  1.55  1.26  1.91  1.47  1.20  1.82  1.30  1.05  1.60 
                       
CHD or Stroke  1301 
176 CHD, 
137 Stroke  1.52  1.19  1.95  1.58  1.23  2.02  1.39  1.00  1.93 
Competing risk 
 (CHD or Stroke)                     
CHD  1301  176  1.24  0.91  1.71  1.45  1.05  1.99  1.60  1.26  2.04 
Stroke  1301  137  2.03  1.35  3.03  1.75  1.17  2.63  1.59  1.05  2.41 
                       
MI or Stroke  1301 
131 MI,  
144 Stroke  1.50  1.15  1.95  1.54  1.78  2.00  1.45  1.11  1.91 
Competing risk  
(MI or Stroke)                     
MI  1301  131  1.17  0.82  1.68  1.39  0.97  2.00  1.37  0.94  2.00 
Stroke  1301  144  1.92  1.30  2.81  1.66  1.13  2.46  1.50  1.01  2.24 
*age, sex, smoking, cholesterol, diabetes, systolic BP 
** age, sex, smoking, cholesterol, diabetes, systolic BP, BMI, adjusted FEV1, cardiomegaly  
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Figure 18 Cumulative incidence curve for death and all cardiovascular 
disease according to Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Cumulative incidence curve for death and all cardiovascular 
disease according to social class 
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Figure 20 Cumulative incidence curve for coronary heart disease and 
stroke according to Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 Cumulative incidence curve for coronary heart disease and 
stroke according to social class 
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Figure 22 Cumulative incidence curve for myocardial infarction and stroke 
according Carstairs Morris index of deprivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23 Cumulative incidence curve for myocardial infarction and stroke 
according to social class 
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Discussion 
In this large prospective cohort study of men and women in the West of Scotland the risk 
of cardiovascular hospitalisation was higher in the most deprived. This association was 
persisted following adjustment for a number of “traditional” risk factors and importantly, 
the risk of a number of different forms of cardiovascular disease was higher in the most 
deprived. This risk was present despite the most deprived also being at a higher risk of all 
cause mortality. Finally, SED conferred a higher risk of a cardiovascular hospitalisation 
over a long period, 28 years. 
Comparison of cardiovascular outcomes 
Previous studies have examined cardiovascular outcomes in isolation 
61,105,125 or composite 
cardiovascular outcomes
56,59. Socioeconomic deprivation is associated with a higher risk of 
myocardial infarction
61, coronary heart disease
59, stroke
99,105 and heart failure
125. However, 
this is the first study to compare the risk associated with SED on a number of 
cardiovascular outcomes in one single population. There was no statistical difference in the 
risk associated with SED and the cardiovascular outcome studied. This may suggest that 
the mechanism by which SED confers its higher risk (and there is debate as to how this 
occurs
38,169) is via a mechanism that may be shared by each disease type. The finding 
would also suggest that any interventions aimed at improving the socioeconomic 
conditions of an individual may have the opportunity to reduce the risk of a number of 
cardiovascular diseases rather than one in particular.  
Adjustment for “traditional” cardiovascular risk factors 
In these analyses the risk associated with SED persisted after adjusting for “traditional” 
cardiovascular risk factors 
140 of age, sex, smoking status, cholesterol, diabetes and systolic 
blood pressure.  The relationship was evident after adjusting for further risk factors such as 
body mass index, FEV1 and cardiomegaly on a chest x-ray. Obviously this would suggest 
that I was unable to adjust for the factors that confer the excess risk, but as noted 
previously, it is unclear what these causal pathways are.
38,169 In a large study of 22,688 
participants in the Women’ health study, adjustment for a number of novel risk factors 
indicative of inflammation ( C-reactive protein, intracellular adhesion molecule-1, 
fibrinogen and homocysteine), on top of the “traditional” risk factors of smoking, 
cholesterol, diabetes etc., did not completely attenuate the risk of CVD related to level of  
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education.
71 This finding in conjunction with that of mine and other authors
38,40,142,226 
would suggest that the risk associated with SED is not completely mediated via traditional 
or even novel risk factors. 
Prolonged excess risk 
In the present study, the risk associated with low SED was evident after 5 years of follow 
up and persisted as individuals were followed through 28 years. Whilst others have 
reported such long lasting effects of SED on ischaemic heart disease mortality
40 few have 
examined the relationship with non-fatal cardiovascular outcomes over such long follow 
up
123. The present analyses demonstrate that the excess risk is higher for a number of 
different types of cardiovascular disease and that the risk persists over a long period of 
time. However, there was evidence of regression dilution bias in the results at 28 years of 
follow up
225. The cohort was not re-screened during follow up, and, therefore, I was not 
able to examine the effect of changing risk factor profiles on outcomes. Instead of using a 
correction technique for regression dilution I truncated follow up at 25 years to limit the 
observed impact of this bias. It is therefore possible that the risk of CVD associated with 
SED was underestimated in these analyses.
225  
The increased risk of death 
Socioeconomic deprivation is associated with higher all cause
31 and cardiovascular 
mortality
7,32,227,228, therefore it is possible that the risk of non-fatal cardiovascular disease 
may be underestimated in this group as they succumb to fatal disease before they can 
experience a non-fatal event. I have reported that the risk of a number of composite 
cardiovascular events which included all cause mortality is higher in the most deprived. 
However, composite endpoints are only one method to account for the competing risk of 
death. In a further analysis where a competing events analysis was performed, despite a 
higher risk of all cause mortality, the risk of a cardiovascular hospitalisation was still 
higher in the most deprived as compared to the least deprived individuals. This suggests 
that the risk of cardiovascular hospitalisations is still higher despite the increased risk of 
death that the most deprived experience. 
Summary  
Socioeconomic deprivation as measured by an area based score and social class is 
associated with an increased risk of cardiovascular hospitalisations, irrespective of the  
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disease type studied. In the multivariable models, SED was as significant contributor to the 
model, as much as the traditional risk factors. The risk associated with SED is evident after 
adjustment for multiple cardiovascular risk factors and is present over a prolonged period 
of follow up. Furthermore, the most deprived are at a higher risk of cardiovascular events 
despite also being at a higher risk of all cause mortality.  
In the next chapter I will go on to describe the results of analyses examining the impact of 
SED on the risk of a recurrent hospitalisation following this first cardiovascular 
hospitalisation.  
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Recurrent hospitalisations and subsequent 
survival 
Introduction and aims 
The literature surrounding the relationship between SED and cardiovascular disease is 
sparse in relation to recurrent (as opposed to “first” or “incident”) cardiovascular events. 
While some data do exist on the risk of recurrent myocardial infarction
76,92,94 and 
stroke
105,117, only one study has examined the association between SED and readmission 
with heart failure
126. No studies have examined the relationship in one cohort making 
comparison difficult. Finally, many studies have either performed unadjusted analyses or 
have adjusted for a number of different risk factors, again making comparison between 
studies difficult. In this chapter I will explore the relationship between SED and the risk of 
a subsequent cardiovascular hospitalisation. I will also examine the relationship between 
SED and subsequent survival following a first cardiovascular hospitalisation. Finally, I will 
explore the risk of suffering a subsequent cardiovascular hospitalisation in a composite 
outcome taking into account of death. 
Methods 
For each of the analyses presented the time of origin was specified as the time at which a 
person experienced a non-fatal cardiovascular hospitalisation. Age in the model was 
entered as the age at which the non-fatal cardiovascular hospitalisation occurred. Follow 
up continued to the point of a subsequent recurrent hospitalisation, or death, or a composite 
of these. Cox proportional hazards models were used to model these outcomes again 
adjusting for known cardiovascular risk factors. Of the cardiovascular risk factors smoking 
has one of the greatest potentials to change over time. In a study of men and women 
deprived women were more likely to quit smoking as they grew older than their least 
deprived counterparts.
150 No association was seen in men.  Higher levels of education and 
occupation are associated with a higher likelihood of smoking cessation following an 
admission to a coronary care unit.
229 Therefore to explore this potential bias, a sensitivity 
analysis was conducted using models with and without smoking in the model.  
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Results  
Baseline characteristics 
The characteristics of those individuals that had experienced a cardiovascular 
hospitalisation during follow up were analysed according to SED.  
Cardiovascular disease 
Of those that experienced a cardiovascular hospitalisation during follow up, when SED 
was measured using Carstairs Morris index the most deprived were more likely to be 
smokers, have bronchitis and have a lower FEV1 (Table 35). Whilst other variables were 
statistically significantly different across SED groups, none showed a clear gradient of 
change. When social class was used as the measure of SED the most deprived were older, 
had higher systolic blood pressure, were less likely to be men and more likely to have 
cardiomegaly and bronchitis (Table 36).  
The individuals who suffered a cardiovascular admission but could not be assigned a 
Carstairs Morris index deprivation category were more likely to have a history of 
bronchitis though the magnitude of this difference was negligible as numbers were small 
(Table 35). Those who were not assigned a social class that suffered a cardiovascular 
admission had higher blood pressure and were less likely to be men or smokers (Table 36). 
 
Coronary Heart Disease 
In statistical testing there were significant differences in the baseline characteristics of 
individuals according to Carstairs Morris index that experienced a coronary heart disease 
hospitalisation during follow up (Table 37). The same was observed using social class as 
the measure of SED, that the most deprived were older, had higher blood pressure, were 
less likely to be men but more likely to be smokers (Table 38).  
Those with missing SED defined by Carstairs Morris index or social class were not 
different to those who were assigned a deprivation category by either classification system 
with the exception that those missing a social class classification were again less likely to 
be men.  
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Table 35 Characteristics of individuals with a non-fatal CVD hospitalisation according to Carstairs Morris index 
    1    3    4    5    6 & 7    P  Missing    P 
N    320    711    1097    1912    1163      11     
    Mean  SD  Mean  SD 
Mea
n  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    55.2  (5.5)  54.0  (5.4)  54.1  (5.6)  53.7  (5.5)  54.7  (5.7)  <0.001  53.6  (5.7)  0.89 
Systolic BP (mmHg)    153.3  (24.0)  151.7  (24.2)  147.6  (24.0)  154.2  (25.2)  150.7  (25.1)  <0.001  148.3  (27.7)  0.87 
Cholesterol (mmol/l)    6.2  (1.1)  6.2  (1.0)  6.2  (1.0)  6.2  (1.1)  6.2  (1.0)  0.29  6.3  (1.0)  0.70 
Body mass index (kg/m
2)    25.7  (3.6)  25.6  (3.6)  25.7  (3.9)  26.3  (4.1)  26.4  (4.6)  <0.001  26.7  (2.7)  0.99 
adjusted FEV1 (% predicted)    98.2  (20.7)  95.4  (20.4)  92.9  (21.1)  91.6  (21.4)  88.3  (22.7)  <0.001  91.9  (34.2)  0.81 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    153         (47.8)  387       (54.4)  519       (47.3)  929  (48.5)  529  (45.4)  0.005  7  (63.7)  0.35 
Smoker       203       (63.4)  453  (63.7)  743  (67.7)  1345  (70.3)  858  (73.7)  <0.001  20  (58.8)  0.25 
Diabetes    3          (0.9)  8          (1.1)  17          (1.6)  25          (1.3)  22   (1.9)  0.59  0  (0)  0.64 
Cardiomegaly    81                (26.2)  139  (20.0)  259       (24.9)  485  (26.3)  344  (31.1)  <0.001  2  (25.0)  0.57 
Bronchitis      7                  (2.2)  17  (2.4)  26         (2.4)  47         (2.5)  63           (5.4)  <0.001  1  (5.8)  0.09 
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Table 36 Characteristics of individuals with a non-fatal CVD hospitalisation according to social class 
  I    II   
III -
NM    III-M    IV    V 
  P 
Missing   
P 
N  169    782    989    1483    1246    422      123     
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    52.7  (5.5)  53.9  (5.4)  54.1  (5.5)  54.0  (5.5)  54.4  (5.7)  54.9  (5.5)  0.0002  54.8  (6.0)  0.48 
Systolic BP (mmHg)    148.1  (20.4)  149.4  (23.9)  150.4  (25.0)  152.1  (23.7)  151.9  (25.7)  155.8  (27.5)  <0.001  156.8  (25.9)  0.01 
Cholesterol (mmol/l)    6.2  (1.0)  6.3  (1.0)  6.4  (1.1)  6.0  (1.0)  6.2  (1.1)  6.2  (0.9)  <0.001  6.1  (1.0)  0.5 
Body mass index (kg/m
2)    25.3  (3.3)  25.9  (3.8)  25.5  (3.8)  26.4  (3.8)  26.9  (4.9)  25.7  (4.4)  <0.001  25.7  (4.4)  0.9 
adjusted FEV1 (% 
predicted)  98.0  (20.8)  96.5  (19.6)  94.5  (22.6)  90.5  (21.3)  88.5  (22.3)  90.2  (23.3) 
<0.001 
102.9  (20.1) 
0.5 
  N   %  N   %  N   %  N   %  N   %  N   %    N   %   
Men  116        (68.6)  387     (49.5)  308     (31.1)  1022  (68.9)  535  (42.9)  134  (31.8)  <0.001  22  (17.9)  <0.001 
Smoker     110    (65.1)  518  (66.2)  637  (64.4)  1111  (74.9)  874  (70.1)  290  (68.7)  <0.001  71  (57.7)  0.05 
Diabetes  3          (1.8)  11         (1.4)  10         (1.0)  15         (1.0)  23  (1.9)  9   (2.1)  0.27  4  (3.2)  0.12 
Cardiomegaly  33                 (20.5)  174  (23.5)  242       (25.3)  347        (24.5)  341           (28.5)  133           (32.6)  0.001  40  (33)  0.08 
Bronchitis  2                 (1.2)  12  (1.5)  20       (2.3)  56        (3.8)  49          (3.9)  20           (4.7)  0.001  2  (1.6)  0.66 
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Table 37 Characteristics of individuals with a non-fatal CHD hospitalisation according to Carstairs Morris index  
    1    3    4    5    6 & 7    P  Missing    P 
N    108    296    406    788    1163      5     
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for trend 
(excluding 
missing SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    54.7  (5.7)  53.5  (5.3)  53.4  (5.6)  53.4  (5.8)  54.  (5.8)  0.009  56.6  (5.4)  0.29 
Systolic BP (mmHg)    152.3  (23.5)  152.5  (23.1)  147.5  (24.1)  152.6  (23.1)  151.4  (24.3)  0.009  148.3  (27.7)  0.95 
Cholesterol (mmol/l)    6.3  (1.1)  6.4  (1.0)  6.3  (1.1)  6.2  (1.2)  6.3  (1.0)  0.28  6.4  (0.9)  0.90 
Body mass index (kg/m
2)    25.8  (3.6)  25.9  (3.6)  25.9  (3.8)  26.4  (3.8)  26.7  (4.8)  0.009  26.0  (2.7)  0.85 
adjusted FEV1 (% predicted)    97.4  (19.5)  97.5  (18.0)  93.1  (19.8)  92.5  (19.8)  89.2  (21.1)  <0.001  82.8  (46.4)  0.37 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    62         (57.4)  182       (61.5)  223       (54.9)  425  (48.3)  232  (51.7)  0.15  4  (80.0)  0.24 
Smoker       77       (71.3)  203  (68.6)  295  (72.7)  566  (71.8)  346  (77.1)  0.12  5  (100)  0.17 
Diabetes    2          (1.9)  4          (1.4)  6          (1.5)  9          (1.1)  5   (1.1)  0.97  5  (0)  0.77 
Cardiomegaly    20                 (19.2)  58  (19.8)  93       (23.7)  195  (25.6)  139  (32.3)  0.004  1  (20)  0.83 
Bronchitis      4                  (3.7)  6  (2.0)  9         (2.2)  20         (2.5)  19           (4.2)  0.29  1  (20)  0.14 
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Table 38 Characteristics of individuals with a non-fatal CHD hospitalisation according to social class 
  I    II   
III -
NM    III-M    IV    V 
  P 
Missing   
P 
N  69    305    377    635    467    158      41     
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    51.5  (5.7)  53.4  (5.2)  53.4  (5.5)  53.7  (5.5)  54.0  (5.7)  54.5  (5.5)  0.004  55.2  (6.0)  0.16 
Systolic BP (mmHg)    148.2  (22.1)  150.2  (23.6)  149.2  (22.5)  151.6  (22.6)  151.6  (25.1)  156.5  (26.9)  0.02  155.1  (20.5)  0.09 
Cholesterol (mmol/l)    6.1  (1.0)  6.4  (1.0)  6.5  (1.2)  6.2  (1.1)  6.2  (1.1)  6.3  (1.1)  0.001  6.0  (1.1)  0.5 
Body mass index (kg/m
2)    25.6  (2.7)  26.1  (3.4)  25.4  (3.6)  26.8  (3.9)  26.4  (4.7)  27.0  (5.0)  <0.001  24.8  (3.6)  0.3 
adjusted FEV1 (% 
predicted)  97.9  (18.9)  96.2  (18.6)  95.2  (22.2)  92.5  (21.3)  88.5  (21.1)  93.9  (19.2)  <0.001  93.9  (19.2)  0.8 
  N   %  N   %  N   %  N   %  N   %  N   %    N   %   
Men  53        (76.8)  187     (61.3)  145     (38.5)  459  (72.2)  233  (47.8)  49  (31.1)  <0.001  12  (29.3)  <0.001 
Smoker   47   (68.1)  213  (69.8)  258  (68.4)  492  (77.5)  341  (73.0)  112  (70.8)  0.02  29  (70.7)  0.9 
Diabetes  1          (1.5)  3         (1.0)  3    (1.0)  6         (1.0)  83  (1.7)  4   (2.5)  0.56  1  (2.4)  0.36 
Cardiomegaly  16                 (24.6)  64  (22.1)  88       (24.0)  150        (24.3)  123           (27.2)  51  (33.3)  0.13  14  (35)  0.32 
Bronchitis  1                 (1.5)  5  (1.6)  9       (2.4)  17        (2.7)  20          (4.3)  7           (4.4)  0.2  0  (0)  0.78 
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Acute myocardial infarction  
Of those that experienced a hospitalisation for myocardial infarction during follow up, the 
most deprived individuals, as measured by Carstairs Morris index were more likely to be 
smokers and also have a lower adjusted FEV1 and to have cardiomegaly (Table 39). When 
social class was used as the measure of SED the most deprived were older, had higher 
blood pressure , lower adjusted FEV1, and less likely to be male (Table 40). Of those who 
experienced a myocardial infarction admission during follow up, those who could not be 
assigned a SED category (either using Carstairs Morris index or social class) were not 
different with respect to baseline variables from those who could be assigned a SED 
category. The only exception was that those who were not assigned a social class were 
again less likely to be male. 
 
Stroke 
In the individuals who were discharged from hospital with a diagnosis of stroke the most 
deprived (measured by Carstairs Morris index) were more likely to have lower adjusted 
FEV1 and have cardiomegaly or bronchitis (Table 41). When social class was used to 
define SED, the most deprived were less likely to be men and have lower adjusted FEV1. 
Whilst other statistically significant differences were found they were not of clinically 
relevant magnitudes (Table 42). Again, no difference was found in those who were 
assigned a deprivation category by either method as compared to those who were not. The 
only exception was that those who were not assigned a social class were again less likely to 
be male. 
 
Heart failure 
A lower adjusted FEV1, younger age, lower systolic blood pressure and more 
cardiomegaly and bronchitis was observed in the most deprived who experienced an 
hospitalisation with HF as compared to the least deprived as measured by the Carstairs 
Morris index(Table 43). When social class was examined the most deprived had lower 
adjusted FEV1, were less likely to be men and had more bronchitis (Table 44). Again only 
the proportion of men in those unassigned a social class was statistically significantly 
different   
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Table 39 Characteristics of individuals with a non-fatal myocardial infarction hospitalisation according to Carstairs Morris index  
    1    3    4    5    6 & 7    P  Missing    P 
N    81    204    290    566    332      2     
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excludin
g missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    54.5  (5.7)  53.8  (5.3)  53.7  (5.7)  53.4  (5.8)  54.5  (5.6)  0.25  58.5  (4.9)  0.28 
Systolic BP (mmHg)    152.4  (23.8)  152.2  (22.1)  148.3  (25.0)  154.1  (24.0)  151.7  (23.8)  0.02  145.0  (4.2)  0.7 
Cholesterol (mmol/l)    6.3  (1.0)  6.3  (1.1)  6.3  (1.0)  6.2  (1.3)  6.3  (1.0)  0.59  6.7  (1.3)  0.58 
Body mass index (kg/m
2)    25.8  (3.6)  25.9  (3.4)  25.9  (3.8)  26.3  (3.9)  26.7  (4.7)  0.07  27.6  (0.2)  0.7 
adjusted FEV1 (% predicted)    97.2  (20.1)  96.9  (17.7)  92.9  (20.8)  93.5  (19.2)  88.8  (21.4)  <0.001  75.7  (3.7)  0.3 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    49         (60.5)  133       (65.2)  170       (58.6)  318  (56.2)  181  (54.5)  0.14  1  (50)  0.85 
Smoker       59       (72.8)  144  (70.6)  211  (72.6)  422  (72.8)  269  (81.0)  0.04  2  (100)  0.4 
Diabetes    2          (2.7)  4          (1.9)  5          (1.7)  8          (1.4)  2   (0.6)  0.86  2  (100)  0.85 
Cardiomegaly    14                 (18.8)  36  (17.8)  65       (22.7)  139  (25.5)  99  (30.9)  0.01  1  (50)  0.5 
Bronchitis     3                  (3.7)  5  (2.0)  6         (2.1)  18         (3.2)  16           (4.8)  0.36  21  (100)  0.7 
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Table 40 Characteristics of individuals with a non-fatal myocardial infarction hospitalisation outcome according to social class 
  I    II   
III -
NM    III-M    IV    V 
  P 
Missing   
P 
N  50    207    268    469    343    87      21     
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    50.6  (5.4)  53.7  (5.6)  53.6  (5.4)  54.3  (5.5)  54.3  (5.7)  54.8  (5.5)  0.0001  54.5  (5.6)  0.7 
Systolic BP (mmHg)    145.8  (22.1)  151.7  (23.9)  150.3  (22.5)  152.3  (22.8)  152.7  (25.7)  156.5  (26.5)  0.1  150.1  (17.3)  0.9 
Cholesterol (mmol/l)    6.1  (1.0)  6.4  (1.0)  6.5  (1.2)  6.1  (1.1)  6.3  (1.1)  6.4  (1.0)  0.002  6.2  (1.1)  0.6 
Body mass index (kg/m
2)    25.6  (2.4)  26.1  (3.3)  25.5  (3.7)  26.5  (3.8)  26.4  (4.8)  26.6  (4.4)  0.01  24.6  (4.1)  0.23 
adjusted FEV1 (% 
predicted)  98.4  (20.2)  96.9  (18.6)  95.9  (21.2)  92.0  (18.8)  90.5  (22.1)  88.99  (22.1) 
<0.001 
90.9  (16.7) 
0.48 
  N   %  N   %  N   %  N   %  N   %  N   %    N   %   
Men  40        (80.0)  131     (63.3)  115     (42.9)  345  (73.6)  174  (50.7)  42  (35.9)  <0.001  5  (23.8)  0.0002 
Smoker   34   (68.0)  149  (72.0)  184  (68.7)  377  (80.4)  260  (75.8)  87  (74.5)  0.009  16  (76.2)  0.77 
Diabetes  1          (2.0)  2         (0.9)  3         (1.1)  5         (1.1)  6  (1.7)  3   (2.6)  0.79  1  (4.8)  0.61 
Cardiomegaly  9                 (18.7)  44  (22.2)  64       (24.4)  111        (24.1)  87           (26.2)  33  (28.9)  0.67  64  (30)  0.99 
Bronchitis  1                 (2.0)  3  (1.5)  8       (2.9)  14        (2.9)  16          (4.6)  6           (5.1)  0.3  0  (0)  0.46 
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Table 41 Characteristics of individuals with a non-fatal stroke hospitalisation according to Carstairs Morris index 
    1    3    4    5    6 & 7    P  Missing    P 
N    81    216    340    546    356      4     
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excludin
g missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    55.8  (5.5)  55.0  (5.2)  55.4  (5.8)  54.6  (5.4)  56.1  (5.6)  0.003  54.5  (5.8)  0.27 
Systolic BP (mmHg)    156.1  (25.7)  154.6  (23.6)  149.3  (22.9)  158.6  (26.2)  154.9  (26.2)  <0.001  130.8  (13.8)  0.2 
Cholesterol (mmol/l)    6.3  (1.2)  6.2  (1.1)  6.2  (1.0)  6.2  (1.1)  6.2  (1.1)  0.79  6.0  (1.3)  0.77 
Body mass index (kg/m
2)    25.3  (3.5)  25.2  (3.5)  25.6  (3.5)  26.7  (4.2)  26.5  (4.5)  <0.001  26.7  (2.2)  0.9 
adjusted FEV1 (% predicted)    98.1  (19.8)  93.9  (20.8)  93.6  (20.3)  90.4  (22.0)  88.9  (22.8)  <0.001  102.9  (20.1)  0.4 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    29         (35.8)  109       (50.5)  151       (44.4)  254  (46.5)  128  (35.9)  0.002  3  (75)  0.11 
Smoker       48    (59.2)  138  (63.8)  227  (66.8)  375  (68.7)  238  (66.9)  0.4  2  (50)  0.7 
Diabetes    1          (1.2)  3          (1.4)  6          (1.7)  11         (2.0)  7   (1.9)  0.97  4  (100)  0.77 
Cardiomegaly    22                 (27.9)  48  (22.5)  80       (24.9)  157  (29.7)  107  (32.0)  0.01  1  (25)  0.6 
Bronchitis    2                  (2.5)  4  (1.9)  7         (2.1)  15         (2.1)  23           (6.5)  0.005  4  (100)  0.1 
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Table 42 Characteristics of individuals with a non-fatal stroke hospitalisation according to social class 
  I    II   
III -
NM    III-M    IV    V 
  P 
Missing   
P 
N  47    200    280    428    404    146      38     
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    54.5  (5.5)  54.9  (5.4)  55.2  (5.6)  54.9  (5.5)  55.4  (5.7)  55.9  (5.3)  0.43  54.9  (5.8)  0.39 
Systolic BP (mmHg)    147.3  (20.7)  152.6  (23.7)  155.4  (27.3)  153.6  (23.7)  156.4  (26.1)  157.4  (26.5)  0.08  162.3  (24.4)  0.17 
Cholesterol (mmol/l)    6.2  (1.1)  6.3  (1.0)  6.1  (1.2)  6.2  (1.0)  6.3  (1.1)  6.3  (1.0)  0.015  6.2  (0.8)  0.57 
Body mass index (kg/m
2)    25.0  (3.3)  25.8  (3.9)  25.6  (3.9)  26.2  (3.8)  26.6  (4.4)  26.2  (4.8)  0.009  26.3  (5.0)  0.31 
adjusted FEV1 (% 
predicted)  96.7  (17.3)  94.9  (21.1)  93.8  (22.0)  91.2  (21.0)  88.9  (21.5)  90.6  (23.1) 
0.004 
92.79  (26.3) 
0.59 
  N   %  N   %  N   %  N   %  N   %  N   %    N   %   
Men  26        (55.3)  85    (42.5)  85    (30.4)  282  (65.9)  152  (37.6)  41  (28.1)  <0.001  3  (7.9)  <0.001 
Smoker   32   (68.0)  130  (65.0)  179  (63.9)  307  (71.7)  265  (65.8)  98  (67.1)  0.28  17  (44.7)  0.02 
Diabetes  1          (2.1)  7         (3.5)  6         (2.1)  4         (1.0)  5  (1.2)  3   (2.0)  0.28  2  (5.2)  0.11 
Cardiomegaly  10                (22.2)  47  (25.0)  80       (29.2)  103        (24.8)  121          (31.6)  38  (26.9)  0.27  16  (43.2)  0.021 
Bronchitis  1                 (2.1)  4  (2.0)  7       (2.5)  17        (3.9)  13    (3.2)  8           (5.5)  0.47  1  (2.6)  0.82 
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Table 43 Characteristics of individuals with a non-fatal heart failure hospitalisation outcome according to Carstairs Morris index  
    1    3    4    5    6 & 7    P  Missing    P 
N    56    91    173    327    195      2     
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excludin
g missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    57.3  (5.3)  55.3  (5.5)  54.9  (5.8)  54.6  (5.5)  55.5  (5.7)  0.003  61.5  (3.5)  0.27 
Systolic BP (mmHg)    159.8  (21.3)  154.4  (27.0)  149.4  (22.2)  157.9  (25.9)  154.2  (24.7)  0.004  197  (21.2)  0.02 
Cholesterol (mmol/l)    6.1  (0.9)  6.2  (1.0)  6.3  (1.0)  6.2  (1.2)  6.2  (1.0)  0.79  6.3  (0.9)  0.90 
Body mass index (kg/m
2)    25.3  (3.5)  25.2  (3.5)  25.6  (3.5)  26.7  (4.2)  26.5  (4.5)  <0.001  26.7  (2.2)  0.9 
adjusted FEV1 (% predicted)    98.1  (19.8)  93.9  (20.8)  93.6  (20.3)  90.4  (22.0)  88.9  (22.8)  <0.001  102.9  (20.1)  0.4 
    N   %  N   %  N   %  N   %  N   %    N   %   
Men    28         (50.0)  44       (48.4)  85       (49.1)  163  (49.9)  92  (47.2)  0.98  1  (50)  0.98 
Smoker       35    (62.6)  568  (61.5)  121  (70.0)  237  (72.4)  139  (71.3)  0.4  2  (50)  0.7 
Diabetes    1          (1.2)  3          (1.4)  6          (1.7)  11         (2.0)  7   (1.9)  0.97  4  (100)  0.77 
Cardiomegaly    22                 (27.9)  48  (22.5)  80     (24.9)  157  (29.7)  107  (32.0)  0.01  1  (25)  0.6 
Bronchitis    2                  (2.5)  4  (1.9)  7         (2.1)  15         (2.1)  23           (6.5)  0.005  4  (100)  0.1 
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Table 44 Characteristics of individuals with a non-fatal heart failure hospitalisation outcome according to social class 
  I    II   
III -
NM    III-M    IV    V 
  P 
Missing   
P 
N  24    127    139    243    214    82      15     
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Test for 
trend 
(excluding 
missing 
SED)  Mean  SD 
Missing 
vs. rest 
Age (years)    54.4  (5.8)  55.6  (5.6)  54.9  (5.8)  54.6  (5.5)  55.5  (5.7)  55.5  (5.6)  0.48  55.8  (5.9)  0.94 
Systolic BP (mmHg)    159.6  (24.4)  150.5  (23.7)  154.3  (27.3)  155.8  (24.3)  155.9  (25.3)  158.3  (27.4)  0.22  156.8  (30.4)  0.78 
Cholesterol (mmol/l)    6.0  (1.0)  6.3  (1.2)  6.3  (1.1)  6.1  (1.0)  6.3  (1.1)  6.2  (1.0)  0.044  5.9  (1.3)  0.86 
Body mass index (kg/m
2)    27.1  (5.5)  26.8  (4.4)  26.6  (3.9)  27.4  (4.1)  26.9  (5.0)  28.8  (5.3)  0.012  25.3  (4.6)  0.49 
adjusted FEV1 (% 
predicted)  92.6  (21.3)  92.9  (19.5)  90.9  (23.4)  87.9  (22.6)  87.1  (22.1)  83.8  (24.8) 
0.035 
89.39  (24.9) 
0.27 
  N   %  N   %  N   %  N   %  N   %  N   %    N   %   
Men  17        (70.8)  60    (47.2)  45    (32.8)  170  (70.0)  94  (43.9)  22  (26.8)  <0.001  5  (33.3)  0.003 
Smoker   15   (62.5)  89  (70.1)  89  (64.0)  190  (78.2)  147  (68.7)  51  (62.2)  0.02  8  (53.3)  0.26 
Diabetes  1          (4.1)  0         (0)  1         (0.7)  3         (1.2)  9   (4.2)  2   (2.4)  0.06  0  (0)  0.42 
Cardiomegaly  5               (22.7)  43  (34.7)  46    (35.1)  76    (32.5)  71        (34.6)  30  (37.5)  0.84  76  (46.8)  0.24 
Bronchitis  0                 (0)  3  (2.4)  2       (1.4)  14          (5.8)  17          (7.9)  3         (3.6)  0.04  0  (0)  0.93 
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The risk of recurrent hospitalisation 
Crude rates of recurrent hospitalisation 
The number of recurrent hospitalisations is outlined in Table 45 and 46. The rate of 
recurrent hospitalisation after an initial cardiovascular disease type by SED as measured by 
Carstairs Morris index is displayed in Figure 24. A trend towards higher rates of recurrent 
hospitalisation was seen for each initial disease type. The rate ratio (RR) for CVD was 1.03 
(95% CI 0.78-0.86), p=0.08. For CHD this was 1.28 (0.87-1.88), p=0.21, MI 1.21(0.65-
2.25) p=0.55, stroke=0.99 (0.97-1.62), p=0.97 and HF 1.12(0.64-1.93), p=0.13 (Table 
47).A similar trend was observed when social class was used as the marked of SED (Table 
48 and Figure 25). 
 
Table 45 Numbers of individuals according to Carstairs Morris index who experienced a 
recurrent cardiovascular admission  
1
st 
hospitalisation 
Recurrent 
hospitalisation  1  3  4  5  6 & 7 
CVD  CVD  149  335  533  908  547 
CHD  CHD  31  116  152  271  159 
MI  MI  12  45  63  113  57 
Stroke  Stroke  20  41  87  116  83 
HF  HF  16  23  55  95  60 
 
Table 46 Numbers of individuals according to social class who experienced a recurrent 
cardiovascular admission 
1
st 
hospitalisation 
Recurrent 
hospitalisatio
n  I  II  IIIN  IIIM  IV  V 
CVD  CVD  88  374  471  683  587  213 
CHD  CHD  25  111  129  235  164  54 
MI  MI  9  39  49  102  66  23 
Stroke  Stroke  13  51  44  95  90  43 
HF  HF  10  43  42  61  64  25  
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Table 47 Rate ratio of most versus least deprived (measured by Carstairs Morris index) for a 
recurrent cardiovascular hospitalisation 
1
st 
hospitalisation 
Recurrent 
hospitalisation  RR 
95% 
CI    P 
CVD  CVD  1.03  0.86  1.23  0.77 
CHD  CHD  1.28  0.87  1.89  0.20 
MI  MI  1.21  0.65  2.26  0.54 
Stroke  Stroke  0.99  0.61  1.61  0.97 
HF  HF  1.11  0.64  1.93  0.72 
 
Table 48 Rate ratio of most versus least deprived (measured by social class) for a recurrent 
cardiovascular hospitalisation 
1
st 
hospitalisation 
Recurrent 
hospitalisation  RR 
95% 
CI    P 
CVD  CVD  1.00  0.78  1.28  0.97 
CHD  CHD  0.97  0.60  1.58  0.91 
MI  MI  1.10  0.51  2.38  0.81 
Stroke  Stroke  1.05  0.56  1.96  0.88 
HF  HF  0.65  0.31  1.37  0.25 
 
 
Kaplan Meier Analysis of Recurrent cardiovascular hospitalisation 
In a Kaplan Meier analysis of recurrent cardiovascular hospitalisation there was no 
significant difference in the rates of recurrent cardiovascular disease hospitalisation 
according to SED measured by Carstairs Morris index or social class (Figures 26-35). 
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Figure 24 Rate of subsequent cardiovascular hospitalisation of the same type according to SED measured by Carstairs Morris index.  
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Figure 25 Rate of subsequent cardiovascular hospitalisation of the same type according to SED measured by social class 
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Figure 26 Kaplan Meier analysis of recurrent cardiovascular hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 Kaplan Meier analysis of recurrent cardiovascular hospitalisation 
over follow up according to social class 
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Figure 28 Kaplan Meier analysis of a recurrent coronary heart disease 
hospitalisation over up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 Kaplan Meier analysis of a recurrent coronary heart disease 
hospitalisation over follow up according to social class 
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Figure 30 Kaplan Meier analysis of recurrent myocardial infarction 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 Kaplan Meier analysis of recurrent myocardial infarction 
hospitalisation over follow up according to social class 
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Figure 32 Kaplan Meier analysis of recurrent stroke hospitalisation over 
follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33 Kaplan Meier analysis of recurrent stroke hospitalisation over 
follow up according to social class 
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Figure 34 Kaplan Meier analysis of recurrent heart failure hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35 Kaplan Meier analysis of recurrent heart failure hospitalisation 
over follow up according to social class 
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Adjusted survival to a recurrent hospitalisation 
In a regression model the association between SED and recurrent events was examined 
(Tables 49 and 50). In both unadjusted and adjusted analyses the risk of a second recurrent 
event was not associated with SED. The removal of smoking from the multivariable model 
made no discernable difference to the results only altering the hazard ratios at the 4
th or 
smaller decimal place. Therefore, smoking was retained in the model. 
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Table 49 Hazard of recurrent hospitalisation of the same type in the most versus least deprived as measured by the Carstairs Morris index.  
  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
CVD  1.02  0.85  1.23  0.797  0.99  0.83  1.19  0.928  1.00  0.83  1.19  0.967  0.97  0.81  1.17  0.761 
CHD  1.28  0.87  1.88  0.205  1.21  0.82  1.77  0.34  1.22  0.83  1.79  0.321  1.27  0.85  1.88  0.239 
MI  1.22  0.65  2.26  0.539  1.16  0.62  2.16  0.647  1.15  0.61  2.14  0.668  1.19  0.62  2.28  0.611 
Stroke  0.99  0.61  1.62  0.972  0.97  0.60  1.58  0.905  0.99  0.60  1.61  0.956  0.98  0.60  1.61  0.935 
HF  1.10  0.64  1.91  0.728  1.04  0.60  1.81  0.894  1.06  0.61  1.84  0.848  1.02  0.58  1.81  0.936 
 
Table 50 Hazard of recurrent hospitalisation of the same type in the most versus least deprived as measured by social class. 
  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
CVD  0.99  0.77  1.28  0.944  1.03  0.79  1.33  0.833  1.03  0.80  1.34  0.807  1.03  0.79  1.35  0.811 
CHD  0.96  0.59  1.56  0.874  0.96  0.59  1.56  0.868  1.02  0.63  1.66  0.936  1.11  0.66  1.84  0.7 
MI  1.30  0.61  2.78  0.494  1.49  0.69  3.22  0.308  1.37  0.63  2.95  0.428  1.52  0.68  3.43  0.31 
Stroke  0.97  0.50  1.86  0.927  0.94  0.49  1.82  0.86  0.92  0.48  1.79  0.814  1.07  0.54  2.13  0.849 
HF  0.63  0.29  1.36  0.24  0.65  0.30  1.42  0.283  0.66  0.30  1.43  0.289  0.60  0.27  1.32  0.206 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly 
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Death following a cardiovascular hospitalisation 
Crude rates  
The numbers of individuals who died following a particular cardiovascular hospitalisation 
are outlined in Tables 51 and 52. The rate of death following a non-fatal cardiovascular 
hospitalisation did show evidence of a gradient by SED (Figure 36 and 37). Following any 
CVD hospitalisation the rate ratio for the rate of death in the most versus least deprived 
was 1.33 (95%CI 1.14-1.56), p=0.0003 (Table 53). Similar trends were observed following 
a CHD hospitalisation 1.21 (0.921-1.59), p=0.1689, MI 1.29(0.95-1.75),p=0.11, stroke 
1.23 (0.93-1.62), p=0.148 and HF 1.20 (0.84-1.69), p=0.314. As with Carstairs Morris 
index, only the rate ratio for death following a CVD hospitalisation was significant when 
social class was used to measure SED (Table 54). Overall rates of death were highest 
following a stroke or heart failure.  
Table 51 Number of Deaths by type of first hospitalisation and socioeconomic deprivation 
measured by Carstairs Morris index 
 
Table 52 Number of Deaths by type of first hospitalisation and socioeconomic deprivation 
measured by social class 
1
st 
hospitalisation  Outcome  I  II  IIIN  IIIM  IV  V 
CVD  Death  99  500  641  1063  884  320 
CHD  Death  42  181  243  433  326  110 
MI  Death  31  133  196  338  255  85 
Stroke  Death  33  158  203  341  321  124 
HF  Death  21  99  109  204  182  69 
 
1
st 
hospitalisation  Outcome  1  3  4  5  6 & 7 
CVD  Death  192  468  738  1321  867 
CHD  Death  62  190  265  525  317 
MI  Death  49  144  198  411  249 
Stroke  Death  61  163  262  433  290 
HF  Death  40  70  138  277  167  
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Table 53 Rate ratio of most versus least deprived (measured by Carstairs Morris index) for 
death following a first cardiovascular hospitalisation 
Initial 
hospitalisation  
Subsequent 
Event   RR 
95% 
CI    P 
CVD  Death  1.34  1.14  1.53  0.0003 
CHD  Death  1.21  0.92  1.59  0.17 
MI  Death  1.29  0.95  1.75  0.12 
Stroke  Death  1.23  0.93  1.62  0.15 
HF  Death  1.19  0.84  1.69  0.31 
 
Table 54 Rate ratio of most versus least deprived (measured by social class) for death 
following a first cardiovascular hospitalisation 
Initial 
hospitalisation  
Subsequent 
Event   RR 
95% 
CI    P 
CVD  Death  1.36  1.09  1.71  0.007 
CHD  Death  1.14  0.79  1.63  0.48 
MI  Death  1.24  0.80  1.84  0.36 
Stroke  Death  1.19  0.81  1.75  0.37 
HF  Death  0.97  0.41  1.11  0.12 
 
Figure 36 Rate of death following a first cardiovascular hospitalisation according to 
Carstairs Morris index 
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Figure 37 Rate of death following a first cardiovascular hospitalisation according to social 
class 
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Kaplan Meier Analysis 
Following a cardiovascular hospitalisation the risk of death was higher in the most 
deprived during the remaining follow up (log rank p=0.0001) (Figures 38 and 39). A trend 
towards a similar association was seen with each of the other cardiovascular events though 
did not reach statistical significance (Figures 40-47).  
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 Figure 38 Kaplan Meier analysis of death following a cardiovascular 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39 Kaplan Meier analysis of death following a cardiovascular 
hospitalisation over follow up according to social class 
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Figure 40 Kaplan Meier analysis of death following a coronary heart 
disease hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41 Kaplan Meier analysis of death following a coronary heart 
disease hospitalisation over follow up according to social class 
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Figure 42 Kaplan Meier analysis of death following a myocardial infarction 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43 Kaplan Meier analysis of death following a myocardial infarction 
hospitalisation over follow up according to social class 
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Figure 44 Kaplan Meier analysis of death following a stroke hospitalisation 
over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45 Kaplan Meier analysis of death following a stroke hospitalisation 
over follow up according to social class 
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Figure 46 Kaplan Meier analysis of death following a heart failure 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47 Kaplan Meier analysis of death following a heart failure 
hospitalisation over follow up according to social class 
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Adjusted survival  
In a regression model the association between SED (measured by Carstairs Morris index) 
and death following an initial hospitalisation was examined (Table 55). In unadjusted 
analyses there was no association with SED. After adjustment for age at event and sex, a 
significantly higher risk of death following a hospitalisation for CVD, HR1.53 (1.31-1.79), 
CHD 1.38(1.05-1.81), and MI 1.37(1.01-1.87) was observed. After adjustment for the 
traditional risk factors (diabetes, cholesterol, systolic blood pressure) and the year of the 
initial event, these associations between SED and death following a CVD, CHD and MI 
event persisted. After further adjustment for BMI, FEV1 and cardiomegaly only the 
relationship between SED and death following a CVD hospitalisation remained significant. 
Whilst the risk of death following a stroke or HF hospitalisation did not reach statistical 
significance a trend towards an increased risk was observed. When social class was used to 
measure SED only recurrent CVD hospitalisations showed a statistically significant 
association with SED after adjustment for traditional risk factors (Table 56). 
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Table 55 Hazard of death following a first cardiovascular hospitalisation in the most versus least deprived as measured by Carstairs Morris index  
  HR*  95% CI    P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
CVD  1.34  1.15  1.57  <0.001  1.53  1.31  1.79  <0.001  1.53  1.31  1.79  <0.001  1.38  1.18  1.63  <0.001 
CHD  1.21  0.92  1.59  0.175  1.38  1.05  1.81  0.021  1.41  1.07  1.85  0.014  1.29  0.97  1.71  0.075 
MI  1.28  0.94  1.73  0.119  1.37  1.01  1.87  0.044  1.42  1.04  1.93  0.026  1.31  0.95  1.80  0.099 
Stroke  1.21  0.91  1.59  0.184  1.24  0.94  1.63  0.133  1.19  0.90  1.57  0.226  1.13  0.85  1.51  0.386 
HF  1.21  0.86  1.71  0.272  1.39  0.98  1.97  0.065  1.36  0.96  1.93  0.085  1.34  0.93  1.92  0.115 
 
Table 56 Hazard of death following a first cardiovascular hospitalisation in the most versus least deprived as measured by social class 
  HR*  95% CI    P  HR**  95% CI    P  HR†  95% CI    P  HR‡  95% CI    P 
CVD  1.36  1.09  1.71  0.007  1.47  1.17  1.84  0.001  1.31  1.04  1.64  0.021  1.18  0.93  1.49  0.165 
CHD  1.12  0.79  1.60  0.519  1.07  0.75  1.54  0.699  0.94  0.65  1.35  0.733  0.92  0.63  1.34  0.668 
MI  1.22  0.81  1.84  0.349  1.24  0.85  1.80  0.267  0.89  0.59  1.35  0.584  0.91  0.59  1.40  0.664 
Stroke  1.19  0.81  1.74  0.381  1.26  0.86  1.85  0.244  1.13  0.77  1.66  0.537  1.05  0.71  1.56  0.793 
HF  0.72  0.44  1.17  0.187  0.71  0.43  1.16  0.174  0.64  0.39  1.06  0.083  0.63  0.37  1.07  0.086 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly 
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Crude rate of death or subsequent recurrent hospitalisation 
The numbers of each of the outcome of death or recurrent hospitalisation are shown in 
Tables 57 and 58. With the exception of cardiovascular disease and coronary heart disease 
there is an imbalance in the numbers of deaths as compared to recurrent myocardial 
infarction, stroke and heart failure hospitalisations.  
Table 57 Number of deaths or recurrent hospitalisation according to first cardiovascular 
event and Carstairs Morris index 
 
 
Table 58 Number of deaths or recurrent hospitalisation according to first cardiovascular 
event and social class 
1
st 
hospitalisation  Outcome  I  II  IIIN  IIIM  IV  V 
CVD  Death/ 
CVD  47/88  252/374  324/471  573/683  453/587  154/213 
CHD  Death/ 
CHD  32/25  116/111  164/129  281/235  215/164  74/54 
MI  Death/ 
MI  27/9  105/39  154/49  258/102  202/66  66/23 
Stroke  Death/ 
Stroke  24/13  114/51  169/44  264/95  246/90  85/43 
HF  Death/ 
HF  13/10  65/43  72/42  146/61  126/64  46/25 
 
 
The rate of death or subsequent recurrent hospitalisation was examined. A clear gradient of 
risk emerged in the risk of recurrent hospitalisation when death was included in the 
composite endpoint when SED was measured by Carstairs Morris index. The relationship 
1
st 
hospitalisation  Outcome  1  3  4  5  6 & 7 
CVD  Death/CVD  96/149  242/335  386/533  669/908  449/547 
CHD  Death/CHD  46/31  116/116  177/152  350/271  210/159 
MI  Death/MI  41/12  110/45  152/63  321/113  199/57 
Stroke  Death/Stroke  46/20  128/41  192/87  334/116  221/83 
HF  Death/HF  27/16  49/23  91/55  194/95  112/60  
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was not as clear with social class as the measure of SED. The rate ratios are given below in 
Table 59 and 60 and the rates displayed in Figures 48 and 49.  
Table 59 Rate ratio for death or recurrent hospitalisation according in the most versus least 
deprived as measured by Carstairs Morris index 
Initial 
hospitalisation  
Subsequent 
hospitalisation   RR 
95% 
CI    P 
CVD  Death/CVD  1.24  1.08  1.43  0.0025 
CHD  Death/CHD  1.36  1.07  1.74  0.0135 
MI  Death/MI  1.35  1.01  1.82  0.0447 
Stroke  Death/Stroke  1.26  0.96  1.64  0.0964 
HF  Death/HF  1.47  1.05  2.06  0.0239 
 
Table 60 Rate ratio for death or recurrent hospitalisation according in the most versus least 
deprived as measured by social class  
Initial 
hospitalisation  
Subsequent 
hospitalisation   RR 
95% 
CI    P 
CVD  Death/CVD  1.18  0.97  1.44  0.09 
CHD  Death/CHD  0.96  0.70  1.31  0.78 
MI  Death/MI  1.10  0.74  1.63  0.64 
Stroke  Death/Stroke  1.23  0.85  1.78  0.28 
HF  Death/HF  0.63  0.39  1.02  0.055 
 
Figure 48. Rate of death or recurrent hospitalisation according to first cardiovascular event 
type and Carstairs Morris index 
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Figure 49 Rate of death or recurrent hospitalisation according to first cardiovascular event 
type and social class 
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Kaplan Meier analysis of the risk of death or recurrent cardiovascular 
hospitalisation 
Kaplan Meier analysis of the association between SED and the composite outcome of 
death or recurrent hospitalisation illustrated the higher risk experienced by the most 
deprived versus the least deprived (Figures 50-59). Whilst the association was not 
statistically significant for those who had experienced a coronary hospitalisation or 
myocardial infarction, the higher risk was still evident in the most deprived.  
Adjusted rates 
The hazard of recurrent hospitalisation or death varied according to socioeconomic 
deprivation when measured by Carstairs Morris index (Table 61). This association was 
statistically significant for CVD and subsequent death or CVD, CHD and subsequent death 
or CHD even after adjustment for traditional risk factors. The risk of death or recurrent MI 
was associated with SED in the unadjusted and adjusted analyses although just failed to 
reach statistical significance. There was no clear association with social class (Table 62). 
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Figure 50 Kaplan Meier analysis of death or recurrent cardiovascular 
hospitalisation following a cardiovascular hospitalisation over follow up 
according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51 Kaplan Meier analysis of death or recurrent cardiovascular 
hospitalisation following a cardiovascular hospitalisation over follow up 
according to social class 
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Figure 52 Kaplan Meier analysis of death or recurrent coronary 
hospitalisation disease event following a coronary heart disease 
hospitalisation over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53 Kaplan Meier analysis of death or recurrent coronary heart 
disease hospitalisation following a coronary heart disease hospitalisation 
over follow up according to social class 
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Figure 54 Kaplan Meier analysis of death or recurrent myocardial infarction 
hospitalisation following a myocardial infarction hospitalisation over follow 
up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55 Kaplan Meier analysis of death or recurrent myocardial infarction 
hospitalisation following a myocardial infarction hospitalisation over follow 
up according to social class 
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Figure 56 Kaplan Meier analysis of death or recurrent stroke hospitalisation 
following a stroke over follow up according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 57 Kaplan Meier analysis of death or recurrent stroke hospitalisation 
following a stroke over follow up according to social class 
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Figure 58 Kaplan Meier analysis of death or recurrent heart failure 
hospitalisation following a heart failure hospitalisation over follow up 
according to Carstairs Morris index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59 Kaplan Meier analysis of death or recurrent heart failure 
hospitalisation following a heart failure hospitalisation over follow up 
according to social class 
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Table 61 Hazard of death or recurrent cardiovascular hospitalisation in the most versus least deprived as measured by Carstairs Morris index.  
Initial 
hospitalisation 
Subsequent 
Event  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
CVD  Death/CVD  1.23  1.07  1.42  0.004  1.21  1.05  1.40  0.007  1.22  1.06  1.41  0.005  1.14  0.98  1.31  0.08 
CHD  Death/CHD  1.35  1.05  1.72  0.017  1.31  1.02  1.67  0.033  1.35  1.06  1.73  0.017  1.30  1.01  1.67  0.044 
MI  Death/MI  1.34  1.00  1.80  0.054  1.34  1.00  1.81  0.051  1.34  1.00  1.81  0.052  1.25  0.92  1.70  0.147 
Stroke  Death/Stroke  1.25  0.95  1.63  0.106  1.23  0.94  1.60  0.133  1.18  0.90  1.54  0.233  1.15  0.87  1.50  0.328 
HF  Death/HF  1.46  1.04  2.04  0.027  1.24  0.88  1.73  0.218  1.21  0.86  1.70  0.269  1.12  0.79  1.59  0.532 
Table 62 Hazard of death or recurrent cardiovascular hospitalisation in the most versus least deprived as measured by social class 
Initial 
hospitalisation 
Subsequent  
Event  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
CVD  Death/CVD  1.18  0.97  1.44  0.098  1.29  1.06  1.57  0.012  1.13  0.92  1.37  0.242  1.08  0.88  1.33  0.458 
CHD  Death/CHD  0.95  0.70  1.30  0.758  1.01  0.73  1.38  0.971  0.82  0.59  1.13  0.217  0.83  0.59  1.15  0.257 
MI  Death/MI  1.15  0.78  1.67  0.481  1.31  0.89  1.92  0.169  0.93  0.64  1.37  0.726  0.94  0.63  1.41  0.776 
Stroke  Death/Stroke  1.13  0.79  1.61  0.511  1.16  0.81  1.66  0.429  0.93  0.65  1.33  0.685  0.95  0.65  1.38  0.778 
HF  Death/HF  0.63  0.39  1.01  0.055  0.63  0.39  1.01  0.057  0.63  0.39  1.02  0.06  0.57  0.35  0.94  0.026 
*Unadjusted 
**Adjusted for age at first hospitalisation and sex  
† Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking and year of first hospitalisation 
‡ Adjusted for age at first hospitalisation, sex, diabetes, cholesterol, systolic blood pressure, smoking, year of first hospitalisation, body mass index, FEV1, 
cardiomegaly  
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Discussion 
As described earlier in the first chapter, SED is related to the first occurrence of a 
cardiovascular event after adjustment for multiple cardiovascular risk factors. However, 
little evidence is available from the literature to suggest that SED is related to the risk of a 
recurrent cardiovascular hospitalisation.
92,105 The analyses presented here indicate that 
SED is not associated with a higher risk of a recurrent cardiovascular hospitalisation but is 
associated with a higher risk of death. A composite outcome of death or recurrent 
hospitalisation revealed similar trends, mainly driven by the association with death.  
Risk of a recurrent hospitalisation 
It is somewhat surprising that the risk of recurrent hospitalisation was not related to SED. 
It has been reported that the most deprived individuals receive less intensive therapy for 
their cardiovascular disease. For example, the most deprived are less likely to receive 
aspirin, beta-blockers and thrombolysis for myocardial infarction
230 and rehabilitation 
following a stroke
118. Those with ischaemic heart disease as less likely to be referred for 
surgical (coronary artery bypass grafting
79) or percutaneous (coronary angioplasty
79,231,232) 
revascularisation with possibly detrimental effects on subsequent mortality
93. For those 
who experience a stroke, rates of carotid endarterectomy were not different according to 
SED but waiting times were longer in the most deprived in one study from Canada 
118. 
Furthermore, more deprived individuals are less likely to adhere to preventative 
medications
233 and attend rehabilitation classes
234,235 and then to complete them
235. Finally, 
lifestyle modification is recommended following the development of cardiovascular 
disease but in a cohort of survivors of a myocardial infarction, the most deprived were less 
likely to reduce their alcohol intake, exercise and adopt a healthier diet.
236 As many of 
these therapies and interventions potentially reduce morbidity as well as mortality we may 
expect that the rates of recurrent cardiovascular events would be higher amongst the most 
deprived who do not receive these treatments or make such changes. However, the lack of 
such treatments may predispose the most deprived to a greater risk of death following their 
cardiovascular hospitalisation and this was evident in this cohort. As a consequence it may 
be that the most deprived simply die before they can experience a recurrent cardiovascular 
hospitalisation. In analyses where a composite of death or recurrent cardiovascular event 
were performed the most deprived were at higher risk. However, from these results I can 
only hypothesise that this is the case for all recurrent CVD hospitalisations as the 
composite was balanced in terms of numbers of events for the fatal and non-fatal parts of  
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the outcome. For all the other composite outcomes, death with CHD, MI, stroke or HF, the 
composite outcome mainly consisted of deaths. 
After experiencing and surviving a cardiovascular event, it is perhaps unsurprising that 
SED, as measured by an area based measure, would continue to confer an excess risk of 
death or recurrence of cardiovascular disease. After discharge it is highly likely that the 
individual will return to their home and their neighbourhood. Therefore, all the potential 
causal mechanisms associated with living in a deprived area will still be present, e.g. 
higher crime, damp housing, poor access to health services, lack of leisure activity etc. 
These will therefore continue to exert a potentially detrimental effect on health.  
Following a cardiovascular event it is possible that individuals may become too ill to 
continue to work. One confounding issue that I was not able to address was the potential 
bias that following a cardiovascular event an individual’s social status may change. Due to 
continuing ill health an individual may not return to work. This would then lower their 
socioeconomic status, thus, possibly increasing their risk of a subsequent mortality and 
possibly cardiovascular events. Indeed, there is evidence that following a myocardial 
infarction recovery of functional status is poorer in the most deprived as compared to least 
deprived in one study of men
237, and, that following a stroke, greater levels of disability are 
experienced by the most deprived
238, both factors which could lead to a loss of 
employment.  
A number of studies have reported that more deprived individuals present with more 
severe disease during their first event. This may explain the higher risk of death and trend 
toward a higher risk of recurrent hospitalisations amongst the most deprived. There is no 
more severe a presentation than death and a number of studies of coronary heart disease 
have reported that more deprived individuals are less likely to reach hospital alive when 
presenting with CHD. In the MONICA studies individuals with a first myocardial 
infarction were less likely to reach hospital alive if they were deprived.
61 In another study 
of coronary deaths in Scotland, the most deprived were more likely to die out of hospital 
with a first coronary event.
64 In a study of patients with MI admitted to a coronary care unit 
more individuals in the deprived cohort presented with heart failure.
133 A number of 
studies have reported that stroke severity is higher in the most deprived as compared to the 
least deprived.
115,117 In one study, the most deprived were more likely to be dependant for 
their activities of daily living at 28 days following a stroke.
99 It has also been reported that 
stroke longer term disability and handicap are higher in the most deprived.
238 Again we 
may expect that the greater severity of disease in the most deprived would increase rates of  
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recurrent events, but it may simply serve to increase case fatality and mortality, reducing 
the chances of a deprived individual to experience further non-fatal outcomes. 
It is not only the presentation that is more severe in patients with CVD. Following a 
cardiovascular event, multiple studies have demonstrated that access to health care 
professionals is lower during or after an event. In individuals with HF
129, stroke
119 and 
coronary disease, the most deprived were less likely to be treated by a specialist, attend a 
high volume i.e. expert hospital, and receive appropriate investigations or further 
interventions
113. All of these factors may explain the higher rates of death and possibly 
recurrence. Indeed, when discharged following a cardiovascular hospitalisation a deprived 
individual may be less likely to have contact with their general practitioner. In a study from 
primary care practices from Scotland those deprived individual with a diagnosis of HF 
were less likely to see their general practitioner each year than the least deprived 
individuals with the diagnosis of HF.
121  
In general deprived individuals tend to exhibit a higher burden of other diseases too. Prior 
studies have documented a higher prevalence in the deprived of comorbidities that increase 
the risk of death following a cardiovascular event such as diabetes, chronic obstructive 
airways disease, cancer and renal impairment.
77,92 This differential distribution of 
comorbidities may partly explain why more deprived individuals are more likely to die 
following a cardiovascular event.  
Limitations 
In these analyses the adjustment was made for risk factors that were measured prior to the 
first hospitalisation an individual experienced. This may bias the result, as risk factors may 
have changed subsequent to experiencing a first cardiovascular hospitalisation.
236  It is 
unlikely that factors such as cholesterol and blood pressure changed substantially as it has 
only been possible to modify these risk factors adequately through pharmacotherapy in the 
latter period of follow up.   
The choice of adjusting variables may also have been incorrect. Whist the risk factors of 
smoking, blood pressure, diabetes and cholesterol may have a deleterious effect on the risk 
of a first cardiovascular event
67, other factors related to the form of cardiovascular event 
experienced, e.g. disability following stroke
117, heart failure after a myocardial 
infarction
77,92, may be more important mediators of subsequent risk following a  
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cardiovascular event. However, for risk factors such as diabetes, the risk associated with 
them persists following a first cardiovascular hospitalisation such as heart failure.
239 
Summary  
The risk of death or a recurrent cardiovascular hospitalisation is higher in the most 
deprived as compared to the least deprived. This is mainly driven by the higher rates of 
death amongst the most deprived. The risk of recurrent hospitalisations displays a trend 
towards higher rates in the deprived though this was not consistent or statistically 
significant. This may be due to the fact that socioeconomic status changes following a 
cardiovascular hospitalisation or that other factors are more important once cardiovascular 
disease has led to a hospitalisation in an individual.  
In the next chapter I will explore how SED is related to the total hospital burden of CVD. 
On the basis of the last chapter where was associated with a higher risk of subsequent 
mortality but not recurrent cardiovascular hospitalisations, and the chapter before where 
SED was associated with a greater risk of a first hospitalisations for CVD, it remains to be 
seen what the total burden by SED is.  
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The Burden of Cardiovascular Disease and Death 
In this section I will examine the burden of disease in relation to SED. Firstly the rate of 
death and premature deaths will be determined, including cardiovascular deaths. The 
numbers of hospitalisations according to SED for each cardiovascular disease type will be 
described. The costs associated with CVD hospitalisations will be calculated by SED. The 
population attributable fraction of SED in relation to a number of cardiovascular disease 
types will be calculated. 
Methods 
Burden of cardiovascular disease 
Hospital burden 
Using the linked Scottish Morbidity Record data the number of discharges for a particular 
cardiovascular disease type was calculated. The length of stay in hospital for the entire stay 
pertaining to that admission was calculated. Mean length of stay for each cardiovascular 
cause was calculated. The total time a person spent out of hospital before their first 
cardiovascular event was calculated from the time on enrolment to the first admission with 
that cardiovascular disease type. Time spent in hospital was computed over the length of 
follow up and the time free from hospital also calculated. Analyses were stratified by SED.  
Burden of death 
Using the linked General Registrar Office data on deaths, the number of deaths in each 
socioeconomic group was calculated. The number of days from enrolment to the end of 
study or death was calculated according to SED and the number of days until death was 
calculated. Deaths occurring before a specific age were also calculated. At the start of the 
study the life expectancy of the cohort was until the age of 75 years approximately (71 
years for men and 76 years for women). This figure was obtained from the General 
Register Office records of life expectancy from the 1970-1972 census for individuals aged 
45-64 years of age at that time (personal communication, General Register Office, 2008). 
All analyses of deaths have examined deaths at end of follow up of the cohort. In addition 
to ascertain if SED had an effect on premature deaths, deaths at age 65 and 70 years, and 
75 (life expectancy) were calculated. These were stratified by SED.   
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Adjusted risk of death 
The adjusted risk of death was calculated using Cox regression. The effect of SED was 
tested in unadjusted and age and sex adjusted models. Models were then additionally 
adjusted for traditional cardiovascular risk factors (diabetes, smoking, cholesterol and 
systolic blood pressure). Finally, other factors known to influence cardiovascular and all 
cause mortality were added to the model (body mass index, FEV1, cardiomegaly).  
Population attributable fraction   
The contribution of a risk factor to a disease or a death can be quantified using the 
population attributable fraction (PAF). The PAF is the proportional reduction in population 
disease or mortality that we would expect to occur if exposure to that risk factor were 
reduced to an alternative ideal exposure scenario (e.g. reduction of smoking levels to nil). 
As with cardiovascular disease, many diseases are caused by multiple risk factors, 
therefore, individual risk factors may interact in their impact on overall risk of disease. 
Consequently, PAFs for individual risk factors often overlap and add up to more than 100 
percent. 
The PAF can be calculated using the formula below:  
 
Where: 
Pr = proportion of population at exposure level with the outcome 
RR = relative risk 
For risk factors with continuous rather than discrete exposure levels there is an analogous 
formula for PAF involving integration of the exposure level distribution. 
However, as noted, calculation of the population attributable fraction can in theory lead to 
all percentages adding to over 100%. This is of course counterintuitive. Furthermore, the 
method above makes no allowance for the potential confounders of the outcome. By failing  
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to adjust for confounders the potential attributable fraction will be overestimated. A 
number of methods are available to adjust for this concern. The commonest approach is to 
use the Levin formula: 
 
Where  p = the prevalence of the risk factor and RR = the relative risk estimate. 
This method requires the assumption that the number of cases in the exposed is the same as 
the unexposed. An assumption that would be violated in this setting. Furthermore, this 
approach can also yield results that add to over 100%. Adjusted risk estimates can also be 
used in this formula. However this method yields inconsistent and biased results.  
The calculation of the average attributable fraction overcomes these limitations by 
producing an estimate of the attributable fraction from a multivariable model adjusted for 
other factors.
240 It uses a logistic regression model to calculate the attributable fraction 
using the following method: 
1.  The risk factor is coded into a dichotomous variable. 
2.  Predicted probabilities for each individual are calculated using the following 
formula: 
 
Where alpha = the estimate of the intercept for the regression model, beta = the 
parameter vector for the covariate in the model and xi = the observations of the 
covariates for each individual with the removed variable set to zero for all individuals 
3.  The sum of the predicted probabilities is the adjusted number of cases that would 
be expected if the risk factor was removed from the population  
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4.  The average attributable fraction is calculated by subtracting the expected cases 
calculated above from the observed number of cases and then dividing by the 
observed number of cases.  
Using this method more meaningful results and unbiased results of the proportion of 
disease attributable to a risk factor in a population can be obtained. In these analyses 
both the simple formula for attributable fraction and the average attributable fraction 
are used. As the average attributable fraction requires that variables be dichotomous, 
age was split in to age 45-54 years and 55-64 years, blood pressure into groups 
<140mmHg and ≥140mmHg, cholesterol into groups <5 mmol/l and ≥5 mmol/l and 
SED into Carstairs Morris index categories 1,3 and 4 (the least deprived) and 5,6 and 
7(the most deprived) and social class into I,II, III-NM and III-M, IV and V.  
Economic costs 
The cost associated with a cardiovascular admission was calculated for each 
socioeconomic group. The cost associated with each type of cardiovascular disease type 
was also calculated. The costs pertaining to the admission type were calculated using the 
NHS Greater Glasgow and Clyde costs for 2007 from the NHS cost book.
241 The health 
board costs for a particular type of admission are collated by the Information Services 
Division of NHS Scotland and updated every year. The summary costs for the whole 
health board were used to try and ensure that a representative figure was used that captured 
the possibility that individuals may have been admitted to hospitals across the Glasgow  
area during their lifetime.  
 
Inflation 
To account for inflation over time the costs for admissions in NHS Greater Glasgow and 
Clyde from 2007 were taken and discounted back by 5% per annum. In a sensitivity 
analysis the historical rates of inflation were obtained from the Office of National 
Statistics.
242 These inflation rates are based on the consumer price inflation index.  These 
rates were then used to calculate the equivalent historical costs associated with admissions. 
As no discernable difference was observed using either method a consistent 5% deflation 
was used.   
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Cost  
The cost associated with a particular type of stay in an acute hospital was obtained. A cost 
per day from the NHS cost book was calculated and multiplied by the actual number of 
days spent in hospital for an admission by an individual. For example, to calculate the cost 
per day of a stroke admission from the NHS cost book, an admission for stroke was 
presumed to have occurred in a general medical ward as stroke units have only recently 
been introduced. The cost per day on a general medical ward was then multiplied by the 
number of days actually spent by an individual in hospital during a hospitalisation for 
stroke during follow up. A myocardial infarction was on average assumed to last 7 days of 
which 2 days would be spent in a coronary care unit. All other cardiovascular, coronary 
heart disease and chronic heart failure admissions were assumed to occur in a cardiology 
ward. The costs per day for an admission to each type of these wards was calculated using 
Greater Glasgow and Clyde data in the NHS cost book. These costs were then totalled 
according to the assumptions above. For example the cost of a myocardial infarction 
admission was calculated as thus: 
Step 1: Calculate average cost per day  
Total cost of myocardial infarction stay = (Cost of stay in coronary care unit/ average 
length of stay in NHS cost book) * 2 + (cost of stay in cardiology ward/ average length of 
stay in cost book)*5 
This was then divided by 7 to give a cost per day. 
Step 2: Calculate the cost for a hospitalisation 
Multiply the actual number of days in hospital during a myocardial infarction 
hospitalisation by the cost per day calculated in step 1.  
 Step 3: Deflation 
This cost was then deflated as outlined above.  
Outpatient and pharmacotherapy costs 
The costs of outpatient attendance were not calculated in these analyses. It has been 
reported that attendance at out patient clinics varies by socioeconomic status in one study  
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243, though not in another
244. The most deprived may attend outpatients clinics more often 
than the least deprived members of society.
243 Due to the uncertainty surrounding the 
direction of effect of socioeconomic status on out patient attendances and the lack of data 
on outpatient attendances in the dataset an average number of visits per admission type 
would have to be applied to all socioeconomic groups, lessening the ability to detect 
between group differences.  
Similarly, the costs of pharmacotherapy were not included. These were not calculated as 
two large assumptions would have to be made thus reducing the validity of such analyses. 
Firstly, assumptions regarding which pharmacotherapies may have been prescribed at 
which time points would have to be made. Over the study period effective 
pharmacotherapies for cardiovascular disease were established. There is no record of 
pharmacotherapies in the Renfrew/Paisley dataset therefore multiple assumptions would 
have to be made in determining which therapies were prescribed. Secondly, the 
prescription of pharmacotherapies differs by socioeconomic status.
155,165,245 Some studies 
have reported no difference
246 and others do not agree on the direction of effect.
165,247 
Therefore, again an assumption around the direction and size of effect of socioeconomic 
deprivation and rates pharmacotherapy prescription would have to be made on top of the 
assumption made previously regarding when certain pharmacotherapies would have been 
likely to have been prescribed over time. This was deemed to introduce an unacceptable 
degree of uncertainty. Therefore, only costs associated with inpatient care were studied so 
that the size and direction of effect associated with socioeconomic deprivation could be 
measured with a degree of certainty. Indirect costs, such as loss of earnings were similarly 
not calculated due to insufficient evidence in the published literature to determine possible 
directions of effect.  
Results 
All cause mortality 
The number of deaths according to deprivation category are outlined in Table 63.The 
absolute numbers in the most deprived groups are higher than in the least deprived and this 
is reflected in the fact that by the end of follow up nearly 72% of the most deprived were 
dead from all causes as compared to only 58% of the least deprived. This gradient was 
evident when deaths prior to the age of 65 years, 70 years and finally 75 years were 
examined. At the age of life expectancy, 75 years, 46% of the most deprived members of  
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the cohort had died as opposed to 31% of the least deprived with a gradient in the 
proportion dead in between. 
Table 63 Number of deaths and proportions of deaths at end of follow up and before 65 
years, 70 years and 75 years of age according to Carstairs Morris index.  
  N  All deaths  %   65 years   %   70 years %  75 years  % 
1  990  578  58.38  108  10.91  197  19.90  307  31.01 
3  2084  1,337  64.16  272  13.05  491  23.56  769  36.90 
4  3347  2,169  64.80  440  13.15  809  24.17  1,288  38.48 
5  5534  3,742  67.62  871  15.74  1,532  27.68  2,355  42.56 
6&7  3389  2,437  71.91  606  17.88  1,031  30.42  1,548  45.68 
Total  15344  10,263  66.89  2,297  14.97  4,060  26.46  6,267  40.84 
 
The number of deaths occurring during follow up by social class is outlined in Table 64. 
As with Carstairs Morris index a gradient in the numbers and proportions on individuals 
dying was seen for all cause mortality at the end of follow up. The gradient in proportion 
of all cause deaths was as clear according to social class for deaths when compared to 
Carstairs Morris index, though the deprived experienced a greater number of deaths.  
Table 64 Number of deaths and proportions of deaths at end of follow up and before 65 
years, 70 years and 75 years of age in each social class.  
  N  All deaths  %  65 years  %  70 years  %  75 years  % 
I  545  315  57.80  69  12.66  121  22.20  191  35.05 
II  2,235  1,330  59.51  268  11.99  488  21.83  760  34.00 
III-
NM  2,804  1,698  60.56  342  12.20  601  21.43  961  34.27 
III-M  4,299  3,114  72.44  785  18.26  1,316  30.61  2,026  47.13 
IV  3,771  2,575  68.28  573  15.19  1,047  27.76  1,589  42.14 
V  1,301  949  72.94  202  15.53  384  29.52  575  44.20 
  14,955  9,981  66.74  2,239  14.97  3,957  26.46  6,102  40.80 
 
 
Years of life lived until death 
The number of years a person lived between enrolment and death was examined according 
to SED (Table 65). On average an individual in the most deprived group lived 
approximately 2 ½ years less than an individual in the least deprived group.  
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Table 65 Number of years between enrolment and death or censoring according to Carstairs 
Morris index. 
  N  total  95% CI  mean  95% CI   
1  990  21838  21324  22352  22.06  21.54  22.58 
3  2084  46430  45630  47230  22.28  21.90  22.66 
4  3347  72167  71177  73157  21.56  21.27  21.86 
5  5534  116802  115475  118129  21.11  20.87  21.35 
6&7  3389  66633  65623  67643  19.66  19.36  19.96 
  15344  323870  319229  328511  21.33  20.99  21.68 
 
A similar pattern was observed when social class was used as the measure of SED (Table 
66). The least deprived survived on average just over 2 ½ years longer than the most 
deprived members of the cohort.  
Table 66. Number of years between enrolment and death or censoring according to social 
class.  
  N  total  95% CI  mean  95% CI   
I  545  12401  12016  12786  22.75  22.05  23.46 
II  2,235  50281  49499  51063  22.50  22.15  22.85 
III-NM  2,804  62943  62059  63827  22.45  22.13  22.76 
III-M  4,299  85917  84736  87098  19.99  19.71  20.26 
IV  3,771  78130  77061  79199  20.72  20.44  21.00 
V  1,301  26085  25436  26734  20.05  19.55  20.55 
  14,955  315757  310807  320707  21.41  21.00  21.81 
 
Adjusted risk of death 
The risk of death from all causes was modelled in a multivariable Cox regression model 
(Table 67) to allow adjustment for multiple cardiorespiratory risk factors. In unadjusted 
analyses the risk of all cause death was highest in the most deprived, approximately 50% 
higher than the least deprived. After adjustment this association persisted. A similar pattern 
of risk was observed when social class was used as the measure of SED (Table 68).  
The risk of death by the age of 65 years, 70 years and 75 years was also modelled. As was 
observed in the proportions of deaths in each SED group above, there was evidence that 
after age and sex adjustment the risk of death associated with SED was higher in the most 
deprived versus the least deprived (Tables 69-74). After adjustment for further 
cardiorespiratory risk factors the risk of death at 65, 70 and 75 years of age were similar to 
that of the risk of death at the end of follow up.  
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Table 67 Hazard of all cause death during complete follow up by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.09  0.98  1.20  0.101  1.20  1.09  1.32  <0.001  1.19  1.08  1.32  <0.001  1.15  1.04  1.27  0.008 
4  3347  1.18  1.07  1.29  <0.001  1.27  1.15  1.39  <0.001  1.26  1.15  1.38  <0.001  1.19  1.08  1.31  <0.001 
5  5534  1.22  1.12  1.33  <0.001  1.36  1.24  1.48  <0.001  1.30  1.19  1.42  <0.001  1.21  1.10  1.32  <0.001 
6&7  3389  1.49  1.36  1.63  <0.001  1.58  1.44  1.73  <0.001  1.53  1.39  1.67  <0.001  1.39  1.27  1.53  <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 68 Hazard of all cause death during complete follow up by social class 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  1.06  0.93  1.19  0.386  1.07  0.95  1.22  0.251  1.05  0.93  1.19  0.405  1.03  0.91  1.17  0.631 
III-
NM  3,894  1.07  0.95  1.21  0.265  1.17  1.04  1.32  0.011  1.14  1.01  1.29  0.034  1.09  0.96  1.23  0.177 
III-
M  6,710  1.52  1.35  1.70  <0.001  1.39  1.24  1.57  <0.001  1.33  1.19  1.50  <0.001  1.25  1.11  1.40  <0.001 
IV  5,815  1.37  1.22  1.54  <0.001  1.39  1.24  1.56  <0.001  1.33  1.18  1.50  <0.001  1.20  1.07  1.36  0.003 
V  2,112  1.52  1.34  1.73  <0.001  1.56  1.38  1.78  <0.001  1.45  1.27  1.65  <0.001  1.29  1.13  1.47  <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
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Table 69 Hazard of all cause death prior to the age of 65 years by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.06  0.85  1.33  0.582  1.12  0.90  1.40  0.314  1.09  0.87  1.36  0.472  1.03  0.82  1.30  0.776 
4  3347  1.13  0.92  1.40  0.249  1.17  0.95  1.45  0.135  1.13  0.92  1.40  0.241  1.03  0.83  1.27  0.808 
5  5534  1.30  1.07  1.59  0.01  1.38  1.13  1.69  0.001  1.26  1.03  1.54  0.023  1.13  0.92  1.39  0.25 
6&7  3389  1.66  1.35  2.03  <0.001  1.71  1.39  2.10  <0.001  1.59  1.29  1.95  <0.001  1.38  1.12  1.70  0.003 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 70 Hazard of all cause death prior to the age of 65 years by social class 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  1.03  0.79  1.34  0.849  1.10  0.84  1.43  0.481  1.06  0.81  1.38  0.681  1.08  0.82  1.43  0.576 
III-
NM  3,894  1.05  0.81  1.37  0.687  1.25  0.97  1.63  0.089  1.20  0.92  1.55  0.177  1.11  0.84  1.46  0.456 
III-
M  6,710  1.69  1.32  2.16  <0.001  1.57  1.23  2.01  <0.001  1.45  1.13  1.85  0.003  1.31  1.01  1.69  0.044 
IV  5,815  1.41  1.10  1.80  0.008  1.50  1.17  1.93  0.001  1.39  1.08  1.79  0.01  1.25  0.96  1.63  0.094 
V  2,112  1.55  1.18  2.04  0.002  1.69  1.29  2.23  <0.001  1.49  1.13  1.97  0.004  1.30  0.98  1.74  0.074 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Table 71 Hazard of all cause death prior to the age of 70 years by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.10  0.94  1.30  0.239  1.17  0.99  1.38  0.067  1.15  0.97  1.35  0.11  1.08  0.91  1.28  0.365 
4  3347  1.19  1.02  1.39  0.029  1.24  1.06  1.45  0.008  1.21  1.04  1.42  0.015  1.10  0.93  1.29  0.265 
5  5534  1.33  1.15  1.55  <0.001  1.42  1.23  1.65  <0.001  1.32  1.14  1.53  <0.001  1.19  1.02  1.38  0.028 
6&7  3389  1.62  1.39  1.89  <0.001  1.67  1.44  1.95  <0.001  1.58  1.35  1.84  <0.001  1.37  1.17  1.61  <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 72 Hazard of all cause death prior to the age of 70 years by social class  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  1.05  0.86  1.28  0.623  1.13  0.93  1.38  0.23  1.10  0.90  1.34  0.367  1.11  0.91  1.37  0.309 
III-
NM  3,894  1.04  0.85  1.26  0.702  1.23  1.01  1.50  0.038  1.19  0.97  1.44  0.09  1.12  0.91  1.37  0.278 
III-
M  6,710  1.62  1.34  1.95  <0.001  1.50  1.25  1.81  <0.001  1.40  1.16  1.69  <0.001  1.29  1.06  1.56  0.011 
IV  5,815  1.45  1.20  1.75  <0.001  1.55  1.28  1.87  <0.001  1.45  1.20  1.75  <0.001  1.30  1.06  1.58  0.01 
V  2,112  1.63  1.33  2.00  <0.001  1.79  1.45  2.20  <0.001  1.60  1.30  1.97  <0.001  1.41  1.14  1.75  0.002 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Table 73 Hazard of all cause death prior to the age of 75 years by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.13  0.99  1.29  0.075  1.20  1.05  1.37  0.006  1.18  1.03  1.35  0.015  1.13  0.99  1.29  0.079 
4  3347  1.23  1.09  1.40  0.001  1.29  1.14  1.47  <0.001  1.27  1.12  1.44  <0.001  1.18  1.04  1.34  0.011 
5  5534  1.35  1.20  1.52  <0.001  1.46  1.30  1.65  <0.001  1.36  1.21  1.53  <0.001  1.24  1.10  1.41  <0.001 
6&7  3389  1.61  1.43  1.82  <0.001  1.67  1.47  1.88  <0.001  1.57  1.39  1.78  <0.001  1.40  1.24  1.59  <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 74 Hazard of all cause death prior to the age of 75 years by social class  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  1.03  0.88  1.20  0.755  1.09  0.93  1.28  0.299  1.06  0.90  1.24  0.475  1.06  0.90  1.25  0.46 
III-
NM  3,894  1.04  0.89  1.22  0.616  1.21  1.03  1.41  0.018  1.17  1.00  1.37  0.052  1.11  0.95  1.31  0.194 
III-
M  6,710  1.60  1.38  1.86  0  1.48  1.27  1.72  0  1.39  1.20  1.61  0  1.29  1.11  1.51  0.001 
IV  5,815  1.40  1.20  1.62  0  1.47  1.27  1.71  0  1.39  1.19  1.62  0  1.25  1.07  1.47  0.005 
V  2,112  1.55  1.32  1.83  0  1.68  1.42  1.98  0  1.52  1.29  1.80  0  1.35  1.14  1.61  0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Death due to cardiovascular disease 
The numbers of deaths due to cardiovascular causes are outlined in Table 75 according to 
Carstairs Morris index. Most cardiovascular deaths occurred in the most deprived. As with 
all cause deaths, a greater proportion of the most deprived individuals suffered a 
cardiovascular death than the least deprived. At the end of follow up 36% of the most 
deprived group had died due to cardiovascular causes, the respective figure was only 29% 
of the least deprived group. This gradient was evident for cardiovascular deaths before the 
age of 65 years and 70 years. At the age of 75 years (life expectancy) 22% of the deprived 
individuals had died of cardiovascular diseases whereas only 17% of the least deprived 
group had died due to cardiovascular disease.  
Table 75 Number of cardiovascular deaths and proportions of cardiovascular deaths at end 
of follow up and before 65 years, 70 years and 75 years of age according to Carstairs Morris 
index .  
 
  N  CVD Deaths  %  65 years %  70 years %  75 years % 
1  990  288  29.09  61  6.16  103  10.40  166  16.77 
3  2084  674  32.34  124  5.95  238  11.42  378  18.14 
4  3347  1,074  32.09  217  6.48  407  12.16  652  19.48 
5  5534  1,849  33.41  417  7.54  761  13.75  1,183  21.38 
6&7  3389  1,232  36.35  291  8.59  507  14.96  741  21.86 
  15344  5,117  33.35  1,110  7.23  2,016  13.14  3,120  20.33 
 
 
When SED was measured using social class the same gradients in cardiovascular deaths 
was observed as with Carstairs Morris index (Table 76). In the most deprived group 37% 
of individuals had died of cardiovascular causes over the course of follow up whilst only 
29% of the least deprived had died of cardiovascular disease.  
Table 76. Number of cardiovascular deaths and proportions of deaths at end of follow up 
and before 65 years, 70 years and 75 years of age in each social class.  
  N  CVD Deaths  %  65 years %  70 years %  75 years % 
I  545  159  29.17  37  6.79  63  11.56  101  18.53 
II  2,235  670  29.98  120  5.37  240  10.74  387  17.32 
III-
NM  2,804  818  29.17  161  5.74  283  10.09  451  16.08 
III-M  4,299  1,568  36.47  403  9.37  675  15.70  1,019  23.70 
IV  3,771  1,283  34.02  276  7.32  530  14.05  802  21.27 
V  1,301  481  36.97  87  6.69  180  13.84  287  22.06 
  14,955  4,979  33.29  1,084  7.25  1,971  13.18  3,047  20.37 
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Adjusted risk of cardiovascular death 
The risk of a cardiovascular death varied according to socioeconomic status. The risk of 
suffering a cardiovascular death at the end of follow up was 60% higher in the most 
deprived versus the least deprived after adjustment for age and sex (Table 77). This excess 
risk persisted after adjustment for multiple cardiovascular risk factors. These relationships 
were evident when social class was used as the marker of socioeconomic deprivation 
(Table 78).  
Cardiovascular deaths prior to the age of 65, 70 and 75 years were also modelled (Tables 
79-84). The age and sex adjusted risk of a cardiovascular death in the most versus the least 
deprived was 40% higher by the age of 65 years (Table 79). The risk of dying from 
cardiovascular disease by the age of 70 years was 50% higher after adjustment for age and 
sex, which was attenuated to a 40% higher risk after adjustment for traditional 
cardiovascular risk factors (Table 81). The risk of cardiovascular death by the age of 75 
was approximately 30% higher in the most deprived versus the least deprived (Table 83).  
The same association between social class and cardiovascular death was observed for 
deaths at each age (Tables 80, 82 and 84).  
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Table 77 Hazard of cardiovascular death by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.11  0.96  1.27  0.152  1.24  1.08  1.42  0.003  1.19  1.03  1.36  0.015  1.15  1.00  1.33  0.049 
4  3347  1.17  1.03  1.34  0.017  1.27  1.12  1.45  <0.001  1.27  1.11  1.44  <0.001  1.22  1.07  1.40  0.003 
5  5534  1.22  1.07  1.38  0.002  1.37  1.21  1.55  <0.001  1.27  1.12  1.44  <0.001  1.21  1.06  1.38  0.003 
6&7  3389  1.51  1.33  1.72  <0.001  1.61  1.41  1.83  <0.001  1.55  1.36  1.76  <0.001  1.43  1.25  1.63  <0.001 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 78 Hazard of cardiovascular death by social class 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  1.05  0.89  1.25  0.561  1.07  0.90  1.27  0.46  1.06  0.89  1.26  0.512  1.06  0.89  1.27  0.531 
III-
NM  3,894  1.02  0.86  1.21  0.81  1.11  0.94  1.32  0.227  1.11  0.93  1.31  0.245  1.09  0.92  1.31  0.316 
III-
M  6,710  1.51  1.28  1.78  <0.001  1.37  1.17  1.62  <0.001  1.33  1.13  1.56  0.001  1.28  1.08  1.51  0.005 
IV  5,815  1.34  1.14  1.59  <0.001  1.36  1.15  1.60  <0.001  1.33  1.12  1.57  0.001  1.25  1.05  1.48  0.011 
V  2,112  1.52  1.27  1.82  <0.001  1.55  1.29  1.86  <0.001  1.46  1.22  1.75  <0.001  1.33  1.10  1.60  0.003 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Table 79 Hazard of cardiovascular death by the age of 65 years by Carstairs Morris index  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  0.85  0.63  1.16  0.307  0.89  0.65  1.21  0.454  0.84  0.62  1.14  0.259  0.82  0.60  1.12  0.204 
4  3347  0.98  0.73  1.30  0.863  1.01  0.76  1.34  0.957  0.97  0.73  1.29  0.838  0.93  0.69  1.24  0.614 
5  5534  1.09  0.83  1.43  0.53  1.15  0.88  1.50  0.31  1.01  0.77  1.33  0.932  0.93  0.71  1.23  0.62 
6&7  3389  1.37  1.04  1.81  0.025  1.40  1.06  1.85  0.016  1.30  0.98  1.71  0.065  1.15  0.87  1.53  0.331 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 80 Hazard of cardiovascular death by the age of 65 years by social class 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  0.85  0.59  1.23  0.381  0.96  0.66  1.38  0.809  0.92  0.63  1.33  0.643  0.95  0.65  1.41  0.807 
III-
NM  3,894  0.91  0.64  1.31  0.618  1.19  0.83  1.71  0.335  1.14  0.80  1.64  0.469  1.13  0.77  1.65  0.532 
III-
M  6,710  1.59  1.13  2.22  0.007  1.45  1.04  2.04  0.03  1.34  0.96  1.88  0.089  1.29  0.90  1.85  0.158 
IV  5,815  1.24  0.88  1.74  0.226  1.39  0.98  1.96  0.063  1.29  0.92  1.83  0.143  1.24  0.86  1.78  0.252 
V  2,112  1.22  0.83  1.79  0.315  1.42  0.96  2.09  0.077  1.26  0.86  1.87  0.236  1.15  0.76  1.73  0.503 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Table 81 Hazard of cardiovascular death by the age of 70 years by Carstairs Morris index 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.00  0.79  1.26  0.988  1.06  0.84  1.34  0.618  1.00  0.79  1.26  0.993  0.96  0.76  1.21  0.731 
4  3347  1.11  0.90  1.38  0.326  1.16  0.93  1.44  0.181  1.13  0.91  1.41  0.256  1.07  0.85  1.33  0.572 
5  5534  1.22  1.00  1.50  0.055  1.30  1.06  1.60  0.012  1.16  0.95  1.43  0.152  1.08  0.87  1.33  0.488 
6&7  3389  1.44  1.17  1.78  0.001  1.48  1.20  1.83  0  1.40  1.13  1.73  0.002  1.24  0.99  1.54  0.056 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
Table 82 Hazard of cardiovascular death by the age of 70 years by social class 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  0.98  0.74  1.29  0.886  1.08  0.81  1.42  0.606  1.05  0.79  1.38  0.745  1.08  0.80  1.44  0.621 
III-
NM  3,894  0.93  0.71  1.22  0.588  1.14  0.86  1.50  0.357  1.11  0.84  1.46  0.451  1.10  0.82  1.47  0.516 
III-
M  6,710  1.53  1.19  1.99  0.001  1.41  1.09  1.82  0.01  1.32  1.02  1.71  0.036  1.29  0.98  1.69  0.07 
IV  5,815  1.36  1.05  1.77  0.021  1.47  1.13  1.91  0.004  1.41  1.08  1.83  0.011  1.34  1.02  1.77  0.037 
V  2,112  1.41  1.06  1.88  0.019  1.56  1.17  2.08  0.003  1.42  1.07  1.90  0.017  1.31  0.97  1.78  0.081 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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Table 83 Hazard of cardiovascular death by the age of 75 years by Carstairs Morris index 
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
1  990  1        1        1        1       
3  2084  1.01  0.84  1.21  0.952  1.08  0.90  1.29  0.429  1.02  0.85  1.22  0.831  1.00  0.83  1.20  0.989 
4  3347  1.13  0.95  1.34  0.169  1.18  0.99  1.40  0.062  1.16  0.98  1.37  0.094  1.12  0.94  1.34  0.196 
5  5534  1.22  1.03  1.43  0.019  1.30  1.11  1.53  0.001  1.18  1.00  1.38  0.051  1.12  0.95  1.32  0.182 
6&7  3389  1.33  1.12  1.57  0.001  1.36  1.15  1.61  0  1.30  1.10  1.53  0.003  1.19  1.00  1.41  0.051 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly 
 
 
Table 84 Hazard of cardiovascular death by the age of 75 years by social class  
  N  HR*  95% CI  P  HR**  95% CI  P  HR†  95% CI  P  HR‡  95% CI  P 
I  744  1        1        1        1       
II  3,209  0.97  0.78  1.21  0.783  1.04  0.84  1.30  0.719  1.02  0.82  1.27  0.85  1.03  0.82  1.29  0.81 
III-
NM  3,894  0.91  0.73  1.12  0.367  1.06  0.85  1.32  0.591  1.05  0.84  1.30  0.672  1.05  0.84  1.32  0.671 
III-
M  6,710  1.43  1.17  1.75  0.001  1.31  1.07  1.61  0.01  1.24  1.01  1.53  0.037  1.22  0.99  1.52  0.064 
IV  5,815  1.26  1.03  1.56  0.026  1.33  1.08  1.64  0.007  1.29  1.04  1.58  0.018  1.24  1.00  1.55  0.049 
V  2,112  1.37  1.09  1.72  0.007  1.45  1.15  1.82  0.001  1.36  1.08  1.71  0.009  1.27  1.00  1.61  0.05 
*Unadjusted, **Adjusted for age and sex , † Adjusted for age, sex, diabetes, smoking, cholesterol, systolic blood pressure, ‡ Adjusted for age at first event, 
sex, diabetes, smoking, cholesterol, systolic blood pressure, body mass index, FEV1, cardiomegaly  
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The burden of admissions  
The number of hospital admissions for all cardiovascular causes is outlined in Table 85. 
The number of admissions per individual in each deprivation category is given. There was 
no clear trend in the number of admissions per person according to SED as measured by 
Carstairs Morris index.  
Similarly no clear trend was observed when social class was used as the measure of 
socioeconomic deprivation (Table 86).  
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Table 85 Number of cardiovascular admissions and admissions per person for any cardiovascular cause according to Carstairs Morris index.  
  N  CVD  
N per  
person  CHD 
N per  
person  MI 
N per  
person  Stroke 
N per  
person  HF 
N per  
person 
1  990  818  0.83  227  0.23  130  0.13  118  0.12  103  0.10 
3  2084  2,011  0.96  734  0.35  341  0.16  336  0.16  159  0.08 
4  3347  3,214  0.96  1,054  0.31  479  0.14  536  0.16  420  0.13 
5  5534  5,362  0.97  1,927  0.35  897  0.16  846  0.15  604  0.11 
6&7  3389  3,272  0.97  1,131  0.33  538  0.16  558  0.16  426  0.13 
  15344  14,677  0.96  5,073  0.33  2,385  0.16  2,394  0.16  1,712  0.11 
 
 
Table 86 Number of cardiovascular admissions and admissions per person for all cardiovascular admissions according to social class.  
  N  CVD 
N per  
person  CHD 
N per  
person  MI 
N per  
person  Stroke 
N per  
person  HF 
N per  
person 
I  545  494  0.91  164  0.30  82  0.15  77  0.14  68  0.12 
II  2,235  2,281  1.02  811  0.36  352  0.16  311  0.14  264  0.12 
III-NM  2,804  2,566  0.92  804  0.29  401  0.14  398  0.14  262  0.09 
III-M  4,299  4,133  0.96  1,566  0.36  759  0.18  686  0.16  460  0.11 
IV  3,771  3,588  0.95  1,190  0.32  541  0.14  615  0.16  433  0.11 
V  1,301  1,222  0.94  423  0.33  204  0.16  246  0.19  170  0.13 
  14,955  14,284  0.96  4,958  0.33  2,339  0.16  2,333  0.16  1,657  0.11 
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Admissions according to age at admission 
The number of admissions occurring before pre-defined ages was calculated. The number 
of cardiovascular admissions per person increased from the least to the most deprived 
when SED was measured using the Carstairs Morris Index when admissions prior to the 
age of 65 were examined (Table 87) . Similarly the number of coronary heart disease 
admissions also increased from the least to the most deprived. When admissions prior to 
the age of 70 and 74were examined the gradient of risk was attenuated. When social class 
was examined no clear gradation of risk was seen (Table 88).  
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Table 87 Number of admissions and number of admissions per person for each cardiovascular disease according to deprivation category. 
 
 
N  CVD 
Number/ 
person  CHD 
Number/ 
person  MI 
Number/ 
person  Stroke 
Number/ 
person  HF 
Number/ 
person 
Age less 65  1  990  185  0.19  62  0.06  45  0.05  10  0.01  8  0.01 
  3  2084  517  0.25  189  0.09  112  0.05  48  0.02  16  0.01 
  4  3347  781  0.23  249  0.07  139  0.04  61  0.02  38  0.01 
  5  5534  1,446  0.26  556  0.10  337  0.06  157  0.03  91  0.02 
  6&7  3389  978  0.29  375  0.11  216  0.06  78  0.02  71  0.02 
    15344  3,907  0.25  1,431  0.09  849  0.06  354  0.02  224  0.01 
Age less 70  1  990  329  0.33  102  0.10  73  0.07  22  0.02  22  0.02 
  3  2084  880  0.42  340  0.16  182  0.09  97  0.05  39  0.02 
  4  3347  1,407  0.42  482  0.14  248  0.07  149  0.04  106  0.03 
  5  5534  2,548  0.46  947  0.17  532  0.10  325  0.06  184  0.03 
  6&7  3389  1,649  0.49  615  0.18  329  0.10  174  0.05  162  0.05 
    15344  6,813  0.44  2,486  0.16  1,364  0.09  767  0.05  513  0.03 
Age less 75  1  990  515  0.52  155  0.16  98  0.10  56  0.06  41  0.04 
  3  2084  1,338  0.64  527  0.25  255  0.12  177  0.08  85  0.04 
  4  3347  2,206  0.66  750  0.22  371  0.11  283  0.08  231  0.07 
  5  5534  3,813  0.69  1,408  0.25  704  0.13  544  0.10  375  0.07 
  6&7  3389  2,323  0.69  832  0.25  423  0.12  338  0.10  252  0.07 
    15344  10,195  0.66  3,672  0.24  1,851  0.12  1,398  0.09  984  0.06 
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Table 88 Number of admissions and number of admissions per person for each cardiovascular disease according to social class. 
 
  N  CVD 
Number/ 
person  CHD 
Number/ 
person  MI 
Number/ 
person  Stroke 
Number/ 
person  HF 
Number/ 
person 
Age less 
65  I  545  120  0.22  50  0.09  33  0.06  4  0.01  7  0.01 
  II  2,235  550  0.25  188  0.08  113  0.05  45  0.02  19  0.01 
  III-NM  2,804  717  0.26  241  0.09  140  0.05  55  0.02  43  0.02 
  III-M  4,299  1,176  0.27  502  0.12  310  0.07  116  0.03  65  0.02 
  IV  3,771  993  0.26  326  0.09  183  0.05  99  0.03  64  0.02 
  V  1,301  278  0.21  106  0.08  63  0.05  28  0.02  18  0.01 
    14,955  3,834  0.26  1,413  0.09  842  0.06  347  0.02  216  0.01 
Age less 
70  I  545  224  0.41  90  0.17  51  0.09  24  0.04  17  0.03 
  II  2,235  1,047  0.47  406  0.18  201  0.09  105  0.05  57  0.03 
  III-NM  2,804  1,205  0.43  392  0.14  219  0.08  119  0.04  84  0.03 
  III-M  4,299  1,957  0.46  799  0.19  463  0.11  222  0.05  160  0.04 
  IV  3,771  1,701  0.45  548  0.15  300  0.08  210  0.06  120  0.03 
  V  1,301  526  0.40  200  0.15  114  0.09  77  0.06  56  0.04 
    14,955  6,660  0.45  2,435  0.16  1,348  0.09  757  0.05  494  0.03 
Age less 
75  I  545  360  0.66  133  0.24  68  0.12  50  0.09  39  0.07 
  II  2,235  1,537  0.69  578  0.26  272  0.12  186  0.08  126  0.06 
  III-NM  2,804  1,762  0.63  580  0.21  300  0.11  223  0.08  144  0.05 
  III-M  4,299  2,978  0.69  1,193  0.28  619  0.14  404  0.09  291  0.07 
  IV  3,771  2,516  0.67  826  0.22  420  0.11  356  0.09  250  0.07 
  V  1,301  799  0.61  300  0.23  150  0.12  149  0.11  96  0.07 
    14,955  9,952  0.67  3,610  0.24  1,829  0.12  1,368  0.09  946  0.06  
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Length of Stay 
The length of stay for each cardiovascular disease according to SED measured by Carstairs 
Morris index is outlined in Table 89. There was a trend towards increased length of stay 
for any CVD admission in the most deprived. However, when specific cardiovascular 
diseases were examined socioeconomic gradients in the mean length of stay were 
observed, though many were non-significant. The length of stay for a coronary heart 
disease admission was nearly 4 days longer in the most deprived versus the least deprived. 
When social class was used as the measure of SED (Table 90) a gradient in the length of 
stay for any CVD admission was seen but no clear gradient for each of the specific 
cardiovascular diseases was observed.  
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Table 89 Length of stay for each type of cardiovascular hospitalisation over follow up according to Carstairs Morris index 
    N  total los  95% CI  Mean  95% CI  P  Median  IQR  P 
CVD  1  990  11727  9375  14079  14.34  11.46  17.21    6  2  13   
  3  2084  40261  30149  50373  20.02  14.99  25.05    6  2  13   
  4  3347  62666  50287  75045  19.50  15.65  23.35    6  2  13   
  5  5534  93185  82194  104176  17.38  15.33  19.43    6  2  13   
  6&7  3389  71791  58436  85146  21.94  17.86  26.02  0.06  7  3  15  0.005 
    15344  279630  230440  328820  18.63  15.06  22.21    6  2  14   
                           
CHD  1  990  1933  1667  2199  8.52  7.34  9.69    7  2  11   
  3  2084  5968  5469  6467  8.13  7.45  8.81    6  2  10   
  4  3347  9489  8341  10637  9.00  7.91  10.09    6  2  11   
  5  5534  21703  16406  27000  11.26  8.51  14.01    7  3  11   
  6&7  3389  14105  7827  20383  12.47  6.92  18.02  0.5  6  2  11  0.36 
    15344  53198  39709  66687  9.88  7.63  12.12    6  2  11   
                           
MI  1  990  1283  1097  1469  9.87  8.44  11.30    8  4  14   
  3  2084  3652  3296  4008  10.71  9.67  11.75    9  5  14   
  4  3347  6197  5123  7271  12.94  10.70  15.18    9  5  15   
  5  5534  13507  9037  17977  15.06  10.07  20.04    10  6  15   
  6&7  3389  10232  3976  16488  19.02  7.39  30.65  0.45  9  5  15  0.008 
    15344  34871  22529  47213  13.52  9.25  17.78    9  5  15   
                           
Stroke  1  990  4622  2696  6548  39.17  22.85  55.49    16  3  37   
  3  2084  25290  15462  35118  75.27  46.02  104.52    15  5  45   
  4  3347  33942  22113  45771  63.32  41.26  85.39    13  4  41   
  5  5534  44877  35743  54011  53.05  42.25  63.84    12  4  37   
  6&7  3389  38372  27244  49500  68.77  48.82  88.71  0.18  14  5  43  0.56 
    15344  147103  103258  190948  59.92  40.24  79.59    14  4  14   
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HF  1  990  1304  1008  1600  12.66  9.79  15.53    7  3  15   
  3  2084  1842  1545  2139  11.58  9.72  13.45    8  4  16   
  4  3347  7052  5387  8717  16.79  12.83  20.76    9  5  17   
  5  5534  8575  7231  9919  14.20  11.97  16.42    8  4  16   
  6&7  3389  6098  5486  6710  14.31  12.88  15.75  0.18  10  5  18  0.03 
    15344  24871  20658  29084  13.91  11.44  16.38    9  5  16   
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Table 90 Length of stay for each type of cardiovascular hospitalisation over follow up according to social class 
    N  total los  95% CI  Mean  95% CI  P  Median  IQR  P 
CVD  I  545  7112  4254  9970  14.40  8.61  20.18    6  2  12   
  II  2,235  30508  27557  33459  13.37  12.08  14.67    6  2  13   
  III-NM  2,804  47009  36862  57156  18.32  14.37  22.27    6  2  13   
  III-M  4,299  72285  60328  84242  17.49  14.60  20.38    7  2  14   
  IV  3,771  77456  64434  90478  21.59  17.96  25.22    7  2  14   
  V  1,301  33349  23976  42722  27.29  19.62  34.96  0.04  7  2  15  <0.001 
    14,955  267719  217412  318026  18.74  14.54  22.95    6  2  14   
                           
CHD  I  545  1306  1074  1538  7.96  6.55  9.38    6  2  11   
  II  2,235  6544  5977  7111  8.07  7.37  8.77    6  2  10   
  III-NM  2,804  10720  4459  16981  13.33  5.55  21.12    7  2  10   
  III-M  4,299  16987  12465  21509  10.85  7.96  13.73    7  2  12   
  IV  3,771  11358  10160  12556  9.54  8.54  10.55    3  3  11   
  V  1,301  3836  3394  4278  9.07  8.02  10.11  0.26  6  3  12  0.17 
    14,955  50751  37529  63973  9.80  7.33  12.28    6  2  11   
                           
MI  I  545  927  725  1129  11.30  8.84  13.77    9  5  14   
  II  2,235  3888  3461  4315  11.05  9.83  12.26    9  5  15   
  III-NM  2,804  8215  1974  14456  20.49  4.92  36.05    9  6  13   
  III-M  4,299  11715  7257  16173  15.43  9.56  21.31    10  6  15   
  IV  3,771  7074  5971  8177  13.08  11.04  15.11    9  5  15   
  V  1,301  2471  2095  2847  12.11  10.27  13.96  0.49  10  5  15  0.2 
    14,955  34290  21484  47096  13.91  9.08  18.74    9  5  15   
                           
Stroke  I  545  3531  757  6305  45.86  9.83  81.89    11  5  25   
  II  2,235  11933  9679  14187  38.37  31.12  45.62    14  4  43   
  III-NM  2,804  21663  14099  29227  54.43  35.42  73.44    13  4  38   
  III-M  4,299  36157  25433  46881  52.71  37.07  68.34    12  4  35    
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  IV  3,771  45294  32920  57668  73.65  53.53  93.77    14  5  40   
  V  1,301  22096  13256  30936  89.82  53.89  125.76  0.19  17  6  50  0.039 
    14,955  140674  96144  185204  59.14  36.81  81.47    14  4  40   
                           
HF  I  545  908  721  1095  13.35  10.60  16.11    11  5  18   
  II  2,235  3639  3092  4186  13.78  11.71  15.86    8  5  16   
  III-NM  2,804  3930  2581  5279  15.00  9.85  20.15    8  5  16   
  III-M  4,299  6132  5358  6906  13.33  11.65  15.01    9  4  16   
  IV  3,771  6746  5358  8134  15.58  12.37  18.79    9  5  17   
  V  1,301  2943  2217  3669  17.31  13.04  21.58  0.26  10  5  18  0.53 
    14,955  24298  19326  29270  14.73  11.54  17.92    9  5  17    
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The cost cardiovascular disease 
The total cost of admissions over the course of follow up was calculated using NHS costs. 
Over the course of follow up the most deprived accrued costs of £10.4 million (95%CI 
£8.6 -12.1 million) whereas the least deprived accrued costs of only £1.8 (1.47-2.2 
million), nearly a fifth of the costs (Table 91). The cost per person was higher in the most 
deprived groups. To account for the shorter life expectancy, the cost per 100 person years 
of follow up were calculated and were similarly higher with increasing deprivation.  
The cost of admissions was also calculated using social class (Table 92). In social class V a 
total of £4.9 million (95%CI £3.6-6.2 million) was spent on hospital admissions for 
cardiovascular disease. In social class I this figure was £1.8 million (£0.7-2.2 million). The 
cost of cardiovascular admissions per person again displayed a gradient with increasing 
cost with increasing deprivation. Similar results were observed when costs per 100 person 
years of follow up were calculated.  
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Table 91 Total cost, cost per person and cost per 100 person years of follow up of cardiovascular hospitalisations by Carstairs Morris index 
    N  Total cost  95% CI 
Cost per  
person  95% CI 
Cost 
per 
100 
person 
years  95% CI 
CVD  1  990  1838840  1474637  2203043  1857  1490  2225  8331  6681  9982 
  3  2084  5864784  4508431  7221137  2814  2163  3465  12737  9792  15683 
  4  3347  9268959  7683509  10900000  2769  2296  3257  13924  11542  16374 
  5  5534  13700000  12200000  15200000  2476  2205  2747  19198  17096  21300 
  6&7  3389  10400000  8644849  12100000  3069  2551  3570  8865  7369  10314 
    15344  41072583  34511426  47624180  2677  2249  3104  12702  10673  14728 
                       
CHD  1  990  287706  249306  326107  291  252  329  1304  1130  1478 
  3  2084  882182  799565  964800  423  384  463  1916  1737  2095 
  4  3347  1424624  1247787  1601461  426  373  478  2140  1874  2406 
  5  5534  3019709  2433039  3606379  546  440  652  4232  3409  5054 
  6&7  3389  1961437  1220061  2702813  579  360  798  1672  1040  2304 
    15344  7575659  5949758  9201559  494  388  600  2343  1840  2846 
                       
MI  1  990  277182  236432  317932  280  239  321  1256  1071  1440 
  3  2084  793952  705877  882026  381  339  423  1724  1533  1916 
  4  3347  1377045  1120015  1634075  411  335  488  2069  1682  2455 
  5  5534  2695642  2041238  3350047  487  369  605  3777  2860  4694 
  6&7  3389  2101779  962366  3241193  620  284  956  1792  820  2763 
    15344  7245600  5065929  9425273  472  330  614  2241  1567  2915 
                       
Stroke  1  990  1067839  640238  1495439  1079  647  1511  4838  2901  6776 
  3  2084  5131479  3279293  6983664  2462  1574  3351  11145  7122  15167 
  4  3347  7010453  4891650  9129256  2095  1462  2728  10531  7348  13714  
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  5  5534  9323859  7537612  11100000  1685  1362  2006  13066  10562  15554 
  6&7  3389  7895208  5782386  10000000  2330  1706  2951  6730  4929  8524 
    15344  30428838  22131179  38708359  1983  1442  2523  9410  6844  11971 
                       
HF  1  990  224401  170240  278561  227  172  281  1017  771  1262 
  3  2084  297537  249058  346015  143  120  166  646  541  751 
  4  3347  1142671  887325  1398016  341  265  418  1717  1333  2100 
  5  5534  1448120  1210626  1685613  262  219  305  2029  1696  2362 
  6&7  3389  9829343  882531  1083356  2900  260  320  8378  752  923 
    15344  12942072  3399779  4791562  843  222  312  4002  1051  1482 
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Table 92 Total cost, cost per person and cost per 100 person years of follow up of cardiovascular hospitalisations by social class 
    N  Total cost  95% CI   
Cost per  
person  95% CI 
Cost per 
100 
person 
years  95% CI 
CVD  I  545  1046991  674484  1419498  1921  1238  2605  8445  5440  11450 
  II  2,235  4734851  4282977  5186724  2119  1916  2321  18144  16413  19876 
  III-NM  2,804  6970454  5624946  8315962  2486  2006  2966  13929  11240  16618 
  III-M  4,299  10400000  8939809  11800000  2419  2080  2745  16535  14214  18761 
  IV  3,771  11300000  9575601  13000000  2997  2539  3447  14487  12276  16666 
  V  1,301  4905107  3574343  6235871  3770  2747  4793  5717  4166  7268 
    14955  39357403  32672160  45958055  2632  2185  3073  12485  10364  14579 
                       
CHD  I  545  190617  159877  221357  350  293  406  1538  1290  1785 
  II  2,235  985167  890892  1079442  441  399  483  3775  3414  4136 
  III-NM  2,804  1498997  760547  2237446  535  271  798  2995  1520  4471 
  III-M  4,299  2278342  1843735  2712948  530  429  631  3622  2931  4313 
  IV  3,771  1703256  1515021  1891492  452  402  502  2184  1942  2425 
  V  1,301  554753  490329  619178  426  377  476  647  571  722 
    14955  7211132  5660401  8761863  482  378  586  2288  1796  2779 
                       
MI  I  545  545  201511  161589  370  296  443  1625  1303  1947 
  II  2,235  2,235  846232  741216  379  332  426  3243  2840  3645 
  III-NM  2,804  2,804  1689665  555996  603  198  1007  3376  1111  5642 
  III-M  4,299  4,299  2260264  1610826  526  375  677  3594  2561  4626 
  IV  3,771  3,771  1579724  1308454  419  347  491  2025  1677  2373 
  V  1,301  1,301  526627  440763  405  339  471  614  514  714 
    14955  14955  7104023  4818844  475  322  628  2254  1529  2978 
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Stroke  I  545  708426  200142  1216711  1300  367  2232  5714  1614  9814 
  II  2,235  2681861  2189098  3174624  1200  979  1420  10277  8389  12165 
  III-NM  2,804  4584828  3090766  6078890  1635  1102  2168  9162  6176  12147 
  III-M  4,299  7392436  5517640  9267232  1720  1283  2156  11753  8773  14734 
  IV  3,771  9204139  6916172  11500000  2441  1834  3050  11800  8867  14743 
  V  1,301  4581412  2803893  6358932  3521  2155  4888  5340  3268  7411 
    14955  29153102  20717711  37596389  1949  1385  2514  9248  6572  11926 
                       
HF  I  545  156416  123162  189671  287  226  348  1262  993  1530 
  II  2,235  617753  518641  716865  276  232  321  2367  1987  2747 
  III-NM  2,804  641908  436262  847553  229  156  302  1283  872  1694 
  III-M  4,299  986445  860832  1112059  229  200  259  1568  1369  1768 
  IV  3,771  1077031  852644  1301417  286  226  345  1381  1093  1668 
  V  1,301  474052  349595  598509  364  269  460  553  407  698 
    14955  3953605  3141135  4766075  264  210  319  1254  996  1512  
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Population attributable fraction 
The population attributable fraction was calculated for the traditional risk factors for 
cardiovascular disease and also for socioeconomic deprivation (Table 93). The fraction of 
cardiovascular disease that was attributable to SED in this cohort was 13.7%. This was 
higher than serum cholesterol but lower than age, sex, smoking, diabetes and hypertension. 
For cardiovascular disease, CHD and MI the attributable risk of SED was generally similar 
to most of the other cardiovascular risk factors of smoking, serum cholesterol and 
hypertension. The attributable risk of SED in stroke and HF was similar to serum 
cholesterol. 
Table 93 Population attributable fraction for cardiovascular risk factors and Carstairs Morris 
index.  
  CVD  CHD  MI  Stroke  HF 
Age (55-64 vs. 45-54)  14.9  4.5  3.7  16.0  2.3 
Sex (Men vs. women)  16.2  8.3  7.3  5.7  1.7 
Smoking vs. non smoking  15.6  6.6  5.8  1.5  1.0 
Cholesterol (>5mmol vs. 
<5mmol)  13.4  5.2  4.4  2.2  1.1 
Diabetes vs. no diabetes  45.7  12.6  4.7  13.6  15.3 
Hypertension (>140mmHg vs. 
<140mmHg)  17.3  6.4  5.1  4.4  2.4 
Deprivation (most vs. least 
deprived)  13.7  5.4  4.3  2.8  1.0 
 
Calculation of the average population attributable fraction associated with SED was similar 
to that of smoking and hypertension following adjustment for the other factors in the table 
(Table 94). This risk was present for all cardiovascular event types.  
Table 94 Average population attributable fraction for cardiovascular risk factors and 
Carstairs Morris index 
  CVD  CHD  MI  Stroke  HF 
Age (55-64 vs. 45-54)  2.1  -0.3  0.3  16.0  8.9 
Sex (Men vs. women)  3.3  10.1  11.5  -8.5  6.4 
Smoking vs. non smoking  10.1  13.8  19.3  1.5  3.3 
Cholesterol (>5mmol vs. 
<5mmol)  13.6  23.9  28.0  2.2  16.5 
Diabetes vs. no diabetes  0.7  0.4  0.07  0.7  1.8 
Hypertension (>140mmHg vs. 
<140mmHg)  10.4  10.8  9.8  17.4  20.7 
Deprivation (most vs. least 
deprived)  7.8  13.0  10.2  22.9  4.3  
  211 
The attributable fraction for SED measured by social class was similar to that of SED as 
measured by Carstairs Morris index (Table 95). A similar relationship to the other risk 
factors was also observed.  
Table 95 Population attributable fraction of cardiovascular risk factors and social class 
  CVD  CHD  MI  Stroke  HF 
Age (55-64 vs. 45-54)  14.9  4.5  3.7  16.0  2.3 
Sex (Men vs. women)  16.2  8.3  7.3  5.7  1.7 
Smoking vs. non smoking  15.6  6.6  5.8  1.5  1.0 
Cholesterol (>5mmol vs. 
<5mmol)  13.4  5.2  4.4  2.2  1.1 
Diabetes vs. no diabetes  45.7  12.6  4.7  13.6  15.3 
Hypertension (>140mmHg vs. 
<140mmHg)  17.3  6.4  5.1  4.4  2.4 
Deprivation (most vs. least 
deprived)  12.4  3.7  3.1  3.6  1.7 
 
When social class was used as the measure of SED the average attributable fraction was 
higher only for cholesterol and hypertension (Table 96).  
Table 96 Average population attributable fraction of cardiovascular risk factors and social 
class 
  CVD  CHD  MI  Stroke  HF 
Age (55-64 vs. 45-54)  -0.7  -5.0  -3.8  14.7  1.5 
Sex (Men vs. women)  4.3  6.9  11.4  -7.6  1.2 
Smoking vs. non smoking  0.5  4.6  7.5  6.5  -7.6 
Cholesterol (>5mmol vs. 
<5mmol)  13.9  33.5  29.8  -7.5  21.3 
Diabetes vs. no diabetes  0.7  4.2  0.5  1.1  1.3 
Hypertension (>140mmHg 
vs. <140mmHg)  13.8  16.8  13.4  18.0  25.0 
Deprivation (most vs. least 
deprived)  11.4  7.3  10.8  13.2  24.7 
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Discussion 
In this chapter I report that greater socioeconomic deprivation is associated with a greater 
risk of death at all ages. Furthermore, this translates into a longer life expectancy amongst 
the least deprived. This risk persists after adjustment for traditional cardiovascular risk 
factors. The risk of a cardiovascular death is also higher in the most deprived and is only 
attenuated but not abolished by adjustment for cardiovascular risk factors.  
The most deprived also experience more hospital admissions for cardiovascular disease 
than the least deprived and tend to stay longer in hospital than the least deprived. Despite 
the shorter life span of the most deprived this increase in the number of hospital 
admissions led to a higher cost per person in the most deprived than the least deprived over 
the period of follow up.  
All cause and cardiovascular mortality 
Multiple previous studies have examined the relationship between socioeconomic 
deprivation and all cause mortality.
7,16,35,51,248-251 In all studies the most deprived display 
consistently higher mortality rates than the least deprived irrespective of the method of 
defining socioeconomic deprivation. Cardiovascular mortality has also been examined by a 
number of authors.
33,40,41,45,52,53,97,142,227,252 Not only is cardiovascular mortality higher in 
the most deprived but also coronary heart disease and stroke mortality. In this study I 
examined cardiovascular mortality and the results are congruent with other studies 
irrespective of the country examined or the measure of socioeconomic deprivation used. 
Few studies, however, have attempted to adjust the association between SED and 
cardiovascular mortality for traditional cardiovascular risk factors. In a study of 14 642 
Finnish men and women Harald et al
142 only adjusted for smoking, hypertension and serum 
cholesterol. Strand et al
40 failed to adjust for the presence of diabetes. One study from 
Western Australia did adjust for all of the “traditional” cardiovascular risk factors and 
found that the risk of cardiovascular mortality was non-significant (HR 1.18 (95% CI 0.78-
1.77)) in those with the least education compared to the most education, though follow up 
was relatively short (9 years).
253 
Premature mortality 
As a consequence of the higher risk of all cause and cardiovascular mortality, the risk of 
death at predefined ages was performed. The association of SED with premature all cause  
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mortality has been reported before.
42,249,254 The relationship is seen in both men and 
women.
254 Similarly, reports of higher premature cardiovascular mortality have been 
published.
41,42,252 However, these studies are based on routine data sources such as 
hospitalisation databases or routine death certificate data and have failed to adjust for the 
cardiovascular risk factors that were adjusted for in this study.  
Socioeconomic deprivation increases the risk of a number of diseases. This may occur 
through a number of pathways. Obvious pathways are through higher rates of smoking 
with in turn increase lung cancer rates. Increasing SED may work through other mediators 
such as poorer housing which may lead to increasing risk of respiratory disease. It is clear 
form these data that the risk of all cause and cardiovascular mortality is independent of 
traditional cardiovascular risk factors and therefore other pathways must mediate this 
relationship. Other suggestions have been explored such as work stress, psychosocial 
stress,
255,256 heart rate variability
195 and response to exercise
195. Other hypotheses such as 
increased pathogen burden as a result of poorer environment have also been explored.
180 
Whilst traditional risk factors do not appear to explain the entire relationship they are a 
large part of it.
38,257 In this study, as in all others, adjustment for traditional cardiovascular 
risk factors attenuates, but does not completely eliminate, the relationship.  
Admissions 
The burden of cardiovascular disease according to socioeconomic status is less well 
studied. Although absolute numbers of admissions have not been measured by SED over a 
period of follow up, it can be extrapolated, from studies of disease incidence that use 
hospitalisations as a proxy, 
68,73,122 that the deprived individuals in a society experience 
more admissions. I have found that despite surviving longer, the least deprived, experience 
less hospital admissions for cardiovascular causes. As a consequence, the costs accrued 
over the lifespan of the most deprived, were higher than the least deprived individuals. 
Neither of these observations have been reported in the literature. These data have 
important implications for health systems around the world and policy makers.  
This may at first sight be an intuitive observation. More deprived individuals tend to have 
poorer health, a worse risk factor profile, poorer health behaviours and more co-morbid 
disease. All of these factors would suggest that they are likely to experience more 
hospitalisations for cardiovascular disease. However, they also are more likely to die 
32,49,97 
and to die at an earlier age
42,252,254. This would appear to present less of an opportunity to 
accrue costs i.e. to spend less time at risk for a hospitalisation. However, as described in  
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this chapter the most deprived are still experiencing more hospitalisations despite this 
increased mortality. Therefore, not only do the most deprived individuals live shorter lives 
but the quality of that life (as denoted by more hospitalisations) is poorer.  
Length of stay 
The length of stay for hospital admissions for a range of cardiovascular diseases has not 
been examined in relation to SED in one cohort before. The more prolonged stays in the 
most deprived may reflect a number of factors. It may reflect more severe presentations in 
the most deprived versus the least deprived, with a consequently longer recuperation time. 
For example, in a study of patients admitted to hospital with stroke, the most deprived 
were more likely to need assistance with walking as a consequence of their stroke than the 
least deprived indicating that they had experienced a more severe stroke.
115 In studies of 
myocardial infarction there is evidence that the severity of the myocardial infarct varies 
with socioeconomic deprivation.
77 In addition, the increased prevalence of co-morbid 
diseases which would slow discharge rates in the most deprived e.g. dementia 
84 may also 
explain why length of stay is higher in the most deprived.  
Another factor influencing the length of stay may also be the treatment received by 
individuals during a hospital stay. It has been described that the most deprived are less 
likely to receive certain pharmacological therapies
230 and procedures such as coronary 
angioplasty
79,231. Whilst most therapies are instituted for the benefit of secondary 
prevention it would appear that the lack of prescription of these therapies may serve as a 
marker for less aggressive treatment in hospital which in turn may be a cause of longer 
lengths of stay.  
Finally, SED is a complex construct of many factors. Not only does it capture material 
wealth, but it also may capture social support mechanisms, social isolation and 
environment.
4 These factors may also lead to increased length of stay. An individual with 
more social support and better finances may be able to leave hospital earlier than someone 
without and recover better
258. They may be more able to return home to a more amenable 
environment following the development of cardiovascular diseases such as stroke than 
someone who lives in a more deprived area and who therefore may need to be re-housed.   
  215 
Cost of cardiovascular disease 
The cost to the NHS in terms of hospitalisations was estimated in these analyses and again 
despite living shorter lives the most deprived accrued the most costs over follow up. This is 
as a result of the number of admissions they suffered and the length of time spent in 
hospital per admission. This has important financial implications for the NHS and policy 
planners. Furthermore, deprivation not only costs society from the direct costs of 
healthcare but also in societal costs (time off work, unemployment, benefit payments) and 
therefore to understand the mechanism behind the drivers of increased costs, more and 
longer admissions, is crucial. As noted in the literature review, there is little information on 
the costs of cardiovascular care by SED.
138 The findings of the present study would 
suggest that the cost of SED to the NHS is high and efforts to reduce these inequalities 
need to be made. 
Limitations 
The cause of death was determined using death certificate data. This raises concerns about 
the validity of the diagnosis of a cardiovascular death. However, studies in the UK
259, 
Finland
260 and USA
261, and elsewhere would suggest that the validity of cardiovascular 
causes of death on death certificates are suitable for epidemiological research. These 
studies confirm that in older age groups the accuracy of a coronary cause of death is lower, 
though they disagree on the age at which the accuracy starts to fall, with a UK study 
259suggesting this is between 65-74 years and a study from the USA
261 suggesting accuracy 
is lower after the age of 75 years. Other studies of stroke and certified deaths from stroke 
in the UK would suggest that the use of a death record indicating that stroke was the cause 
of death has good accuracy and predictive value for identifying a stroke.
262  
The full burden of cardiovascular disease according to socioeconomic deprivation could 
not be calculated in this study. No data were available on what drug therapy each 
individual was prescribed or the primary care or outpatient care that they received. This 
area requires further research to help define and refine the full costs to a healthcare system 
of socioeconomic deprivation.  
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Summary  
In this chapter I have demonstrated that SED is associated with a higher risk of all cause 
mortality, cardiovascular mortality and premature mortality. This association is present 
after adjustment for cardiovascular risk factors. The most deprived also used more hospital 
resources over the course of follow up. This was due to a larger number of cardiovascular 
admissions and a longer length of stay in the most deprived groups. This translated into a 
larger total cost to the NHS during the course of follow up. Finally, I report that the 
population attributable fraction of SED in a number of cardiovascular disorders was similar 
to that of classical risk factors for cardiovascular disease. 
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Discussion  
Summary of findings 
The aim of these studies was to assess the association between socioeconomic deprivation 
and the risk of a number of forms of cardiovascular disease in a large cohort of men and 
women over a prolonged period of time, and to determine whether an association persisted 
following adjustment for known cardiovascular risk factors. In this cohort, SED was 
associated with a higher risk of an incident cardiovascular hospitalisation, death following 
an incident cardiovascular hospitalisation, cardiovascular and all-cause mortality, lifetime 
hospital burden and cost of hospitalisations. There was however, no association between 
SED and the risk of recurrent cardiovascular hospitalisations following adjustment for 
recognised cardiovascular risk factors.  
The relationship between socioeconomic deprivation and 
cardiovascular disease 
In these analyses I have shown that SED is associated with the risk of a hospitalisation for 
cardiovascular disease, any coronary heart disease, myocardial infarction, stroke and heart 
failure. Whilst at first sight these findings are in keeping with the literature presented in the 
first chapter of this thesis, these analyses are important additions to the literature as no 
prior study has been able to examine this relationship in both men and women or to 
examine all these forms of cardiovascular disease in one cohort. This is a major strength of 
these studies. Previous high quality longitudinal studies such as the Whitehall studies
263 are 
limited by the inclusion of only men with a limited range of occupational experiences and 
therefore are not representative of the population. Also this study is the first to examine all 
forms of cardiovascular disease. Many studies have tried to find a mechanistic link 
between SED and cardiovascular disease.
38,226,255,257 However these analyses would 
suggest that SED mediates a higher risk for cardiovascular disease through either one 
common factor to all forms of cardiovascular disease or through multiple factors that are 
differentially important in the pathogenesis of each different form of cardiovascular 
disease. William of Occam stated “Pluralitas non est ponenda sine necessitate; Plurality 
should not be posited without necessity”. Following Occam’s razor it should be expected 
that a simpler explanation of a common pathway mediating SED and CVD risk would 
seem the most likely. However, Chatton’s anti razor also may hold true in this setting in  
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that “If three things are not enough to verify an affirmative proposition about things, a 
fourth must be added, and so on” thus it may be that SED exerts its effect via different 
pathways. Much of current literature suggests that SED may exert its effect via different 
pathways.
38,255,257  
Employing a classical biological model of disease, the differential distribution of risk 
factors in different socioeconomic groups has long been proposed as a potential 
mechanism. Multiple authors report that differential distribution of risk factors explain 
most, if not all, of the differential rates of cardiovascular disease.
100,142,226,257 However, in 
these analyses the association between SED and each cardiovascular disease was still 
present after accounting for the different distribution of cardiovascular risk factors through 
the multivariable analyses. What is clear is that risk factors do tend to cluster in the most 
deprived. Understanding why this occurs and what may be done to change these unhealthy 
patterns is needed.  
Should socioeconomic deprivation be a cardiovascular 
risk factor? 
The variation in cardiovascular disease rates varies according to the distribution of the 
traditional risk factors of smoking, hypercholesterolaemia, hypertension and diabetes. 
However, the entire variation of CVD rates is not explained by these factors.
38,71,264 
Socioeconomic factors seem to explain the remainder of this variation. This study, as well 
as others in the published literature, suggests that SED is indeed an independent risk factor 
even after adjustment for the above CVD risk factors. Kuller
265 has set out criteria to 
determine if a factor should indeed be called a risk factor. These criteria for a new risk 
factor are  
1. It should be shown experimentally that it would increase the extent of atherosclerosis or 
its complications in suitable animal models.  
This is of course very difficult, if not impossible to do in this context. 
2. Persons with CVD would have either a higher risk (if the factor is directly correlated 
with coronary disease) or lower risk of disease (if inversely correlated with the level of the 
risk factor) than carefully matched controls.   
  219 
Whilst this is not a case control study, prior case control studies have reported that SED is 
associated with a higher risk of CVD.
266 
3. Distribution of risk factors should be correlated with the incidence, prevalence, and 
mortality of atherosclerotic disease within and between populations.  
This study has shown that SED is correlated with the incidence and mortality of CVD.  
4. People exposed to the factor would have a higher risk of coronary disease in 
longitudinal studies.  
Again these analyses of a longitudinal cohort clearly demonstrate that over a long period of 
time in both men and women the risk of CVD is higher in the most deprived.  
5. There should be a time-dose relation: the higher the dose the earlier the onset of the 
disease.  
A number of studies have reported that SED in early life is associated with the 
development of CVD in adulthood, suggesting that a prolonged exposure to deprivation 
leads to a greater risk of CVD in comparison to those who increase their social status 
through life.
267-269   
6. The results of studies should be consistent from study to study, and ideally in different 
cultural settings.  
This study adds to the totality of the literature surrounding SED and CVD. It should be 
acknowledged that this cohort is limited in terms of its ethnic make up. However, other 
studies would suggest that the relationship between SED and CVD is present in different 
ethnic groups.
102,145 
7. The relation between the risk factor and the disease should be independent of other 
known risk factors unless it enhances the predictive power of these risk factors.  
Investigation of this rule is a central part of this thesis. I have demonstrated that SED is a 
risk factor independent of the traditional risk factors for CVD. This relationship has been 
demonstrated in these studies for multiple forms of CVD i.e. coronary heart disease, stroke 
and heart failure.   
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8. Evidence should be available in either humans or a suitable animal model that 
modification of the risk factor would result in the reversal of the progression of 
atherosclerosis or clinical disease.  
This rule is difficult to prove in the context of SED and CVD. Not only is changing SED 
difficult but it is very difficult to determine the causal link with any subsequent decrease in 
CVD rates.  
9. The risk factors should make sense in relation to a biological model for cardiovascular 
disease. 
Studies have reported that SED affects levels of other physiological cardiovascular risk 
factors and health behaviours which confer cardiovascular risk.  
As can be seen these studies and others allow most of the above criteria to be filled by SED 
in relation to becoming a CVD risk factor. Kuller reported that few of the major risk 
factors met all of the above criteria for a relation with coronary disease. However, SED 
would appear to meet most of the above prerequisites for a new risk factor.  
Utilising socioeconomic deprivation as a risk factor 
Developed countries require risk factor screening that acknowledges the higher risk of the 
most deprived members of its society. Only through correct identification of these 
individuals will their higher risk be appreciated and interventions designed to lower their 
risk be accurately delivered. Brindle et al
270 examined the Framingham risk score in the 
Renfrew Paisley cohort and determined how it performed in each socioeconomic group. 
Cardiovascular disease mortality was underestimated by 48% in the manual participants of 
the cohort (i.e. the most deprived) as compared to 31% in the non-manual classes, the least 
deprived. A similar finding was reported for the relationship between SED as measured by 
Carstairs Morris index and the ability of the Framingham risk score to predict events. This 
leads to the conclusion that current risk scores underestimate the risk of cardiovascular 
mortality in the most deprived individuals in society. It is not only in Scotland that this has 
been observed. In the USA, a study of the Atherosclerosis Risk in Communities study 
examined the model discrimination and calibration of the Framingham risk score with and 
without SED as measured by income and by education.
271 In the most deprived the risk of 
coronary heart disease as estimated by the Framingham risk score was 3.7% as compared 
to 3.9% in the least deprived. The observed risks were 5.6% and 3.1% respectively again  
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demonstrating that this risk score underestimates risk in the most deprived. After addition 
of SED to the risk score the predicted risk was 3.1% in the least deprived and 5.2% in the 
most deprived, more closely matching the observed rates. These findings were also 
validated in the same study in another cohort, the National Health and Nutritional 
Examination Study.  
In recognition of these findings, the UK now has two risk scores that incorporate SED into 
the risk score. The ASSessing cardiovascular risk, using SIGN (ASSIGN) risk score was 
developed in the Scottish Heart Health Extended Cohort to allow better risk predication 
amongst individuals of all socioeconomic groups.
272 In this study SED was measured using 
the Scottish Index of Multiple Deprivation (SIMD). This score incorporates multiple 
components from a number of social agencies. Small areas are assigned a score from 0.54 
(the least deprived) to 87.6 (the most deprived) and the population is then divided in to 
quintiles. ASSIGN classified more people with social deprivation and positive family 
history as high risk, anticipated more of their events, and abolished the gradient in 
cardiovascular event rates seen when risk was predicted solely using the Framingham 
score. In England and Wales a prospective cohort study in a large UK primary care 
population was used to develop a risk prediction model that included SED.
273,274 In this 
study, version 14 of the QRESEARCH database, a large, validated electronic database 
representative of primary care and containing the health records of 10 million patients over 
a 17 year period from 529 general practices was used to develop and validate the score. In 
this risk score, SED was defined on the basis of the area based score, the Townsend score. 
An analysis of a risk score in acute coronary syndromes has also been tested with regards 
to its calibration according to SED and has been found to be useful in all groups 
irrespective of SED.
275 Therefore, increasing awareness of this issue will hopefully lead to 
SED being taken into account in the development of future risk scores.  
Limitations of the studies 
The current studies are not without their limitations. A strength of this study is that two 
measures of SED were examined, social class and Carstairs Morris index. However, social 
class could not be assigned to every individual in the cohort and women were assigned the 
social class of their husband if they did not have an occupation. Using an area based 
measure of SED can lead to the “ecological fallacy”, i.e. that the relationship between SED 
and CVD is the same at an individual level and the area level measure in the Carstairs 
Morris index. The assumption that individual members of the area are correctly defined by  
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the average characteristics of the small area assigned may in fact be false. However, the 
Carstairs Morris index is based on small enough areas that the ecological fallacy is less of a 
concern and the index has been well validated.
10,11  
There are limitations to the historical nature of this cohort. Whilst a mature cohort study is 
necessary to examine associations over a prolonged period, the long follow up does give 
rise to some problems. The cohort was examined at baseline only; follow up clinical 
measures were not available. The effect of changing risk factor profiles could not be 
assessed in these data therefore. Risk factors such as blood pressure and cholesterol change 
over time, often increasing with advancing age. However subjects in this cohort may have 
undergone lifestyle, behavioural and/or pharmacotherapeutic interventions aimed at 
modifying CVD risk factors over the course of follow up. There is evidence that the 
traditional cardiovascular risk factors have changed differentially by SED over time with 
those in the most deprived groups developing more unfavourable risk factor profiles.
146 For 
example, a large proportion of participants were smokers at baseline. With only one 
assessment of smoking status, taken at baseline, I could not assess how many people quit 
during follow up. Nor could I assess the potential impact of a CVD hospitalisation on 
smoking. Studies would suggest that the impact of a CVD hospitalisation on risk factors, 
such as smoking through cessation rates, differs by SED, with the least deprived being 
more likely to quit.
229 Other factors may be similarly affected differentially by SED such 
as cholesterol levels through differing rates of prescription of cholesterol lowering 
therapies.
165 These are limitations of the studies. Similarly, no information was collected 
during follow up regarding the use of evidence based therapies that might alter 
cardiovascular risk.  Finally, whilst the long period of follow up is a major strength of 
these studies it is also a potential limitation. Regression dilution occurred as follow up 
progressed.
225 Past the period of 25 years of follow up the hazard ratios associated with 
SED started to fall. This is not due to the lack of an effect but rather regression dilution. 
However, the impact of regression dilution affects all variables but it is unclear how it 
affects SED specifically. 
SED was also measured at only one time point in this study. The Carstairs Morris index 
applied was derived from the 1981 census. Therefore, the index may not have accurately 
captured the socioeconomic conditions of the cohort at recruitment. In addition by middle 
age, SED status is fairly well fixed it is not impossible that some movement in SED status 
occurred during follow up.
276 A number of other possible mediators between SED and the 
risk of CVD have been described in the literature such as behaviour, stress, job control
255, 
physiological variables such as heart rate recovery
195 etc. These variables were not  
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recorded or measured in this cohort and the effect of these on the associations between 
SED and CVD seen in this cohort cannot be estimated. As noted above, the continued 
effect or “dose” of SED may have a role to play in the development of CVD over a 
lifetime. SED was measured at the point of midlife, between the ages of 45-64 in this 
cohort. It is unknown what the cumulative life course “dose” of SED was in this cohort as 
childhood SED status is unknown in this cohort. Therefore, a life course approach to SED 
could not be made in this particular cohort. Finally, a family history of premature 
cardiovascular disease is recognised as a major risk factor alongside, diabetes, 
hypertension, smoking and serum cholesterol. This was not recorded in the cohort. 
However, the Framingham risk score also did not include family history of CVD as a 
variable and therefore the results of these studies are still valid.  
Finally, it must be acknowledged that this cohort was restricted to the ages of 45-64 years 
at enrolment. Whilst the relationship between SED and CVD is certainly present in 
younger age groups
41 (and studies would suggest that the relationship is stronger
65), 
caution should be used in extrapolation of the results of this thesis to other age groups. 
How do we change the risk of the most deprived? 
Efforts at the level of the individual 
The above studies and results would suggest that SED is an important risk factor for 
cardiovascular disease, over and above the traditional risk factors. However, the exact 
mechanism by which this excess risk if conferred is open to speculation. What is becoming 
clearer from the literature is that SED exerts its effect through many pathways. Therefore, 
any intervention to change the risk of the most deprived needs to acknowledge this and try 
to change multiple possible pathways. Immediately it seems as if these interventions are 
out of the reach of individual health care professional. Altering SED seemingly relies on 
policy and government action to alter the disparities in society. Government level action is 
needed for example to change housing standards for the most deprived members of a 
society or help lower unemployment. The minimum wage is another area where policy 
change can have beneficial effects on inequities in a society or similarly banning unhealthy 
behaviour such as smoking will impact upon all parts of society. Other initiatives such as 
the introduction of health targets or reallocation of health care resources to more deprived 
areas are other examples of how policy may help to reduce the differences in CVD 
according to SED. Other factors are harder for the state to intervene in such as the  
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possibility that social support mediates part of the relationship between SED and CVD. 
However, through the improvement of communities and facilities this may lead to 
improvements in social structures and hence support mechanisms. However, more complex 
interventions will be needed to tackle the inequalities not only in cardiovascular health but 
health in general. I will return to these later.  
These are difficult and daunting tasks for the clinician or health care professional. 
However, multiple areas exist where an individual health care professional can make a 
difference to the risk of CVD associated with SED. The first issue is of identification of 
risk. The ASSIGN
272 and QRISK
273,274 scores attempt to do this by including SED in their 
CVD risk scores. This will ensure that high risk individuals are appropriately identified in 
primary care and evidence based therapies that are known to lower risk of CVD are 
appropriately prescribed. This in turn will help to reduce the inverse care law 
24, where the 
most deprived in most need of health care are less likely to receive it.  
Change is also required early on in an individual’s life course to alter the risk of future 
disease, and as a health care professional engaging with young adults about poor life style 
choices around risk factors such as smoking is possible and beneficial. Indeed risk factor 
management may have one of the largest roles to play in reducing the differences in CVD 
rates in the deprived members of society.
257 The INTERHEART studies indicated that the 
large proportion of attributable risk for myocardial infarction was explained by nine risk 
factors, smoking, diabetes, hypertension, abdominal obesity, exercise, alcohol, 
apoB/apoA1 lipoprotein ratio, and a psychosocial index that measured the presence of 
depression and stress at work and at home.
67 These factors accounted for 90.5% of the 
attributable risk of myocardial infarction in the 12461 cases of myocardial infarction in the 
study. In a recent analysis of the INTERHEART study, the addition of education as a 
marker of SED increased this attributable risk to only 92.7%.
68 This would suggest that 
most, if not all, inequalities in myocardial infarction rates could be eliminated if the nine 
modifiable risk factors could be improved. This does not mean that SED is not a risk factor 
or important risk factor for CVD but that the absolute inequalities may be explained by 
these risk factors, which explain the majority of cases in a population, even though they do 
not explain all of the association between SED and CVD. Thus, in absolute terms, 
treatment of known risk factors in a population such as smoking and high cholesterol will 
reduce SED differences in CVD rates. To further illustrate this point, take the following 
hypothetical example. If a population existed where all individuals smoked, were diabetic 
and had hypertension the relative differences in SED and CVD would be explained by the 
other factors such as cholesterol. However, whilst an intervention to reduce serum  
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cholesterol would reduce the relative inequalities in CVD it would not reduce the absolute 
burden of CVD which was driven by the ubiquity of the other major risk factors in this 
theoretical population. Therefore, health care professionals have the opportunity to reduce 
relative and absolute burdens of CVD in the population by adequately addressing the risk 
factor profile of patients at risk of CVD. A study of this theory was conducted in the 
Whitehall cohort.
257 The authors reported that reducing the burden of classical 
cardiovascular risk factors, blood pressure, cholesterol, diabetes and smoking would 
reduce by 69%, if current best available practice or pharmacotherapies were applied. If risk 
factors could be removed the reduction would be 86%. Therefore, despite this some 
inequality in coronary heart disease mortality would remain. The underlying reasons for 
such persisting difference are of course the subject of much current research in this area as 
the classical cardiovascular risk factors do not explain the entire gradient.  
As noted the INTERHEART studies highlighted the important contribution of 
psychosocial factors to the risk of myocardial infarction. However, psychosocial factors 
may also explain part of the relationship between SED and CVD. Depression can be 
screened for using simple tools.
277,278 Through the identification of such patients 
appropriate pharmacological therapy or non-pharmacological therapy such as cognitive 
behavioural therapy could be prescribed in an effort to reduce such psychosocial risks. The 
reduction of other psychosocial stressors such as financial or housing worries is more 
difficult and lends itself to a political approach to altering SED differentials in CVD risk.  
Finally, the use of multidisciplinary teams by health care professionals may also lead to 
improvements in health outcomes in all members of society. It is difficult for one health 
care professional to address all the determinants of health. The use of multidisciplinary 
teams maximises the chances of therapies being prescribed in appropriate doses, and, 
maximises the support an individual may receive in making hard lifestyle choices and 
alterations such as smoking cessation. Specialist knowledge on the complex societal and 
contextual effects of the causes of smoking
153, such as that held by smoking cessation staff 
may help to improve the chances of an individual ceasing to smoke.  
Whilst most of these interventions are not targeting SED per se they do target the known 
modifiable risk factors for CVD that most health care professionals are comfortable 
dealing with. These interventions do however focus the health care professional to try and 
supply these treatments and services to the most deprived, and indeed all members of 
society, and try to ensure equitable access in an attempt to reduce social inequities and the 
burden of CVD overall in society.   
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Political efforts to reduce health inequalities  
Whilst the individual health care professional can make some efforts to improve the health 
of individuals and therefore society as a whole, it is perhaps clear that given 
socioeconomic differences in health and CVD are the function of complex causes, that 
society level intervention will be required to help reduce these inequalities. From this 
study, and others, it has been shown that SED not only acts at the level of the individual 
but also at the level of small areas of residence.  
Since devolution, a number of policy documents have focused on the issue of health 
inequalities in Scotland. The first, the 1999 White Paper, Towards A Healthier Scotland
21, 
recognised that health improvement initiatives should include not only lifestyle choices 
and the major diseases but also include life circumstances i.e. housing, employment, 
education, welfare benefits, childcare and community care. All actions were designed to 
reduce health inequalities. Policies outlined in this document were associated with funding 
commitments and aimed to redress inequalities through a number of schemes. For 
example, interventions were aimed at families and young children to improve social 
support through after school care and education, childcare tax credits. Other interventions 
were aimed at housing such as improving the insulation in homes of low income families; 
the Warm Deal Initiative. Towards a Healthier Scotland was followed by subsequent 
policy documents. The 2003 White Paper, Partnership for Care
279, Improving Health in 
Scotland: The Challenge
22, 2003, and the 2005 Delivering for Health report
280, all of which 
highlighted the need to reduce inequalities in health. 
In 2007, the Scottish Government set up a Ministerial Task Force on Health Inequalities. 
The report of the Task Force, Equally Well
281, was published in 2008 and outlined a 
number of recommendations for dealing with the underlying causes of health inequalities. 
These recommendations fell under a number of headings: early years & young people; 
tackling poverty and increasing employment; physical environments and transport; harms 
to health and well being, alcohol, drugs and violence; health and wellbeing.  
Equally Well was followed in 2008 by the Equally Well Implementation Plan
282 which 
sought to outline how the aims of the Equally Well report could be achieved via policy. A 
further publication listed the indicators to be used in assessing progress in tackling 
inequalities - Long-term monitoring of health inequalities: first report on headline 
indicators
283. Finally, it was originally aimed that the Ministerial Task Force on Health 
Inequalities would be reconvened to review progress since the publication of Equally Well  
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in 2008. The Task Force is expected to report by the summer of 2010. The review will 
specifically consider whether any further actions are required to tackle the inequalities 
outlined in the three social policy frameworks - Equally Well, the Early Years Framework 
and Achieving Our Potential. This will consider the prevailing financial climate, new 
trends or concepts or evidence in health inequalities.  
The reduction of health inequalities plays a pivotal role in the Scottish Government’s 
overall purpose of sustainable economic growth. The Government has committed to 
increase healthy life expectancy and the proportion of income earned by the three lowest 
income deciles as a group by 2017. Inequality-related indicators also make up some of the 
forty-five national indicators being used to track progress towards the achievement of 
national outcomes.
284 Examples include, decreasing the proportion of individuals living in 
poverty, increasing healthy life expectancy at birth in the most deprived areas, and 
reducing mortality from coronary heart disease among the under 75s in deprived areas.  
In parallel to these social model approaches to tackling inequalities, the health services in 
Scotland are being redeveloped according to proposals in a report on health care 
delivery.
285 This shifted the focus of care onto preventative measures, in an attempt to 
prevent these inequalities in health from occurring. This has not been the only change in 
preventative healthcare in Scotland. NHS Health Scotland has as one of its aims to reduce 
health inequalities. In Glasgow the establishment of the Glasgow Centre for Population 
Health was intended to develop a better understanding of health in Glasgow and to 
evaluate the impact of strategies with the aim of enhancing health and in particular 
reducing inequalities.  
Future areas of research 
This study consolidates the current level of evidence that SED is indeed related to the risk 
of cardiovascular disease, but furthers it by confirming the relationship in a number of 
cardiovascular outcomes, over a prolonged period, independent of cardiovascular risk 
factors. Just as these analyses examined a gap in the current evidence, other gaps still 
remain and should be the focus of further research.  
As was noted above, the traditional cardiovascular risk factors only explain part of the 
association between SED and CVD. It is important to now try and elucidate the mechanism 
by which SED confers this extra risk. Authors have examined such issues as pathogen 
burden
180, access to healthcare
286, and the influence of peri-natal life
162 to name but a few  
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examples. However, no one unifying hypothesis has yet been found. As noted above, no 
one explanation may be found, though further research may elucidate the many pathways 
by which SED ultimately leads to a higher cardiovascular risk.  
In recent years the rate of research in the field of genetic epidemiology has increased 
considerably. Some authors have examined focussed genetic differences in an attempt to 
explain differences in disease rates by SED.
163 However, overall this field of research is 
underutilised in the realm of SED and health, although this approach will need careful 
consideration of the ethical issues.
287  
Finally, one further major gap in our knowledge surrounding SED and CVD requires 
further investigation. In this thesis I was not able to examine the relationship between SED 
and other forms for cardiovascular disease such as atrial fibrillation and venous 
thromboembolism. These other cardiovascular disease have also been understudied with 
respect to SED differences in incidence, survival, treatment etc.
288,289 Further research on 
these and less studied cardiovascular diseases is required.  
Conclusions 
The conclusions and outcomes of the analyses presented in this thesis can be summarised 
as follows: 
Socioeconomic deprivation is associated with higher rates of hospitalisation for 
cardiovascular disease in men and women irrespective of the measure of SED, either social 
class or the area based score of the Carstairs Morris index.  
The association between SED and hospitalisations persists after adjustment for the 
traditional cardiovascular risk factors of age, sex, smoking, systolic blood pressure and 
diabetes. 
The further adjustment for lung function as measured by FEV1, obesity as measured by 
BMI and cardiomegaly on a chest x-ray failed to explain or diminish this relationship. 
The association between SED and CVD is similar in coronary heart disease, myocardial 
infarction and stroke and all cause mortality.  
The effect of SED is long lasting and persists beyond 25 years of follow up.  
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SED is associated with higher mortality following an admission to hospital with 
cardiovascular disease again after adjustment for cardiovascular risk factors of age, sex, 
smoking, systolic blood pressure and diabetes and adjusting for the year of first developing 
cardiovascular disease.  
SED is not associated with the risk of a recurrent cardiovascular hospitalisation.  
The risk of all cause death is highest in the most deprived. Again this association persists 
after adjustment for cardiovascular risk factors.  
The most deprived stay longer in hospital than the least deprived for a number of 
cardiovascular disease types including myocardial infarction and stroke.  
The costs associated with cardiovascular disease admissions to hospital are higher in the 
most deprived despite their higher risk of dying during follow up. This is mediated by a 
higher number of admissions per person and longer in hospital stays in the most deprived.  
The population attributable risk associated with SED is comparable to that of other 
traditional cardiovascular risk factors.  
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Appendix 1 
Search strategy employed in the search of the literature.  
 
1. exp Occupations/ 
2. exp Income/ 
3. exp Employment/ 
4. exp Population characteristics/ 
5. exp Education/ 
6. exp Health Behavior/ 
7. exp Poverty/ 
8. exp Poverty Areas/ 
9. exp Socioeconomic Factors/ 
10. exp Social Class/ 
11. exp Social Conditions/ 
12. exp Unemployment/ 
13. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12  
14. (poverty or deprivation or deprived or ghettos or slums or disadvantaged or 
unemployed or unemployment).ti,ab. 
15. (socio?economic$ or socio?demographic or inequality or inequalities or (inner adj 
(city or cities)) or ((low or high) adj1 (income or wage or salary or salaries))).ti,ab. 
16. ((standard$1 adj2 living) or (blue adj collar) or (white adj collar) or ((working or 
middle) adj2 class$)).mp. [mp=title, original title, abstract, name of substance, mesh 
subject heading] 
17. (socio?economic$ or poverty or depriv$).ti. 
18. (poverty or deprivation or deprived or ghettos or slums or disadvantaged or 
unemployed or unemployment or (socio?economic$ or socio?demographic or 
inequality or inequalities or (inner adj (city or cities)) or ((low or high) adj1 (income or 
wage or salary or salaries))) or ((standard$1 adj2 living) or (blue adj collar) or (white 
adj collar) or ((working or middle) adj2 class$) or (social adj inclusion adj 
partnership))).ti. 
19. 14 or 15 or 16 or 17 or 18 
20. exp Heart Diseases/ 
21. *Cardiovascular Diseases/ 
22. exp Cardiovascular Diseases/ 
23. (cardiovascular or heart or coronary or cardiac or myocardial or stroke or 
cerebrovascular).ti. 
24. 20 or 21 or 22 or 23 
25. 13 and 24 
26. 19 and 24 
27. 25 or 26  
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Appendix 2 
This appendix gives some examples of the results of the full multivariable models from the 
analyses of cardiovascular hospitalisations. Only the results concerning the analysis of a 
first cardiovascular outcome are provided to demonstrate the validity of the other variables 
in the models The full results of the unadjusted model, the model adjusted for age, sex, 
diabetes, smoking, cholesterol and blood pressure as well as the models including 
bronchitis, body mass index, cardiomegaly on chest x-ray and adjusted FEV1 are included.  
Table 97 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  1.10  0.08  1.31  0.191  0.95  1.27 
Deprivation Category 4  1.15  0.08  2.01  0.044  1.00  1.31 
Deprivation Category 5  1.22  0.08  3.1  0.002  1.08  1.39 
Deprivation Category 6 & 7  1.42  0.10  5.13  <0.001  1.24  1.62 
 
Table 98 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  1.10  0.08  1.33  0.183  0.95  1.27 
Deprivation Category 4  1.16  0.08  2.15  0.032  1.01  1.33 
Deprivation Category 5  1.19  0.08  2.62  0.009  1.04  1.35 
Deprivation Category 6 & 7  1.39  0.09  4.79  <0.001  1.21  1.58 
Age (per year)  1.04  0.00  12.94  <0.001  1.03  1.04 
Sex (male vs. female)  1.49  0.05  12.25  <0.001  1.39  1.58 
Diabetes  2.19  0.24  7.17  <0.001  1.77  2.71 
Smoker  1.44  0.05  10.5  <0.001  1.34  1.54 
Cholesterol (per mmol/l)  1.07  0.02  4.58  <0.001  1.04  1.10 
Systolic blood pressure (per mmHg)  1.01  0.00  14.44  <0.001  1.01  1.01 
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Table 99 Full model for all CVD hospitalisations at 25 years with Carstairs Morris index 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
bronchitis, body mass index and adjusted FEV1.  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  1.09  0.08  1.2  0.229  0.95  1.27 
Deprivation Category 4  1.12  0.08  1.61  0.107  0.98  1.28 
Deprivation Category 5  1.14  0.08  2  0.046  1.00  1.30 
Deprivation Category 6 & 7  1.30  0.09  3.81  <0.001  1.14  1.49 
Age (per year)  1.04  0.00  12.27  <0.001  1.03  1.04 
Sex (male vs. female)  1.51  0.05  12.29  <0.001  1.41  1.61 
Diabetes  2.20  0.25  7  <0.001  1.77  2.75 
Smoker  1.44  0.05  10.09  <0.001  1.34  1.54 
Cholesterol (per mmol/l)  1.07  0.02  4.75  <0.001  1.04  1.10 
Systolic blood pressure 
(per mmHg)  1.01  0.00  11.97  <0.001  1.01  1.01 
Bronchitis  1.35  0.12  3.44  0.001  1.14  1.61 
Body mass index (per 
kg/m
2)  1.01  0.00  2.84  0.005  1.00  1.02 
Cardiomegaly  1.20  0.05  4.89  <0.001  1.12  1.29 
Adjusted FEV1 (per %)   1.00  0.00  -5.2  <0.001  0.99  1.00 
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Table 100 Full model for all CVD hospitalisations at 25 years with social class 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
 Social Class I                
Social Class II  1.22  0.11  2.17  0.03  1.02  1.46 
Social Class III-NM  1.19  0.11  1.88  0.06  0.99  1.42 
Social Class III-M  1.47  0.138  4.35  <0.001  1.23  1.74 
Social Class IV  1.29  0.11  2.88  0.004  1.09  1.54 
Social Class V  1.40  0.14  3.46  0.001  1.16  1.70 
 
 
Table 101 Full model for all CVD hospitalisations at 25 years with social class adjusted for 
age, sex, diabetes, smoking, cholesterol and systolic blood pressure 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
 Social Class I                
Social Class II  1.29  0.12  2.73  0.006  1.07  1.54 
Social Class 
III-NM  1.31  0.12  2.99  0.003  1.10  1.57 
Social Class 
III-M  1.37  0.12  3.55  <0.001  1.15  1.63 
Social Class 
IV  1.33  0.11  3.2  0.001  1.12  1.59 
Social Class V  1.44  0.14  3.69  <0.001  1.19  1.75 
Age (per year)  1.04  0.002  12.84  <0.001  1.03  1.04 
Sex (male vs. 
female)  1.48  0.05  11.56  <0.001  1.39  1.58 
Diabetes  2.17  0.24  6.93  <0.001  1.74  2.70 
Smoker  1.45  0.05  10.71  <0.001  1.36  1.56 
Cholesterol 
(per mmol/l)  1.07  0.01  4.86  <0.001  1.04  1.10 
Systolic blood 
pressure (per 
mmHg)  1.01  0.0006  13.96  <0.001  1.01  1.01 
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Table 102 Full model for all CVD hospitalisations at 25 years with social class adjusted for 
age, sex, diabetes, smoking, cholesterol and systolic blood pressure, bronchitis, body mass 
index and adjusted FEV1.  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
 Social Class I                
Social Class II  1.27  0.120866  2.53  0.011  1.06  1.53 
Social Class III-NM  1.31  0.122884  2.86  0.004  1.09  1.57 
Social Class III-M  1.32  0.11995  3.02  0.002  1.10  1.57 
Social Class IV  1.28  0.117988  2.63  0.009  1.06  1.53 
Social Class V  1.36  0.138722  2.97  0.003  1.11  1.66 
Age (per year)  1.04  0.003054  12.15  <0.001  1.03  1.04 
Sex (male vs. female)  1.51  0.053251  11.71  <0.001  1.41  1.62 
Diabetes  2.18  0.252124  6.75  <0.001  1.74  2.74 
Smoker  1.45  0.052863  10.18  <0.001  1.35  1.56 
Cholesterol (per mmol/l)  1.08  0.016114  5  <0.001  1.05  1.11 
Systolic blood pressure (per 
mmHg)  1.01  0.000679  11.64  <0.001  1.01  1.01 
Bronchitis  1.36  0.120321  3.5  <0.001  1.15  1.62 
Body mass index (per kg/m
2)  1.01  0.004327  2.79  0.005  1.00  1.02 
Cardiomegaly  1.21  0.045828  4.95  <0.001  1.12  1.30 
Adjusted FEV1 (per %)   1.00  0.00073  -5.19  <0.001  0.99  1.00 
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Appendix 3 
This appendix gives some examples of the results of the full multivariable models from the 
analyses that examined the risk of a recurrent cardiovascular hospitalisation according to 
SED. Only the results concerning the analysis of a recurrent cardiovascular hospitalisations 
are provided to demonstrate the validity of the other variables in the models The full 
results of the unadjusted model, the model adjusted for age, sex, diabetes, smoking, 
cholesterol and blood pressure as well as the models including bronchitis, body mass 
index, cardiomegaly on chest x-ray and adjusted FEV1 are included.  
Table 103 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  1.01  0.10  0.13  0.894  0.84  1.23 
Deprivation Category 4  1.07  0.10  0.72  0.471  0.89  1.28 
Deprivation Category 5  1.05  0.09  0.6  0.548  0.89  1.25 
Deprivation Category 6 
& 7  1.02  0.09  0.26  0.797  0.85  1.23 
 
 
Table 104 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
year of first CVD event 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  0.99  0.10  -0.08  0.935  0.82  1.20 
Deprivation Category 4  1.05  0.10  0.51  0.608  0.87  1.26 
Deprivation Category 5  1.02  0.09  0.19  0.848  0.85  1.21 
Deprivation Category 6 & 7  0.99  0.09  -0.15  0.885  0.82  1.18 
Age (per year)  0.98  0.00  -4.68  <0.001  0.98  0.99 
Sex (male vs. female)  1.11  0.05  2.35  0.019  1.02  1.21 
Diabetes  1.13  0.17  0.76  0.445  0.83  1.52 
Smoker  1.08  0.05  1.64  0.101  0.99  1.18 
Cholesterol (per mmol/l)  1.09  0.02  4.5  <0.001  1.05  1.13 
Systolic blood pressure 
(per mmHg)  1.00  0.00  2.89  0.004  1.00  1.00 
Year of first CVD event  1.00  0.00  -0.11  0.915  0.99  1.01 
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Table 105 Full model for all recurrent CVD hospitalisations at 25 years with Carstairs Morris 
index adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, 
year of first CVD event, bronchitis, body mass index and adjusted FEV1.  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Deprivation Category 1                
Deprivation Category 3  1.00  0.10  -0.03  0.973  0.82  1.21 
Deprivation Category 4  1.04  0.10  0.39  0.7  0.86  1.25 
Deprivation Category 5  0.99  0.09  -0.13  0.896  0.83  1.18 
Deprivation Category 6 & 
7  0.96  0.09  -0.41  0.684  0.80  1.16 
Age (per year)  0.98  0.00  -4.76  <0.001  0.97  0.99 
Sex (male vs. female)  1.17  0.07  2.8  0.005  1.05  1.31 
Diabetes  1.07  0.17  0.39  0.694  0.78  1.46 
Smoker  1.10  0.05  1.93  0.054  1.00  1.21 
Cholesterol (per mmol/l)  1.09  0.02  4.56  <0.001  1.05  1.14 
Systolic blood pressure 
(per mmHg)  1.00  0.00  2.06  0.04  1.00  1.00 
Year of first CVD event  1.00  0.00  0.5  0.616  0.99  1.01 
Bronchitis  1.04  0.13  0.31  0.756  0.81  1.33 
Body mass index (per 
kg/m
2)  1.00  0.01  0.53  0.598  0.99  1.01 
Cardiomegaly  1.18  0.06  3.38  0.001  1.07  1.31 
Adjusted FEV1 (per %)   1.00  0.00  -0.71  0.48  1.00  1.00 
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Table 106 Model for all recurrent CVD hospitalisations at 25 years with social class  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Social Class I                
Social Class II  0.94  0.11  -0.56  0.578  0.74  1.18 
Social Class III-
NM  0.90  0.11  -0.88  0.38  0.72  1.13 
Social Class III-M  0.91  0.10  -0.82  0.41  0.73  1.14 
Social Class IV  0.93  0.11  -0.65  0.518  0.74  1.16 
Social Class V  0.99  0.13  -0.05  0.957  0.77  1.27 
 
Table 107 Full model for all recurrent CVD hospitalisations at 25 years with social class 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, year of 
first CVD event 
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Social Class I                
Social Class II  0.95  0.11  -0.41  0.681  0.75  1.20 
Social Class III-NM  0.93  0.11  -0.59  0.552  0.74  1.18 
Social Class III-M  0.90  0.10  -0.91  0.361  0.72  1.13 
Social Class IV  0.94  0.11  -0.49  0.624  0.75  1.19 
Social Class V  1.02  0.13  0.15  0.884  0.79  1.31 
Age (per year)  0.98  0.00  -4.81  <0.001  0.97  0.99 
Sex (male vs. female)  1.12  0.05  2.45  0.014  1.02  1.22 
Diabetes  1.15  0.18  0.92  0.358  0.85  1.57 
Smoker  1.09  0.05  1.74  0.083  0.99  1.19 
Cholesterol (per 
mmol/l)  1.09  0.02  4.3  <0.001  1.05  1.13 
Systolic blood 
pressure (per mmHg)  1.00  0.00  2.77  0.006  1.00  1.00 
Year of first CVD 
event  1.00  0.00  0.01  0.99  0.99  1.01 
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Table 108 Full model for all recurrent CVD hospitalisations at 25 years with social class 
adjusted for age, sex, diabetes, smoking, cholesterol and systolic blood pressure, year of 
first CVD event, bronchitis, body mass index and adjusted FEV1..  
Variable 
Hazard 
Ratio  SE  z  P 
95% 
Confidence 
Interval    
Social Class I                
Social Class II  0.94  0.12  -0.52  0.605  0.74  1.19 
Social Class III-NM  0.94  0.11  -0.55  0.579  0.74  1.19 
Social Class III-M  0.90  0.11  -0.86  0.391  0.72  1.14 
Social Class IV  0.94  0.11  -0.51  0.61  0.74  1.19 
Social Class V  1.00  0.13  0.01  0.989  0.77  1.30 
Age (per year)  0.98  0.00  -4.87  <0.001  0.97  0.99 
Sex (male vs. 
female)  1.18  0.07  2.89  0.004  1.06  1.33 
Diabetes  1.09  0.18  0.55  0.583  0.79  1.50 
Smoker  1.10  0.05  1.99  0.047  1.00  1.22 
Cholesterol (per 
mmol/l)  1.09  0.02  4.37  <0.001  1.05  1.14 
Systolic blood 
pressure (per mmHg)  1.00  0.00  1.87  0.062  1.00  1.00 
Year of first CVD 
event  1.00  0.00  0.61  0.539  0.99  1.01 
Bronchitis  1.01  0.13  0.11  0.91  0.79  1.30 
Body mass index 
(per kg/m
2)  1.00  0.01  0.59  0.556  0.99  1.01 
Cardiomegaly  1.18  0.06  3.2  0.001  1.06  1.30 
Adjusted FEV1 (per 
%)   1.00  0.00  -0.75  0.454  1.00  1.00 
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